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Paramecium bursaria chlorella virus (PBCV-1), a member of the family
Phycodnaviridae, is a large dsDNA, plaque-forming virus that infects the unicellular
green alga Chlorella NC64A. The 331 kb PBCV-1 genome is predicted to encode 365
proteins and 11 tRNAs. To follow global transcription during PBCV-1 replication, a
microarray containing 50-mer probes to the PBCV-1 365 protein-encoding genes (CDS)
was constructed. Competitive hybridization experiments were conducted employing
cDNAs from poly A-containing RNAs obtained from cells at seven time points after
virus infection. The results led to the following conclusions: i) the PBCV-1 replication
cycle is temporally programmed and regulated; ii) 360 (99%) of the arrayed PBCV-1
CDSs were expressed at some time in the virus life cycle in the laboratory; iii) 227 (62%)
of the CDSs were expressed before virus DNA synthesis begins; iv) these 227 CDSs were
grouped into two classes: 127 transcripts disappeared prior to initiation of virus DNA
synthesis (considered early) and 100 transcripts were still detected after virus DNA
synthesis begins (considered early/late); v) 133 (36%) of the CDSs were expressed after
virus DNA synthesis begins (considered late); vi) expression of most late CDSs is

inhibited by adding the DNA replication inhibitor, aphidicolin, prior to virus infection.
This study provides the first comprehensive evaluation of virus gene expression during
the PBCV-1 lifecycle.
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CHAPTER I
INTRODUCTION AND BACKGROUND

1. OVERVIEW
The traditional concept that viruses are strictly submicroscopic entities with
minimal genomes has changed. To date, many large DNA viruses infecting a wide range
of hosts have been characterized: they are ubiquitous in nature, exhibit extraordinary
diversity in genome structure and composition, and in some instances, their genomes
overlap those of the smallest bacteria (e.g., ~1.2-Mb amoeba virus vs. ~0.5-Mb
Mycoplasma genitalium) [1, 2]. Among these viruses, the Phycodnaviridae family
encompasses a morphologically similar but genetically diverse group of icosahedral
double-stranded DNA (dsDNA) viruses that infect eukaryotic algal hosts from marine
and freshwater environments [3]. Members of this group, as implied by the family name,
are strictly DNA viruses that infect certain types of algae [4]. The phycodnaviruses are
now recognized as key elements in the ecology of aqueous environments, playing a
significant role in the dynamics of algal blooms, nutrient cycling, algal community
structure, and possibly gene transfer between organisms [3, 5, 6, 7, 8, 9].
Current estimates indicate that there are approximately 100,000 to several million
species of algae; however only ~40,000 have been identified [10]. In addition, at any one
time, as many of 20% of the photosynthetic microorganisms in the ocean (including
prokaryotes) are infected with a virus [11]. From this perspective, if one considers that
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only 150 phycodnaviruses have been partially characterized and approximately 100
others have been mentioned in the literature, it indicates there is a vast array of algal
viruses yet to be discovered [10]. At present, the phycodnaviruses are divided into six
genera based on their host range: Chlorovirus, which includes the type-species
Paramecium bursaria chlorella virus-1 (PBCV-1), Coccolithovirus, Phaeovirus,
Prasinovirus, Prymnesiovirus, and Raphidovirus [3, 4]. These divisions are supported by
phylogenetical analysis using the DNA polymerase gene and fragments and whole gene
sequences of the major capsid protein as markers (Fig. 1) [12]. The Chloroviruses are the
only viruses that infect freshwater algae, while other members of the family are found in
marine environments. The genomes of ten phycodnaviruses, represented by four genera
(Chlorovirus, Coccolithovirus, Phaeovirus, and Prasinovirus) have been sequenced and
their genomes range in size from 154 kb to 406 kb [10, 13, 14, 15]. However, this range
is even larger since a virus infecting the microalga Pyramimonas orientalis with a
genome of ~ 560 kb has been described [16]. Genome comparison between Chlorovirus,
Coccolithovirus and Phaeovirus members revealed that from a pool of approximately
1000 genes, only 14 are shared among them. This suggests extraordinary viral diversity
within the group and also indicates that group divergence was not a recent event [10].
The phycodnaviruses are closely related to other large DNA viruses that infect a
wide range of eukaryotic hosts including protists (mimivirus) and metazoans (poxviruses,
African swine fever virus, and iridoviruses). Collectively, these viruses are referred to as
Nucleo Cytoplasmic Large DNA Viruses (NCLDVs) with respect to their large size and
replication site. The genome size of members of this group ranges from 100 kb to 1.2
Mb. They have nine common genes (core genes) involved in metabolic processes and
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Figure 1. Phylogenetic tree based on alignment of DNA PolB protein sequences from
the Phycodnaviridae family and mimivirus. Only the conserved region of the protein
was used. The tree was rooted using homologous sequences from two iridoviruses FV-3
and LCDV-1. Group A, clade of virus sequences with unknown hosts; group B, clade
containing viruses infecting Pyramimonas orientalis; group C, different clusters of
sequences from the metagenome survey Previous identified operational taxonomic unit
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(OTUs) are indicated by name and GenBank accession number, while sequences
obtained from the Sargasso Sea metagenome are indicated by accession number alone.
Sequences reported in this study are marked in bold. Nodes with >75% bootstrap values
are marked by black dots, while actual bootstrap values are shown for nodes with values
between 50 and 75%. Currently assigned genus names are shown to the right of the tree.
The scale bar indicates the number of amino acid substitutions per residue. Adapted from
[12].

virus structure and they are thought to be monophyletic [17]. In addition, NCLDVs carry
a diverse assemblage of not only prokaryotic and eukaryotic, but also archaeal, gene
homologs. This high degree of genome diversity suggests that NCLDVs have an ancient
origin, possibly predating the divergence of the three kingdoms of life [18]. Interestingly,
sequence analysis, where available, indicates that NCLDV genomes are only distantly
related to their host genome, contradicting the concept that frequent horizontal gene
exchange occurs between virus and host.
Starting with a short description of the algal host and the discovery of algal
viruses, this chapter will then focus on the virus Paramecium bursaria chlorella virus 1
(PBCV-1), the subject of this research. PBCV-1 general characteristics, the proteinencoding genes (CDSs), and advances in the understanding of the infection cycle are
reviewed. A comparison of PBCV-1 with other sequenced chloroviruses and a brief
overview of other algal host systems will conclude the first chapter.
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2. THE ALGAL HOST CHLORELLA NC64A
Algae are one of the most important primary producers on Earth with a dominant
impact on global productivity and biogeochemical cycling [19]. They are common in
nature and can be found mostly in aquatic environments but also in terrestrials’ habitats.
Algae constitute a diverse group of photosynthetic organisms, ranging from the most
simple cell structure to large spreading seaweeds belonging to different phylogenetic
groups and many taxonomic divisions. Algae constitute part of the phytoplankton
responsible for the release of large amounts of oxygen into the atmosphere and account
for over 50% of the fixed carbon on the planet. Because most algae require only light,
simple salts, and a nitrogen source for growth, they are potential producers of proteins,
carbohydrates, and fats for feeding humans and animals [20]. Furthermore, algae are a
source of useful compounds such as E-carotene, alginic acid, carrageen, and agar. They
are also used to remove heavy metals from wastewaters [21]. In addition, there is also a
growing economical interest to use algae as a source for renewable biofuels as an
alternative to fossil fuel [22, 23].
Algae are currently classified in the Kingdom Protist. Cyanobacteria, or bluegreen algae, were traditionally considered to be algae; however, they were removed from
this group because of their prokaryotic cell structure. The diversity within this group of
organisms can be seen with: (i) the structure and composition of the cell wall (e.g., some
algae have predominantly cellulosic cell walls and others have chitinaceous or silicacious
wall; (ii) the characteristics of stored polysaccharides and lipids (e.g., starch, oil
droplets); (iii) and the pigment molecules associated with light-harvesting antenna
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complexes that drive photosynthetic electron transport (e.g., green algae have
chlorophylls a and b and various carotenoids, red algae have phycobiliproteins, and
diatoms and dinoflagellates have xanthophylls) [19].
The genus Chlorella (Phylum Chlorophyta, Class Trebouxiophyceae) consists of
small, spherical, unicellular green algae. Algae originally included in this genus (>100)
are very heterogeneous; the GC composition of the genomic DNA from different species
ranges from 43 to 79% [24]. The cell wall composition, containing a variety of
polysaccharides and a small amount of protein and lipids, varies as well. This diversity is
confirmed by recent molecular taxonomy analysis showing that many of the isolates
originally classified as Chlorella species are in fact dispersed over two classes of
chlorophytes, the Trebouxiophyceae and the Chlorophyceae [26, 27]. One such study
suggests that only three Chlorella species should be included in the “true” Chlorella
genus, i.e., C. sorokiniana, C. lobophoro, and C. vulgaris str. Beijerinck [28].

Figure 2. P. bursaria with endosymbiotic algae.
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Most Chlorella species are free-living, however, Chlorella sp. NC64A is a
hereditary endosymbiont of the ciliate Paramecium bursaria (Fig. 2). Although they both
retain the ability to grow independently, algal-free P. bursaria are rare in natural
environments [29]. “Green” P. bursaria have several hundred Chlorella cells enclosed
individually in the perialgal vacuole in the cytoplasm of the protozoan. Interestingly,
timing in cell divisions for both algae and host is well coordinated and synchronized
according to environmental conditions. The successful interaction is established by
mutual symbiosis: (i) the host provides nitrogen components and CO2 to the algae and
offers protection against viruses; (ii) the algae supply the host not only with
photosynthetic products, maltose and oxygen, but also have a photoprotective role. In
addition, P. bursaria grows better in the presence of algae and photosynthetic products of
Chlorella are related to expression of circadian rhythms in the host [29].
The genome of Chlorella sp. NC64A has recently been sequenced (G. Blanc et
al., manuscript in preparation). The 46.2 Mb genome is predicted to encode 9, 791
protein-encoding genes (CDSs) that are presumably distributed among 13 chromosomes.
Chlorella NC64A has a nuclear genome with a high GC content (67%). It also contains a
circular chloroplast DNA (~124 kb, 34% GC) and a partially sequenced circular
mitochondrial DNA (~68 kb, 29% GC). Furthermore, Chlorella NC64A as well as other
Chlorella species were previously thought to be non-motile and only reproduce
asexually. However, gene annotation reveals the presence of a significant subset of
proteins found in flagella and all the known meiosis-specific proteins. As expected, the
genome content also shows adaptation to endosymbiosis with the presence of many cell
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transporters and several families of proteins containing protein-protein interaction
domains (Blanc et al., manuscript in preparation).

3. THE DISCOVERY OF ALGAL VIRUSES
The first report of virus infecting algae occurred in the Russian literature between
1950s and 1966, where the authors describe the lysis of a free-living green alga,
Chlorella pyrenoidosa [30, 31, 32, 33]. However, they acknowledged the fact that cells
were contaminated with bacteria, and in fact, many of the reported viruses may have been
bacteriophages. In the 1970s, several independent reports described the presence of
viruses or virus-like particles (VLP) in algae: (i) viruses infecting Sirodotia tenuissima, a
red algae [34]; (ii) viruses infecting Oedogonum sp., a green alga [35]; (iii) viruses
infecting Chorda tomentosa, a brown alga [36], and (iv) viruses infecting the
coccolithophore Emiliania huxleyi [37]. The first virus to eventually be classified as a
phycodnavirus was isolated from the marine unicellular alga Micromonas pusilla in 1979
[38]. These early observations were not further pursued by virologists for several reasons
that include: (i) evidence for the presence of viruses in algae was solely microscopic and
many times it corresponded to a single observation; (ii) in some cases, algae were fieldcollected and they were no longer available for study; (iii) cultures were not axenic; (iv)
technical problems regarding virus isolation (e.g., low concentration); (v) the inability to
culture the host [20].
In 1978, Kawakami and Kawakami [39] described virus-like particles in
Chlorella isolated from the protozoan Paramecium bursaria. However, the virus particles
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were neither isolated nor characterized. The beginning of algal virology as a field
occurred in the early 1980s, when Van Etten and Meints [40] characterized a large virus
with polyhedron structure present in the isolated symbiotic alga Chlorella isolated from
Hydra viridis. They reported that the virus lysed the whole algal population in 24 h and
virus particles were absent in endosymbiotic Chlorella. Further characterization
determined that the virus possessed a 250 kb dsDNA with at least 19 structural proteins,
including a 46 kDa major capsid protein. Six other hydra Chlorella viruses were isolated
within a short time concurrently with the isolation of a virus from symbiotic Chlorella
from Paramecium bursaria, named Paramecium bursaria chlorella virus-1 (PBCV-1)
[41, 42]. Initial restriction fragment analysis of all the chloroviruses revealed four
different types of isolates and show no correlation between genomic composition and
geographical origin of the viruses. Hydra Chlorella virus showed a very different DNA
pattern from PBCV-1. Taking advantage of the fact that paramecium free-Chlorella can
be grown in culture along with technical difficulties in isolating Chlorella from Hydra,
made the laboratory concentrate all the efforts in the study of the virus PBCV-1 [20].
After testing many symbiotic and free-living Chlorella, three isolates supported
PBCV-1 growth: NC64A, ATCC 30562, and N1a. Koch’s postulates for the virus were
fulfilled and plaque-assay in lawns of NC64A was developed providing a sensitive
bioassay for studies and is still used today. Subsequently, many viruses infecting
Chlorella NC64A, called NC64A viruses, have been discovered from freshwater
collected around the globe.
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To date, viruses infecting endosymbiotic Chlorella (also referred to as
chloroviruses) in association with Paramecium bursaria, Hydra viridis, and
Acanthocystis turfacea have been reported [43]. Chlorella NC64A and Chlorella Pbi are
symbionts of P. bursaria, and their viruses are called NC64A viruses and Pbi viruses,
respectively. Sequenced NC64A viruses are PBCV-1 and NY-2A, and sequenced Pbi
viruses are MT325 and FR383 [44, 45]. Recently, a chlorovirus infecting Chlorella
isolated from the helizoon A. turfacea was sequenced and characterized and is referred to
as ATCV-1 [46]. A comparative analysis of PBCV-1 and these other chloroviruses will
be described later in this chapter.

4. PARAMECIUM BURSARIA CHLORELLA VIRUS -1
Paramecium bursaria chlorella virus-1 (PBCV-1) is the prototype of the
Phycodnaviridae family, a group of large, icosahedral, plaque-forming, dsDNA viruses
that infect certain freshwater chlorella-like green algae. PBCV-1 infects Chlorella
NC64A, a natural endosymbiont green alga of the protozoa Paramecium bursaria.
PBCV-1 has a linear 330,744 bp non-permutated dsDNA genome with a GC content of
approximately 40%. The ends of the PBCV-1 genome form a hairpin loop-like structure
consisting of a 35 nucleotide-long region that is covalently closed and unevenly basepaired [47]. The 35-nucleotides are complementary when the sequences are inverted.
Adjacent to the hairpin ends are identical 2221 bp repeats that possibly house the
initiation point for DNA replication site [48]. The PBCV-1 genome also contains
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methylated nucleotides (1.9% of the cytosines are m5C and 1.5% of the adenines are
m6A) [20, 49, 50].

4.1. PBCV-1 structure
PBCV-1 has a multilayer structure, with an outer glycoprotein capsid that
surrounds a lipid bilayer membrane and a dsDNA genome [51, 52]. Vp54, a glycoprotein
and the major component of the capsid, represents about 40% by weight of the total
protein content in the virus. The crystal structure of Vp54 showed that the subunit
consists of two 8-stranded, antiparallel E-barrel, “jelly-roll” domains. The monomeric
VP54 forms a trimeric capsomer (a “major capsomer”), which has pseudo-6-fold
symmetry, relating the jelly-roll structures [52].
Using cryoelectron microscopy (cryoEM) and assuming icosahedral symmetry
[51], it has been shown that the virion has a diameter ranging from 1.650 Å, measured
along the 2-fold and 3-fold axes, and 1,900 Å, measured along the 5-fold axes. The
PBCV-1 glycoprotein shell is composed of 20 triangular units, or “trisymmetrons”, and
12 pentagonal caps, or “pentasymmetrons” at the 5-fold vertices. Each trisymmetron and
pentasymmetron consists of a pseudohexagonal array of 66 and 30 trimeric casomers,
respectively. The triangulation number (T) is 169d (h = 7, k = 8), where T represents the
number of jelly rolls in the icosahedral asymmetric unit [53].
Recent 5-fold symmetry, 3D reconstruction analyses indicate that PBCV-1 has a
quasiicosahedral structure, which means it does not have a perfect icosahedral
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conformation. Instead, it has a unique vertex composed of special capsomers (Fig. 3)
[53]. The unique vertex contains a pocket on the inside and a cylindrical spike structure
on the outside of the capsid (Fig. 3). While this pocket is predicted to house enzymes to
be used in the initial stages of the infection (i.e., cell wall degrading enzymes), the spike
might be used to puncture the host cell, similar to the ones described in some
bacteriophages [53]. The spike is too narrow for DNA to pass through it.

Figure 3. The 5-fold-averaged cryoEM structure of PBCV-1 viewed down a quasi-2fold axis. (A) Hexagonal arrays of major capsomers form trisymmetrons and
pentasymmetrons (yellow). The unique vertex with its spike structure is at the top.
Capsomers in neighboring trisymmetrons are related by a 60° rotation, giving rise to the
boundary between trisymmetrons. (B) Central cross-section of the cryoEM density. (Scale
bar: 500 Å.) (C) The same view as in B but colored radially, with red density being
within 680 Å, yellow between 680 and 745 Å, green between 745 and 810 Å, light blue
between 810 and 880 Å, and dark blue greater than 880 Å. Note the typical lipid lowdensity gap surrounding the red nucleocapsid density. Figure from [53].
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4.2. PBCV-1 CDSs
Initial sequencing of the PBCV-1 genome revealed 697 potential open reading
frames (ORFs), of which 373 were predicted to be protein-encoding genes (CDSs) [54,
55, 56, 57, 58]. A CDS is defined here as a gene sequence flanked by start and stop
codons that presumably codes for a protein, as opposed to tRNAs genes. The following
criteria were used to define a CDS: (i) minimal size of 65 codons or more initiated by an
ATG site; (ii) the largest CDS was chosen when CDSs overlapped; (iii) the putative
promoter region (50 nucleotides upstream of the start codon) is AT-rich (>70%). The
total number of CDSs from PBCV-1 has changed since the first publication describing
the sequence because of sequencing mistakes. Now, the following CDSs are considered
to be a single CDS: A92/93L, A111/114R, A122/123R, A140/145R, A181/182,
A189/192, A219/222/226R, and A554/556/557L. The former annotation number is
maintained to avoid confusion. It is possible that other CDSs will be detected with the
upcoming re-sequencing of PBCV-1 and other chloroviruses. In addition, sequence
comparisons with other chloroviruses help to identify sequencing mistakes. Currently,
PBCV-1 is predicted to encode 365 CDSs [59]. The CDS density is 1.11 CDS/kb, which
is similar to that reported for other large DNA viruses (e.g., Ostreococcus tauri virus-5 is
1.45 CDS/kb and Feldmania sp. virus-1 is 0.968 CDS/kb) [13, 15].
PBCV-1 CDSs are evenly distributed on both strands of the virus genome and
intergenic space is minimal (>100 nucleotides). The exception is a 1788 nucleotide
region near the middle of the genome that contains many stop codons and harbors 11
tRNA genes. In addition, this area has 900 nucleotides that are GC rich (>60%) and the
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observed-to-expected ratio of CpG dinucleotides is 1.45, characteristics of a CpG island.
The 2221 bp inverted terminal repeat region contains 4 duplicated CDSs [55, 60].
Approximately 35% of the PBCV-1 CDSs have a match in the public databases
and these can be classified into a cluster of orthologous groups (COG) according to their
putative functions. The CDSs resemble genes from all three domains of life, with the
majority being bacterial-like. Prokaryotic CDSs tend to be clustered in islands towards
the extremity of the virus genome and are co-localized with bacterial-like insertion
sequences [18]. The functions of at least 44 PBCV-1 recombinant proteins have been
characterized and show the expected activity [61]. Interestingly, a few PBCV-1 proteins
revealed unusual characteristics. For example, some proteins are bifunctional (e.g.,
dCMP deaminase can also function as a dCTP deaminase) [62]; other virus-encoded
enzymes have extremely high activity (e.g., virus topoisomerase II activity is 30x faster
than human topoisomerase II) [63, 64]; and a few PBCV-1 proteins were the first
characterized from a virus (e.g. K+ ion channel protein) [65]. A detailed description of
PBCV-1 CDSs according to their COG as well as highlights of current research will be
presented. A review of PBCV-1 infection cycle will follow.

DNA replication, recombination, and repair
It is assumed that early PBCV-1 CDSs are transcribed in the nucleus, translated in
the cytoplasm, and the proteins then return to the nucleus to initiate virus DNA synthesis
(60-90 min p.i.) [66]. Large DNA viruses are known to code for most of the machinery
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needed for viral DNA replication. Thus, PBCV-1 encodes 18 CDSs involved in DNA
replication, recombination, and repair.
For the DNA replication process, PBCV-1 encodes a DNA polymerase G family
protein (A185R) that contains a proof-reading 3’-5’ exonuclease domain [67]. This gene
has a 101-nucleotide (nt) intron that is spliceosomal-processed [68]. This presence of this
intron was recently confirmed by the transcriptome sequencing of infected Chlorella
NC64A at 20 min p.i. (G. M. Yanai-Balser, unpublished results). PBCV-1 also encodes
two sliding clamp processivity factor proteins (PCNA) (A193L and A574L). It is unlikely
that they are a result of gene duplication as they have low similarity at the amino acid
level (26%) and more closely resemble PCNAs from other organisms than with each
other. PCNAs not only interact with enzymes involved in DNA replication but also with
enzymes involved in DNA repair and post-replicative processing such as DNA
methyltransferases and DNA transposases [69]. Since PBCV-1 encodes proteins involved
with DNA repair, DNA methylation, and transposases, it is possible that the two PCNAs
serve different roles in PBCV-1 replication.
PBCV-1 also encodes a replication factor C (RFC) (A417L), a protein complex
required for the ATP-dependent loading of PCNA onto DNA in eukaryotes and archaea
[70, 71]. RFCs from eukaryotes and the corresponding protein (called J-complex) in
bacteria are heteropentamers, whereas RFC from archaea are heterodimers [72, 73].
PBCV-1’s RFC resembles the archaea protein.

Other proteins possibly involved directly in DNA replication include an ATPdependent DNA ligase (A544R), an RNase H (A399R), and a type II DNA
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topoisomerase (A583L). The PBCV-1 topoisomerase II is smaller than other
characterized topoisomerase II enzymes and it has a 30x greater DNA cleavage
processivity than human topoisomerase IIa [64]. The viral enzyme lacks a nuclear
localization signal and PSORT analysis predicted that the virus topoisomerase II resides
in the cytoplasm. Assuming this is true and viral DNA replication occurs in the host cell
nucleus, this suggests the enzyme has a role in DNA packaging which does occur in the
cytoplasm [61].

PBCV-1 also encodes an archaeo-like DNA primase (A468R) that initiates
synthesis of new DNA strands by synthesizing short RNA oligomers on ssDNA [74]. In
addition, this primase displays amino acid sequence similarity to a specific class of
trifunctional

primase/helicase/origin

recognition

proteins

(M.

Griep,

personal

communication). The helicase portion of the viral protein resembles the superfamily III
helicases. A DNA binding protein (A437L) is located in the virion and is predicted to aid
in neutralizing virus dsDNA.

PBCV-1 encodes a 5’-3’ exonuclease homolog (A166R), which is probably
involved in DNA recombination and it is known to be functional. In a study using
temperature-sensitive mutants, it was established that genetic recombination occurs in
PBCV-1 at a frequency of ~2% [75]. Finally, the virus has a CDS encoding a homolog of
the bacteriophage T4 pyrimidine dimer-specific glycosylase (PDG). This is a well
characterized DNA repair enzyme involved in pyrimidine photodimer excision [76].
Comparative studies revealed that PBCV-1 PDG cleaves both cys-syn and trans-syn II
cyclobutane pyrimidine dimers, whereas the T4 enzyme only cleaves the cis-syn form.
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PBCV-1 PDG also excises two other monomeric products induced by UV radiation or
hydroxylradicals, 4,6-diamino-5-formamidopyrimidine and 2,6 diamino-4-hydroxy-5formamidopyrimidine [77]. Moreover, PBCV-1 PDG is more processive than the T4
enzyme and is the first trans-syn II specific glycosylase identified to date.

DNA restriction/modification

PBCV-1 and other chloroviruses genomes have varying amounts of methylated
nucleotides. Cytosine methylation (m5C) can range from 0.12% to 47.5% of the total
cytosine and adenine methylation (m6A) varies from 1.5% to 37%. The finding that
methylated bases occur at specific DNA sequences led to the discovery of virus encoded
restriction/modification (R/M) systems [49, 50].

DNA methyltransferases (MTases)

protect the DNA from cleavage by methylating one of the bases in the same nucleotide
sequence, and DNA restriction endonuclease (REases) recognize and cleave specific
nucleotide sequences. The number of virus-encoded MTases and REases varies among
the different chloroviruses. About 25% of the virus-encoded DNA MTases have a
companion REases.

PBCV-1 has two R/M systems: (i) the CviAI R/M system, which consists of the
REase R.CviAI (A252R) (cleaves /GATC, but not GmATC sites) and the adenine MTase
M.CviAI (A251R) (methylates GATC sequences) [78], (ii) the CviAII system consists of
R.CviAII (A579L) (cleaves C/ATG, but not CmATG) and the adenine MTase M.CviAII
(A581R) (methylates CATG sequences) [79]. In addition to these two R/M systems,
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PBCV-1 also encodes three other MTases (A517L, A530R, A683L) but they lack a
companion REase [61].

Until recently, the biological function of the virus encoded R/M systems was
unknown. However, analysis of host chromosomal DNA in PBCV-1-infected cells using
pulsed-field gel electrophoresis revealed that host chromosomes were degraded within
minutes after PBCV-1 infection (2-5 min p.i.). The DNA degradation was impervious to
protein synthesis inhibitors or UV inactivation of virus particles, indicating that a virion
packaged protein, probably is the cause. Mass spectrometry analysis of PBCV-1 virion
revealed that the two PBCV-1 REases were present in the virion but not their companion
MTases (D. Dunigan, manuscript in preparation). Nuclease activities, including those of
the two known REases and an uncharacterized general nuclease(s), were detected in
disrupted PBCV-1 particles. This nuclease(s) degraded host and virus DNA in vitro,
however, it did not degrade virus DNA in vivo, suggesting differential intracellular
trafficking of the virion-associated nucleases [80].

Nucleotide metabolism

Host chromosome degradation starts 2-5 min after PBCV-1 infection [80]. Virus
DNA replication begins 60-90 min p.i. and by 4 h p.i., the total DNA in the cell increases
at least four to five-fold [61]. With a ~330 kb genome, PBCV-1 requires a large quantity
of dNTPs for replication that cannot be accounted for by simply recycling
deoxynucleotides from degraded host DNA. To guarantee a supply of deoxynucleotides
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in non-proliferating host cells, large DNA viruses frequently encode nucleotide synthesis
enzymes. PBCV-1 genome encodes 11 CDSs involved in nucleotide metabolism and
many of them have been functionally characterized.

Most PBCV-1 nucleotide enzymes are directed to the de novo dTTP synthesis
pathway (Fig. 4) by producing key intermediates in dTTP formation [62]. PBCV-1
encodes: (i) the two subunits for ribonucleotide reductase (A476R and A629R), which is
responsible for the reduction of UDP or UTP to dUDP and dUTP, respectively (Fig 4A);
(ii) the first known bifunctional dCMP deaminase (A596R) that deaminates dCMP into
dUMP and also deaminates dCTP to dUTP (Fig. 4B and C, respectively) [62]; (iii) the
deoxyuridine triphosphatase (dUTPase) (A551L) that catalyzes the hydrolysis of dUTP to
dUMP and PPi. PBCV-1 dUTPase forms a trimer and has properties similar to dUPTases
from eukaryotes, bacteria and other viruses (Fig 4D) [81]; (iv) a FAD-dependent
thymidylate synthase X (ThyX) (A674R) (Fig 4E). This was unexpected because most
organisms have the homodimeric thymidylate A (ThyA) enzyme. However, the PBCV-1
enzyme resembles the homotetramer ThyX, common in pathogenic bacteria. While ThyA
uses the substrate methylenetrtrahydrofolate as both methylene donor and reductant,
ThyX uses it only as methylene donor. The PBCV-1 recombinant protein converts dUMP
to dTMP more efficiently than other characterized ThyXs [82].

Recombinant proteins from most of these enzymes involved in nucleotide
synthesis were functionally characterized, except for ribonucleotide reductase. It is not
surprising that many PBCV-1 nucleotide CDSs encode enzymes involved in the three
pathways that lead to dUMP production, possibly as a means to compensate for
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differences in DNA content of the host (PBCV-1 genome is 40% GC and host Chlorella
NC64A nuclear genome is 67% GC.

A

B
D
C
E

Figure 4. The three known pathways for synthesis of dUMP, an intermediate in dTTP
synthesis. The enzymes shown in the diagram in red are encoded by chlorovirus PBCV-1.
Asterisks indicate enzymes known to be functional. Adapted from [62].

In addition, PBCV-1 encodes an aspartate transcarbamylase (ATCase) (A169R), a
key regulatory enzyme that controls the de novo biosynthetic pathway of pyrimidines.
PBCV-1 ATCase resembles several plant ATCases including the catalytic domain;
however, it lacks the regulatory domain [83]. Recently, the PBCV-1 glutaredoxin
(A438L) was functionally characterized and it is predicted to provide the reducing power
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to ribonucleotide reductase [84]. PBCV-1 glutaredoxin contains an unusual monothiol
active site rather than the typical dithiol active site.

Other PBCV-1 enzymes predicted to be involved in nucleotide metabolism
include deoxynucleoside kinase (A416R), thioredoxin (A427L), cytosine deaminase
(A200R), and NTP pyrophosphohydrolase (A326L).

Transcription

A whole genome transcription analysis using microarrays has been done for
PBCV-1 virus and details about the time of expression of each CDS will be discussed in
Chapter II. PBCV-1 gene expression is temporally regulated and the first viral transcripts
are detected 5-10 min p.i. and chloroplast, but not cytoplasmic, rRNA degradation begins
about 30 min p.i. [85]. Virus infection rapidly inhibits most host transcription. The virus
has at least two ways to inhibit host transcription: (i) by host chromosome degradation
using viral encoded restriction endonucleases, and (ii) by methylating histone H3 at
Lys27 using a viral encoded vSET (A625L) [86]. PBCV-1 vSET is a small 120 amino
acid proteins that contains a nuclear localization signal and is known to trigger gene
silencing in eukaryotes. Both restriction endonuclease(s) and vSET are packaged in the
PBCV-1 virion (Dunigan, manuscript in preparation).

A few PBCV-1 CDSs can overlap or possibly form polycistronic transcripts. The
virus can also post-transcriptionally modify mRNAs since introns are present in at least
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two PBCV-1 CDSs (DNA polymerase [A185R] and TFIIS [A125L]). Transcripts also
often extend beyond the translational stop codon [87, 88, 89] and this is confirmed by the
preliminary analysis of a recent transcriptome-sequencing project (Yanai-Balser,
unpublished). Recently, three putative promoter sequences were identified for PBCV-1
CDSs and their relationship with time of expression will be reported in Chapter III.

PBCV-1 encodes many genes involved in transcription; however, it still depends
on host transcription machinery because it does not encode a recognizable RNA
polymerase or a subunit of it. No RNA polymerase activity was detected in purified
PBCV-1 virions. The lack of a virus-encoded RNA polymerase suggests that infecting
viral DNA must go the cell nucleus and a host RNA polymerase initiates viral
transcription, possibly in conjunction with virus-packaged transcription factors.
Consistent with this possibility, PBCV-1 encodes at least three transcription factor-like
elements: (i) TFIIB (A107L); (ii) TFIID (A552R); (iii) TFIIS (A125L).

Other PBCV-1 CDSs involved in transcription are two enzymes involved in
forming the mRNA cap structure, RNA triphosphatase (A449R) [90] and RNA
guanylyltransferase (A103R) [91]. The size, amino acid sequence, and biochemical
properties of the PBCV-1 capping enzymes resemble yeast-capping enzymes more than
poxvirus and African swine fever virus multifunctional RNA capping enzymes [92, 93].

PBCV-1 also encodes an active RNAse III (or ribonuclease III) (A464R), which
is a multifunctional, ubiquitous enzyme present in prokaryotic and eukaryotic organisms.
RNAse III is involved in the processing of cellular and viral precursor RNAs to produce
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mature functional rRNAs, mRNA, and tRNAs. It is also involved in the degradation of
specific mRNAs and recognizes dsRNA structures and cleaves them at specific sites.
Orthologs of this enzyme also participate in gene inactivation by RNA interference and in
gene regulation during development. PBCV-1 RNAse III resembles bacterial enzymes
both in size and its activity is presumably responsible for processing either virus mRNAs
or tRNAs [94]. According to Nishida et al. (1999) [95] tRNAs from the chlorovirus
CVK2 are transcribed as a polycystronic message at early and late times after infection
and are aminoacetylated in vivo [95].

Lastly, PBCV-1 encodes three proteins that contain sequence elements of
superfamily II helicases (A153R, A241R, 363R) that are probably involved in
transcription. A CDS for a SWI/SNF helicase (A548L) and a SWI/SNF chromatin
remodeling complex (A189/192R) are also present in the PBCV-1 genome.

Protein synthesis, modification, and degradation

PBCV-1 infection inhibits host protein synthesis and some early virus proteins
appear within 15 min p.i. Viral proteins are synthesized on the cytoplasmic ribosomes
and not on organellar ribosomes since cycloheximide, not chloramphenical, inhibits viral
replication [96]. The mechanisms which allow the virus to take over the host translational
machinery forcing it to translate virus mRNAs are not known.
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PBCV-1 codon usage is biased to codons ending in A/U (63%) over those ending
in C/G (37%). This bias is expected since PBCV-1 DNA is 40% GC, whereas host
nuclear DNA is 67% GC (Blanc et al, manuscript in preparation). Therefore, finding that
PBCV-1 encodes 11 tRNA genes is not surprising, as viral tRNAs might overcome codon
usage barriers that exist between virus and its host ensuring virus maximal replication
potential. Some chloroviruses encode as many as 16 tRNAs [95, 97]. There is a strong
correlation between the abundance of virus-encoded tRNAs and the virus gene codon
usage. The virus encoded tRNAs contain internal A and B boxes characteristic of RNA
polymerase III promoter elements, suggesting that tRNAs might be transcribed
individually by RNA polymerase III. However, as mentioned previously, chlorovirus
tRNA genes are transcribed as a large precursor RNA and processed via intermediates to
mature tRNA at both early and late stages of virus replication. Some, if not all, of the
tRNAs are aminoacetylated in vivo, suggesting they probably function in viral protein
synthesis [95].

The chloroviruses were the first viruses reported to encode a translation
elongation factor enzyme (EF-3) [98]. The putative protein from PBCV-1 (A666L) is
similar to EF-3 from fungi, which is known to stimulate EF-1D-depending binding of
aminoacyl-tRNA to the A site of the ribosome. Like fungal EF-3 proteins, the PBCV-1
protein has an ABC transporter family motif and two ATP/GTP-binding site motifs.
Possibly, the virus-encoded EF-3 in combination with the viral tRNAs alter the host
protein synthetic machinery to preferentially translate viral mRNAs.
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Including glycosylation (discussed in the Sugar Metabolism section), PBCV-1
encodes several enzymes involved in post-translational modification. Like several large
dsDNA viruses, PBCV-1 encodes an ERV/ALR protein that functions as a protein thiol
oxireductase (465R) [99]. PBCV-1 also encodes a putative protein disulfide isomerase
(A448L) and a prolyl 4-hydroxylase (A85R) that converts Pro-containing peptides into
hydroxyl-Pro-containing peptides and was functionally characterized [100]. As many as 8
putative protein kinases are present in the PBCV-1 genome and will be described in the
Signaling section.

PBCV-1 encodes two putative proteins that interact with ubiquitin, a ubiquitin Cterminal hydrolase (A105L) and a Skp1 protein (A39L). This last protein belongs to the
SFC-E3 ubiquitin ligase family that target cell cycle and other regulatory factors for
degradation. Other PBCV-1 CDSs possibly involved with protein degradation are a zinc
metallopeptidase (A604L) and a ATPase (AAA+ class) (A44L).

Signaling
PBCV-1 was the first virus discovered to encode a functional K+ channel protein.
The 94-amino acid protein (called Kcv) produces a K+ selective and slightly voltagesensitive conductance in Xenopus oocytes [65], mammalian HEK293 (human embryonic
kidney cells) [101] and Chinese-hamster ovary cells [102]. Kcv has minimal structure:
the channel monomer consists of two transmembrane domains (TM), a pore loop, and a
12 amino acid-long cytoplasmic N-terminus. Like other K+ channels, PBCV-1 Kcv forms
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a functional tetramer and electrophysiology experiments established that it has many
properties similar to more complex K channels, including gating, selectivity, sensitivity
to voltage, and susceptibility to channel blockers.
The biological function of PBCV-1 Kcv is hypothesized to be involved in host
membrane depolarization upon infection [103]. Virus attaches and degrades the Chlorella
host cell wall, which is followed by fusion of the viral internal membrane and the host
membrane. This facilitates entry of the viral DNA and virion-associated proteins into the
cell, leaving an empty virus capsid on the outside. Rapid depolarization of the host
membrane occurs and results in an immediate loss of K+ from the host, a process which
energetically favors ejection of viral DNA into the host [104]. Virus competition assays
indicated that host membrane depolarization might also prevent the infection of the host
by another virus [105].
Additional PBCV-1 signaling proteins include eight Ser/Thr protein kinases (PK)
(A34R, A248R, A277L, A278L, A282L, A289L, A614L, A617R). A Ser/Thr PK
(A248R) is adjacent to the Kcv CDS (A250R). Some of the PKs are clustered in the
PBCV-1 genome and recombinant proteins from all of them have been biochemically
tested and shown to be functional (P. Valbuzzi, unpublished results).

Cell wall degradation

Recent genomic analysis of virus the host, Chlorella NC64A, indicates it encodes
a complex array of synthesizing and modifying polysaccharides (Blanc et al., manuscript
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in preparation). Surprisingly, genes involved in the synthesis of cellulose and hemicellulose, major components of the primary cell wall of green plants, are absent. Instead,
paralogs for chitin synthase and 25 paralogs for chitin deacetylase (which converts chitin
into chitosan) are present. Two chitinase- encoding genes (plant and bacterial types) and
four chitosanase genes for the degradation of chitin and chitosans are also present. As
mentioned previously, the cell wall of Chlorella species, including Chlorella NC64A,
contains glucosamine polymers.

Consequently, to be able to penetrate the host, PBCV-1 and other chloroviruses
have CDSs involved with chitin and chitosan degradation, including two chitinases
(A181/182R, A260R), a chitosanase (A292L), a E-1,3-glucanase (A94L), and E and D 1,4
linked glucuronic lyase (A215L). Recombinant proteins produced from these five genes
have the expected enzyme activities [106, 107, 108, 109, 110, 111, 112]. All of these
proteins, except for the E-1,3-glucanase, are expressed late; however, none of them are
packaged in the virion (Dunigan, manuscript in preparation). The chitosanase CDS was
studied in another chlorovirus, CVK2, and it is transcribed late and encodes two proteins
with chitinase activity (37 kDa and 65 kDa). The larger protein is packaged in nascent
virions, whereas the smaller one occurs only in infected cells [112]. Interestingly, PBCV1 contains the same chitinase CDS flanked by two CDSs common to CVK2.

Phylogenetic analysis of chitosanase and chitin synthase from the host Chlorella
NC64A and PBCV-1 indicate the sequences are evolutionary related. However, no direct
evidence for gene exchange was obtained. The fact that higher plants do not have gene
families encoding enzymes involved in either chitin or chitosanase synthesis suggests that
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the host genes involved in chitin metabolism might have come from the viruses,
contradicting the concept that viruses always acquire genes from their hosts.

Sugar metabolism

The PBCV-1 genome encodes several enzymes involved in nucleotide sugar
metabolism including two enzymes from the highly conserved pathway that converts
GDP-D-mannose to GDP-L-fucose: (i) GDP-D-mannose 4,6 dehydratase (GMD)
(A118R) and (ii) the bifunctional GDP-4-keto-6-deoxy-D-mannose epimerase/reductase
(GMER) (A295L). Experiments with recombinant GMD and GMER established that
both virus proteins have properties comparable to human and bacterial enzymes, however
PBCV-1 GMD is more stable than GMDs from other organisms. In addition to the
dehydratase activity, the PBCV-1 GMD also catalyzes NADPH-dependent reduction of
the intermediate GDP-4-keto-6-deoxy-D-mannose, forming GDP-D-rhamnose. As a
consequence, in vitro reconstruction of the biosynthetic pathway using PBCV-1 GMD
and GMER produces both GDP-L-fucose and GDP-D-rhamnose in the presence of
NADPH [113].

Fucose and rhamnose are present in the glycans attached to the virus major capsid
protein, Vp54. However, uninfected Chlorella NC64A cell walls contain rhamnose and
trace amounts of fucose [114], suggesting that the virus-encoded pathway could
circumvent a limited supply of GDP-sugars by the host. Other genes involved in sugar
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metabolism are D-lactate-dehydrogenase (A53R) and fructose-2,6-biphosphatase
(A297L) but their functions have not been tested.

-

Protein glycosylation

Structural proteins of many viruses, including herpesviruses, poxviruses, and
paramyxoviruses, as well chloroviruses, are glycosylated. Typically, viral proteins are
glycosylated by host-encoded glycosyltransferases located in the endoplasmic reticulum
(ER) and Golgi, and then transported to a host membrane [115, 116]. Nascent viruses
acquire the glycoprotein(s) and only become infectious by budding through the
membrane, usually as they are released from the cell. Consequently, the glycan portion of
virus glycoproteins is host-specific.

Several observations indicate that chloroviruses differ from the above scenario: (i)
PBCV-1 Vp54, the major capsid protein located on the viral surface, is one of the three
glycosylated viral proteins. The glycan portion of Vp54 contains several neutral sugars
that contribute to the protease resistance and antigenicity of the virus [117]. Polyclonal
antibodies to wild-type PBCV-1 and its antigenic variants do not react with many other
independent virus isolates that infect Chlorella NC64A. (ii) Vp54 crystal structure
revealed four N-linked glycosylation sites and two O-linked oligosaccharides. However,
the four glycosylated Asn resides are not located in consensus sequences typical of
eukaryotic N-linked glycans [52]. (iii) PBCV-1 encodes most, if not all,
glycosyltransferases involved in constructing the glycans attached to Vp54 (A64R,
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A111/114R, A219/222/226R, A473L, and A546L). None of these have an identifiable
signal peptide that would target them to the ER. Furthermore, cellular protein localization
analysis using PSORT predicts that all of these proteins, except for A473L which is
predicted to localize in a membrane, are cytoplasmic.

-

Host cell surface changes

PBCV-1 is unusual because it encodes the enzyme hyaluronan synthase (HAS)
(A98R) that synthesizes hyaluronan (or hyaluronic acid) [118, 119]. Hyaluronan is a
ubiquitous constituent of the extracellular matrix in vertebrates, and consists of ~20,000
alternating E-1,4-glucuronic acid and E-1,3-N-acetylglucosamine residues [120].
Hyaluronan synthesis occurs at the plasma membrane and is simultaneously extruded
through the membrane to the exterior of the cell. Previously, hyaluronan was thought to
occur only in vertebrates and a few pathogenic bacteria, where it forms an extracellular
capsule, presumably to avoid the immune system [120, 121].

PBCV-1 also encodes two enzymes involved in the biosynthesis of hyaluronan
precursors, glutamine:fructose-6-phosphate amidotransferase also known as glucosamine
synthase (A100R) and UDP-glucose-dehydrogenase (UDP-GlcDH) (A609L) [121]. All
three CDSs are expressed early during PBCV-1 infection. These results let to the
discovery that hyaluronan lyase-sensitive hair-like fibers begin to accumulate on the
surface of PBCV-1 infecting host cells by 15 min p.i. and by 4 h p.i. the infected cells are
covered with a dense fibrous hyaluronan network [119].
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HAS is present in many, but not all, chloroviruses isolated from diverse
geographical regions [119]. Surprisingly, many chloroviruses that lack HAS have a gene
encoding a functional chitin synthase (CHS). Furthermore, cells infected with these
viruses produce chitin fibers on their external surface [122]. Chitin, an insoluble linear
homopolymer of E-1,4-linked-N-acetyl-glucosamine residues, is a commom component
of insect exoskeletons, shells of crustaceans, fungal and algal cell walls [123]. A few
chloroviruses contain both HAS and CHS CDSs, and form both hyaluronan and chitin on
the surface of their infected cells [122, 124]. Finally, a few chloroviruses probably lack
both genes because no extracellular polysaccarides are formed on the surface of infected
cells [119]. The fact that many chloroviruses require a huge expenditure of ATP for their
synthesis, are important in the virus life cycle. However, at present this function(s) is
unknown.

Lipid metabolism
PBCV-1 encodes six enzymes involved in lipid metabolism. A patatin-like protein
(A173L) is present in the virus genome. Patatins are plant storage glycoproteins that have
lipolytic activity and they are thought to serve as a defense against plant parasites and
they have been shown to participate in plant signal transduction. Many bacteria also
encode patatin-like proteins [125]. In addition, two acetyltransferases (A254R and
A654L), a glycerophosphoryl diesterase (A49L), a lysophospholipase (A271L), and a
lipoprotein lipase (A402R) are also encoded by PBCV-1.
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Integration and Transposition
PBCV-1 has a large number of CDSs involved with genome integration and
transposition: seven GIY-YIG endonucleases (A539R, A351L, A134L, A287R, A315L,
A495R, A651L), six HNH endonucleases (A478L, A354R, A422R, A490L, A267L,
A87R), and two transposases (A625R, A366L). Currently, the functions of these CDSs
are unknown.

Structural proteins
SDS-PAGE mass-spectrometry revealed ~130 proteins associated with the
PBCV-1 virion (Dunigan et al., unpublished results). At least 9 CDSs are predicted to
serve a structure role in the virion. They include the major capsid protein (A430L),
A140/145R, 189/192R, A363R, A384L, A540L, A558L, A561L, A622L. Homologs of
all of these proteins are present in the virions of other chloroviruses.

Polyamine biosynthetic enzymes
Polyamines are small cationic organic molecules that are known to have an
important role in the replication of many viruses. They are present (as putrescine,
spermidine and spermine) in large amounts in the capsid of some viruses, where they can
neutralize up to 50% of the viral nucleic acid. In some instances, virus infection can
result in an increase in polyamines in the host cell and inhibition of polyamine synthesis
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can interfere with virus replication. In contrast, host polyamines can also confer
resistance to some viruses. All of these reports have assumed that polyamines are made
by the host cells. PBCV-1 is unusual because it encodes four enzymes for the polyamine
biosynthesis: (i) ornithine decarboxylase (ODC) (A207R), which converts ornithine to
putrescine, but can also use arginine as a substrate. Because of its dual function and
because it shows higher activity with arginine, currently the virus ODC is reclassified as
ODC/ADC (A207R) [126]. The virus also encodes two enzymes necessary to produce
putrescine from agmatine: (ii) agmatine iminohydrolase (A638R) and (iii) Ncarbamoylputrescine amidohydrolase (A78R). In addition, PBCV-1 encodes (iv)
homospermidine synthase (HSS) (A237R) [127] that synthesizes the rare polyamine
homospermidine from two molecules of putrescine. Because spermidine synthase is
lacking, the end product of the pathway in the virus is likely homospermidine. All of
these four recombinant polyamine enzymes were functional [126, 127, 128].
The importance of polyamines in PBCV-1 pathogenesis remains unclear since the
host cell also produces polyamines. Little change occurs in either polyamine
concentration

or

in

composition

(putrescine,

cadaverine,

spermidine,

and

homospermidine are present) during the first hour of virus infection [127]. However, by
240 min p.i., the concentration of putrescine increases about 3.5-fold, whereas the other
polyamines decrease. The net result is that polyamine concentration decreases slightly
during virus replication. Also, it is unlikely that polyamines play a role in neutralizing
virus DNA because the number of polyamine molecules per PBCV-1 virion is so low that
they can only neutralize ~0.2% of the virus phosphate residues. Furthermore, the
physiological significant of the polyamines in the PBCV-1 particles must be limited
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because they are only loosely associated with the virions (they can be replaced by Tris or
displaced by washing the particles in a polyamine-free buffer without affecting virus
infectivity [127].

4.3. Current infection cycle
PBCV-1 binds to the host cell and specifically attaches to the cell wall probably at
a unique vertex [53]. Following attachment, virus punctures a hole in the cell wall and
cell membrane using a spike-like structure. It has been suggested that the spike is then
released because of the lower density linking the spike and the unique vertex [53]. Host
cell wall degrading enzymes possibly located in the virus “pocket” [53] at the unique
vertex are released and the host cell wall is degraded at the point of contact (Fig. 4A).
The virus internal membrane fuses with host plasma membrane, causing a K+
efflux possibly mediated by viral K+ ion channel (Kcv) [104]. H+ flux and H2O flux occur
as well causing host membrane depolarization. It is suspect that this depolarization might
prevent other viruses from attaching to the cell [105]. Secondary active transport of the
cells is also rapidly inhibited by infection [129]. Finally, viral DNA along with DNAassociated proteins are ejected into the cell leaving an empty capsid outside (Fig. 4B).
Host chromosome degradation caused by restriction endonucleases packaged in
the virion occurs within 2-5 min p.i. [80]. We predict that the DNA and virus-associated
proteins goes quickly to the nucleus and commandeer the host transcription machinery;
the first viral transcripts can be detected at 5-10 min p.i.
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Figure 5. Infection of Chlorella strain NC64A by PBCV-1. A. Digestion of the wall at
the point of attachment (1-3 min p.i.) . B. The contents of the virus are released into the
cell (3-5 min p..i). C. Cytoplasmic virus assembly centers at 3-5 h p.i. D. Release of
progeny virus by lysis of host cell at 6-8 h p.i.

Virus DNA replication begins between 60-90 min p.i. At 240 min, cells are
covered with hyaluronan [120]. Virus assembly occurs at 3-5 h p.i. in localized regions of
the cytoplasm called virus assembly centers (Fig 4C). Finally, at 6-8h p.i., host cell lysis
occurs and release of progeny virions (Fig. 4D). Typically, about 1000 particles per cell
are released and about ~25% of them are infectious.
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5. OTHER CHLOROVIRUSES
Five additional chlorovirus genomes have been sequenced: NY-2A and AR158
that infect Chlorella NC64A (same host for PBCV-1); MT325 and FR483 that infect
Chlorella Pbi, and ATCV-1, that infects Chlorella SAG 3.83. Both NC64A and Pbi are
normal endosymbionts of the protozoa P. bursaria, while SAG 3.83 is an endosymbiont
of the heliozoon Acanthocystis turfacea [44, 45, 46]. Chlorovirus genomes have CDSs
distributed evenly on both strands and have minimal intergenic space; the GC content is
host-specific. The main genomic features for each new chlorovirus can be seen in
TABLE 1 in comparison to the prototype PBCV-1.

Table 1. Comparison of sequenced chlorella virus genomesa
Virus

Hostb

Genome (bp)

CDSs

tRNA genes

GC (%)

PBCV-1

NC64A

330,743

365

11

40

NY-2A

NC64A

368,683

404

7

40.7

AR158

NC64A

344,690

360

6

40.7

MT325

Pbi

314,335

331

10

45.3

FR483

Pbi

321,240

335

9

44.6

288,047

329

11

49.4

ATCV-1
SAG 3.83
a
Adapted from [46]
b

Specific Chlorella strains

Most CDSs involved in the main metabolic functions (i.e., DNA replication and
nucleotide biosynthesis) are conserved among chloroviruses (~80%). Despite the strong
conservation each virus has unique features. For example, (i) NY-2A has the largest
genome and it is also heavily methylated: 45% of cytosines are 5-methylcytosine (5mC)
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and 37% of the adenines are N6-methyladenine (6mA) compared to 1.9% 5mC and 1.5%
6mA in PBCV-1. In addition, two NY-2A CDSs encode inteins (the first detected in
chloroviruses), the large subunit of ribonucleotide reductase and a superfamily II
helicase. (ii) AR158 is the only NC64A virus that does not encode a full-length K+ ion
channel protein (Kcv). (iii) MT325 is the first virus to encode a water channel, an
aquaglyceroporin (AQV). The K+ ion channel (Kcv) from MT325 differs in structure
from PBCV-1 Kcv [130]. (iv) The virus FR483 lacks both AQV and Kcv, but it encodes
a putative potassium ion transporter protein and an alkyl sulfatase [45]. (v) Like PBCV-1,
ATCV-1 also encodes GDP-D-mannose 4,6 dehydratase (GMD) and functional studies
revealed it has the expected dehydratase activity but lacks the additional reductase
activity present in the PBCV-1 encoded enzyme [131]. (vi) The ATCV-1-Kcv is the
smallest functional K+ ion channel reported to date (82 amino acids) and is more
permeable to K+ than Rb+, which differs from PBCV-1 Kcv [132].
NC64A viruses have three types of introns in their CDSs. PBCV-1 and NY2-A
have a self-splicing intron in a transcription factor TFIIS-like CDS [44, 56]. A
spliceosomal-processed intron is present in the DNA polymerase gene and a 81nucleotide spliceossomal-processed intron exists in the pyrimidine dimmer-specific
glycosylase gene from some viruses [111]. However, initial analyses of Pbi virus
genomes did not detect any intron or inteins in their CDSs, although a single tRNA in
MT235 and FR483 contains an intron [45].
Considerable variation occurs in chlorovirus genomes and the total number of
genes in the chlorovirus gene pool exceeds that of a single isolate. In addition, not all
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PBCV-1 genes are required for virus replication, since PBCV-1 mutants with large
deletions (27-37 kb) [133] can replicate in Chlorella. Large insertions also occur in some
chloroviruses, for example, the virus CVK2 contains an extra 22 kb insert [95, 134]. The
different sizes and diversity of the chlorella virus genomes suggest that dynamic and
frequent rearrangements of virus genomes occur in natural environments.

6. NATURAL HISTORY OF CHLOROVIRUSES
Even after almost 30 years of study, the natural history of chlorella viruses is still
poorly understood. At present, chloroviruses have been isolated from three different
Chlorella: (i) Chlorella NC64A (host for the sequenced PBCV-1, NY-2A, and AR158),
(ii) Chlorella Pbi (host for MT235 and FR383), and (iii) Chlorella SAG 3.93 (host for
ATCV-1). Chlorella NC64A and Pbi are natural endosymbionts of the protozoan
Paramecium bursaria. Chlorella SAG 3.83 is a natural endosymbiont of the heliozoon
Acanthocystis turfacea.
Chlorella NC64A and Pbi were originally isolated from American and European
strains of P. bursaria, respectively. Although NC64A and Pbi viruses have similar
morphology and biological and biochemical properties, viruses infecting Chlorella
NC64A cannot infect or attach to Chlorella Pbi. The component sugars in the cell walls
of the two Chlorella differ considerably [135] and it was predicted that host receptor for
the viruses could also be the recognition factor for the paramecia. However, this is not
true since both Chlorella can establish symbiotic relationships with paramecium isolated
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from American and European waters. A. turfacea virus was isolated from Chlorella from
a German freshwater pond. Furthermore, viruses of the more recently discovered
Chlorella SAG 3.83 endosymbiont of A. turfacea also only attach to and infect this
Chlorella isolate.
Chlorella NC64A viruses have been isolated from freshwater collected all over
the world: the United States [136, 137, 138], Japan, Brazil [139], Australia (Van Etten
and J Rohozinski, unpublished), China [140], Argentina and Israel (Y Zhang, M Nelson,
JL Van Etten, unpublished), South Korea, and Italy [20]. Chlorella Pbi viruses were
originally collected in Europe [141], and more recently in Australia, Canada, and the
northern United States (Minnesota, Wisconsin, and Montana) or at higher elevations in
the western United States (M. Nelson, unpublished results). Some water samples from
Nebraska (United States) and Australia contained both NC64A and Pbi viruses (J. Van
Etten, and J. Rohozinski, unpublished; M. Nelson, unpublished). The most important
factors influencing the distribution of NC64A and Pbi viruses are probably latitude and
altitude.
Chlorella virus titers in indigenous water vary from 1-100 plaque-forming units
(PFU) per ml, but titer as high as 1 x 105 PFU/ml have been obtained. The concentration
of chlorella viruses fluctuates with the seasons, with the highest titers found in late spring
[139, 142]. A water sample collected through ice had a titer of >1000 PFU/ml (M.
Nelson, unpublished).
It is not known whether Chlorella NC64A and Pbi viruses replicate exclusively in
the Chlorella free of the paramecium or whether they have another host(s). In fact, it is
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not even known if the symbiotic Chlorella are free living in natural environments. A
single paramecium can contain up to 1000 Chlorella cells; if each infected Chlorella can
produce ~250 infectious viruses, then, it is predicted that Chlorella cells released from a
single paramecium could produce up to 250,000 virus particles. This could explain the
high virus titers occasionally observed.
The occasional high titers in indigenous water are also surprising because viruses
are constantly exposed to solar radiation, that damages viral DNA and inactivates viruses.
Inactivation of bacteriophages and cyanophages occurs at rates of 0.4 to 0.8 per hour in
full sunlight [143, 144]. Chlorella viruses have adapted to solar radiation by having
access to two independent DNA repair systems [76]. PBCV-1 uses a (i) pyrimidine
dimmer-specific glycosylase that initiates UV-induced thymidine dimer repair, which
functions in the light and in the dark; and (ii) host photolyase to repair UV-induced
thymidine dimers (also called host cell reactivation) [76]. PBCV-1 also encodes a
putative Cu/Zn superoxide dismutase that could help protect DNA from reactive oxygen
species.
Plaque-forming viruses are specific to certain species of Chlorella, since attempts
to find viruses infecting other Chlorella hosts or the green alga, e.g., Chlamydomonas
reinardt, have been unsuccessful. It is possible that some viruses might exist in a
lysogeny state with their hosts, but no evidence for lysogeny has been detected for
chloroviruses.
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7. OTHER ALGAL VIRUSES
Perhaps the next best studied algal virus is the coccolithovirus that infects the
unicellular free-living calcifying Emiliania huxleyi, which is best known for forming
large costal and open ocean algal blooms. Much of the appreciation for aquatic viruses
came with the identification of the Emiliania huxleyi virus (EhV-1), partially responsible
for the termination of E. huxleyi blooms. EhV-1 has a 407 kb circular genome (40% GC)
that encodes 472 protein-encoding genes, of which 14% have a match in the public
database [145]. The virus particle is a 160-200 nm icosahedron and the genome encodes
for some unusual genes involved in sphingolipid biosynthesis, two desaturases, and eight
proteases, but more importantly, encodes for 6 subunits of the RNA polymerase, which is
lacking in PBCV-1. Upon infection, EhV-1 capsid remains at the cell surface, and it is
speculated that binding occurs in the underlying plasma membrane of the host [146].
Interestingly, shell-less algae (haploid) are resistant to virus infection [147] and during
release, EhV-1 buds through the membrane in an animal-like cell extrusion [146].
Another well characterized phycodnavirus belongs to the genus Phaeovirus. To
date, eight classes of brown algae (macroalgae) are reported to be infected by viruses
[15], however only two phaeovirus genomes have been sequenced: the 335 kb
Ectocarpus siliculosus virus (EsV-1) [13] and the smaller genome (158 kb) of Feldmania
sp. virus (FsV) [15]. The viruses in this group are probably the most diverse in terms of
genome size (ranging from 150-335 kb) and they can infect more than one host from
different families. This last factor probably reflects the unusual life style of these viruses
that unlike the other phycodnavirus members that are lytic, integrates its genome into the
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host genome and live in lysogeny. EsV-1 is the type-species of the group and perhaps the
best characterized Phaeovirus. EsV-1 infects only free-swimming wall-less gametes or
spores and after infection, virus DNA integrates to the host genome. The host exhibits no
symptoms of infection, except for a partial or total inhibition of sexual reproduction, and
the virus genome can be transmitted by mitosis. EsV-1 controls the host by only
expressing genes in reproductive organ cells, where the virus disintegrates the organelles
and forms a dense pack of virus particles. Upon certain environmental stimuli, EsV-1
induces lysis which releases spores and gametes, guaranteeing synchronous infection
[13]. The FsV has two genome sizes, 158 kb and 178 kb that co-occur. Although the two
genomes present similar restriction fragments and integration sites, they integrate in
distinct regions in the host genome.
EsV-1 also encodes for a K+ ion channel that structurally resembles PBCV-1 Kcv
and eukaryotic K+ channels. Despite their similarity, the EsV-1 protein (named Kesv), is
sorted to the mitochondria whereas PBCV-1 Kcv goes to the plasma membrane. Mutation
analysis revealed that the N-terminus and structural features in the second transmembrane
domain are responsible for the mitochondrial signal in Kesv [148].
Recently, two viruses infecting the green alga Ostreococcus tauri, (OtV-5 and
OtV-1), currently unclassified in the Phycodaviridae family, were isolated and their
genomes sequenced [14, 149]. The host O. tauri is the smallest free-living,
photosynthetic marine eukaryote, whose genome has also been sequenced [150]. OtV-5
and OtV-1 have a linear dsDNA genome (186 kb and 191 kb, respectively) and show
high level of colinearity. Their genomes are predicted to encode 268 and 232 CDSs,
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respectively. O. tauri lacks a cell wall and when it is attacked by high amounts of OtV-5
(high multiplicity of infection) not all cells become infected, suggesting either host
resistance or a lack of virus receptor in the host cell membrane. This indicates that
attachment is specific and a crucial step during infection. A 50 nm space can be
microscopically observed between the virus and the host cell membrane and may indicate
the presence of an envelope around host plasma membrane. The OtV-5 burst size (25
virus particles/cell) is smaller than that observed in other phycodnaviruses. OtV-5
encodes for DNA methyltransferases but not the companion restriction endonuclease as
identified in PBCV-1, and during the lytic infection cycle the host chromosome remains
intact [14].
It seems that algal virus diversity is even more spectacular than previously
thought as shown by additional virus characterizations. In 2003, Tai and colleagues [151]
reported the first single-stranded RNA (ssRNA) virus infecting the raphytophyte
Heterosigma akashiwo and in 2004, another ssRNA virus infecting the marine diatom
Rhisozolenia sp. [152]. In the same year, a double-stranded RNA (dsRNA) virus (24.6
kb) infecting the prasinophyte Micromonas pusilla was reported by Brussaard et al.
(2004) [153]. Later in 2005, a virus infecting Chaeotocerus salsugenum, a marine diatom,
has an intriguing genome type: the genome is composed of a 6-kb closed circle ssDNA
with a 1-kb linear, partially paired ssDNA [154]. Finally, in 2008, Tomaru et al. [155]
reported a ssDNA virus that seems to have a fragmented genome in the marine diatom
Chaetocerus debilis. Furthermore, ssRNA and dsDNA viruses infecting dinoflagellates
(Dinophyceae),

and

additional

dsDNA

viruses

infecting

(Haptophyceae) and Pelagophyceae were recently identified [156].

prymnesiophytes
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Collectively, algal viruses infect a wide range of hosts and presents a remarkable
variety in size (25 to above 220 nm), genome type (dsDNA, ssDNA, dsRNA, ssRNA),
genome structure (linear, circular, fragmented), and genome size (4.4 to above 500 kb)
[156]. The diversity of algal viruses described so far is impressive considering this field
is only in the beginning.
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CHAPTER II

MICROARRAY ANALYSIS OF CHLORELLA VIRUS
PARAMECIUM BURSARIA CHLORELLA VIRUS-1
TRANSCRIPTION

1. OVERVIEW
Paramecium bursaria chlorella virus 1 (PBCV-1), the prototype of the genus
Chlorovirus (family Phycodnaviridae), is a large, icosahedral (190 nm in diameter),
plaque-forming virus that infects the unicellular, eukaryotic green alga Chlorella NC64A.
The PBCV-1 virion has a lipid membrane located inside an outer glycoprotein capsid.
The 330-kb genome is a linear, non-permutated, dsDNA molecule with covalently closed
hairpin ends that has approximately 365 protein encoding genes (CDS), as well as 11
tRNA encoding genes (reviews [1, 2, 3]). The CDSs are evenly distributed on both
strands and intergenic space is minimal (typically less than 100 nucleotides); the
exception is a 1788 bp sequence in the middle of the genome that encodes the tRNA
genes. Approximately 35% of the 365 PBCV-1 gene products resemble proteins in the
public databases.
PBCV-1 initiates infection by attaching rapidly and specifically to the cell wall of
its host [4, 5], probably at a unique virus vertex [6, 7]. Attachment is immediately
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followed by host cell wall degradation by a virus-packaged enzyme(s) at the point of
contact. Following wall degradation, the viral internal membrane presumably fuses with
the host membrane causing host membrane depolarization [8], potassium ion efflux [9],
and increase in the cytoplasm pH [10]. These events are predicted to facilitate entry of
the viral DNA and virion-associated proteins into the cell.

PBCV-1 lacks a gene

encoding a recognizable RNA polymerase or a subunit of it and RNA polymerase activity
is not detected in PBCV-1 virions. Therefore, viral DNA and virion-associated proteins
are predicted to migrate to the nucleus and early viral transcription is detected 5-10 min
post-infection (p.i.), presumably by commandeering a host RNA polymerase(s) (possibly
RNA polymerase II) [11, 12]. Virus DNA synthesis begins 60-90 min p.i., followed by
virus assembly at 3-5 h p.i. in localized regions of the cytoplasm, called virus assembly
centers [4]. At 6-8 h p.i., virus-induced host cell lysis occurs resulting in release of
progeny virions (~1,000 viruses/cell of which ~25% are infectious). These events are
depicted in Fig. 1.
To initiate PBCV-1 transcription, the host RNA polymerase(s), possibly in
combination with a virus transcription factor(s), must recognize virus DNA promoter
sequences. Recently, three short nucleotide sequences were identified in putative virus
promoter regions (150 bp upstream and 50 bp downstream of the ATG translation site)
that are conserved in PBCV-1 and other Chlorovirus members [13]. PBCV-1 CDSs are
not spatially clustered on the genome by either temporal or functional class suggesting
that transcription regulation must occur via cis- and possible trans-acting regulatory
elements.
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Figure 1. Timeline representing the PBCV-1 lifecycle in Chlorella NC64A. Numbers
represent minutes after infection. CDSs expressed before viral DNA synthesis begins
were classified as early (black arrow), CDSs expressed after DNA synthesis begins were
classified as late (white arrow), and CDSs expressed before and after DNA synthesis
begins were classified as early/late (arrow with diagonal lines). Electron micrographs A
and B were reproduced from [5] and micrographs C and D were reproduced from [4]
with permission.

To understand the dynamics of PBCV-1 global gene expression during virus
replication, we constructed a microarray containing 50-mer probes to each of the 365
PBCV-1 CDSs. cDNAs from poly A-containing RNAs isolated from cells at seven times
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after PBCV-1 infection were competitively hybridized against a reference sample on the
microarray. To further delineate early and late gene expression, cells were treated with
the DNA replication inhibitor, aphidicolin, prior to infection. The results provide the first
comprehensive transcriptional map of the virus genome, conferring insights about the
characterization of each PBCV-1 CDS, the majority of which have unknown functions.
In addition, the microarray data suggest that viral DNA replication plays a significant role
in the temporal regulation of gene expression.

2. MATERIALS AND METHODS
2.1. RNA isolation and drug treatment. Chlorella NC64A cells (1 x 108 cells/ml) were
infected with PBCV-1 at a multiplicity of infection of 5 to ensure synchronous infection.
Uninfected cells and cells at 20, 40, 60, 90, 120, 240 and 360 min p.i. were harvested by
centrifugation (4,000 rpm) for 5 min at 4ºC and disrupted with glass beads (0.25-0.30 mm
in diameter) using a bead beater (Disruptor Genie, Scientific Industries, Bohemia, NY) in
the presence of Trizol (Invitrogen, Carlsbad, CA).

RNAs were isolated using the

Absolutely RNA Miniprep Kit (Stratagene, La Jolla, CA) according to the manufacturer’s
instructions. RNA integrity was verified in denaturing 1% agarose gels by monitoring
host cytoplasmic and chloroplast ribosomal RNAs. Total RNA was quantified with a
NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE).
To determine the effect of virus DNA synthesis on virus gene expression,
aphidicolin (20 Pg/ml) was added to the cells 15 min prior to infection and samples were
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collected at the same times after infection as described above. Control samples were
obtained from infected non-treated cells at the same times. Preliminary experiments to
determine optimal drug dosage and time of application indicated that 20 Pg/ml of
aphidicolin completely inhibits DNA synthesis in 15 min.

2.2. Microarray construction and hybridization. The PBCV-1 genome is predicted to
have 365 CDSs and 11 tRNA encoding genes. The tRNAs sequences were not included
in the microarrays. Fifty-mer probes representing each CDS in the PBCV-1 genome were
designed and synthesized by MWG Biotech (Ebersberg, Germany) (20-80% GC, 60-80º
C melting temperature). A table with the probes’ sequences is in Supplement 1. Probes
were spotted onto CMT-GAPS silane-coated slides (Corning, Lowell, MA) using
Omnigrid 100 (Genomic Solutions, Ann Arbor, MI) according to manufacturer’s
instructions. Probes were printed in quadruplicates on every slide. For each time point,
20 Pg of total RNA was reverse-transcribed using oligo(dT) as a primer and cDNAs were
labeled with either Cy3 or Cy5-dUTP (GE Healthcare, Piscataway, NJ) using the
SuperScript Indirect cDNA Labeling System (Invitrogen) following the supplier’s
directions. The reference sample, for the time course experiments, consisted of a pool of
transcripts obtained by mixing equal amounts of total RNA from each time point.
Competitive hybridization experiments were conducted for each sample against the
reference sample [14, 15, 16]. For the aphidicolin experiments, a direct comparison was
carried out with each treated sample versus the corresponding non-treated infected
control.

71

Labeled cDNAs were resuspended in pre-heated (68ºC) 40 Pl of Ambion
hybridization buffer #2 (Ambion, Austin, TX). Arrays were hybridized (42ºC) for 16
hours in a Corning hybridization chamber (Corning, Lowell, MA). Slides were washed
twice (42ºC) in 2x SSC (1x SSC is 0.15 M sodium chloride, 0.015 M sodium citrate),
0.5% SDS for 15 min followed by two washes in 0.5x SSC, 0.5% SDS for 15 min. Slides
were then dried with low-speed centrifugation and subjected to fluorescence detection
with an Axon 4000B scanner (Molecular Devices, Sunnyvale, CA).

2.3. Microarray analysis. Results from three independent experiments were analyzed
using the GenePix Pro v.6.0 software (Molecular Devices) and TIGR microarray
software suite (TM4) [17]. Several transformations were performed to eliminate low
quality data, to normalize the measured intensities using the Lowess algorithm, and to
regulate the standard deviation of the intensity of the Cy5/Cy3 ratio across blocks. CDSs
that displayed statistically significant modulation were identified by a one-way analysis
of variance (ANOVA), using P values of <0.01 as a cutoff.

For the aphidicolin

experiments, Significant Analysis of Microarray (SAM) [18] was used to identify CDSs
with statistically significant changes in expression in comparison to a non-treated
infected sample (False discovery rate  5%). CDSs with similar expression profiles were
grouped into different clusters with a K-means algorithm using Euclidean distance and 50
maximum iterations. PBCV-1 microarray data sets were deposited at NCBI’s Gene
Omnibus Express (GEO) under the accession number GSE18421.
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Figure 2. Heatmap illustrating the expression of 360 PBCV-1 CDSs during the
infection cycle. cDNAs from each time point were labeled with Cy5 and the reference
control was labeled with Cy3. Color code represents the log2 (Cy5/Cy3) ratio for each
time point.

CDSs with similar expression profiles were grouped into three classes

representing early, early/late, and late using K-means algorithm.

Each column

corresponds to the time point when total RNA was collected (numbers represent minutes
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after infection). Each row represents a different CDS in PBCV-1. A list of all of the CDSs
is available in Supplement 2.

3. RESULTS AND DISCUSSION
3.1. Microarray quality check. To evaluate our probes, equal amounts of PBCV-1
genomic DNA (2 Pg) were labeled in two independent reactions with either Cy3-dCTP or
Cy5-dCTP (GE Healthcare) using random primers (Invitrogen). The two reactions were
then competitively hybridized with the probes in the microarray. No difference was
detected in hybridization of the two DNA samples on all spots (results not shown)
indicating the probes were specific and also excluding any preferential hybridization to
one of the dyes. In addition, to check for host cross-hybridization, PBCV-1 DNA (2 Pg)
was labeled with Cy3-dCTP and host Chlorella NC64A DNA (2 Pg) with Cy5-dCTP.
Only two PBCV-1 CDSs (A260R and A625R) hybridized with host DNA; however,
these two CDSs are false-positives since recently available Chlorella NC64A genome
sequence did not have detectable homologous sequences.

3.2. PBCV-1 transcription program. RNAs were isolated from infected cells at 20, 40,
60, 90, 120, 240, and 360 min p.i. Competitive hybridization results from each time
point against the RNA reference pool revealed that transcripts of 360 (99%) of the 365
PBCV-1 CDSs display statistically significant variation in at least one of the
experimental time points (Fig. 2). CDSs A60L, A328L, A482R, and A646L did not pass
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statistical tests in the time course experiment. CDS A689L was not spotted onto the array
because it was accidentally omitted during the probe synthesis. The gene expression
analysis was based on relative levels, rather than absolute levels of expression. Mapping
the PBCV-1 transcription pattern to the genome revealed no large regions that were
biased as to time of expression, indicating that gene expression in PBCV-1 is mostly
controlled by multiple initiation sites (Fig. 3). However, a few early or late CDSs
clustered in small regions of the genome as can be seen in shaded areas in Fig. 3.
Interestingly, these small regions are also clustered and conserved in another sequenced
chlorovirus (NY-2A) that infects the same host Chlorella (results not shown). Unlike the
phage T4 genome, where most late CDSs are located in contiguous regions on the same
DNA strand [19], PBCV-1 expression did not show a strong strand-specific bias. In
addition, there is no relationship between time of expression and G+C content of the
genome (Fig. 3).
Classification of PBCV-1 CDSs was based on when the transcript was detected by
the microarray. Globally, the 360 statistically significant CDSs were grouped into three
classes (Fig. 4): i) 227 (62%) of the CDSs were expressed before viral DNA synthesis
begins at 60-90 min p.i.; ii) these 227 CDSs were divided into two classes: transcripts of
127 CDSs disappeared prior to initiation of virus DNA synthesis (considered early) while
transcripts of 100 CDSs were still detected after virus DNA synthesis begins (considered
early/late); iii) transcripts of 133 (37%) CDSs were detected after virus DNA synthesis
begins (considered late).

Functional categorization of PBCV-1 CDSs was reported

elsewhere [20] and functional distribution compared to each transcriptional category is
summarized in Fig. 4 and 5. Forty-four of the PBCV-1 encoded proteins have been
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expressed and recombinant proteins shown to be functional enzymes.

These are

indicated with an asterisk in Fig. 5. The functions of the remaining CDSs are either
putative or unknown.
A previously described putative promoter sequence (AATGACA) and a similar
sequence (ATGACAA) [13, 11] were detected in 50 early or early/late PBCV-1 CDSs.
However, promoter sequences for most early, early/late, and late CDSs remain
unidentified.

3.3. Early CDSs. One hundred and twenty-seven (35%) of the 360 PBCV-1 CDSs were
expressed early, 20-60 min p.i. (Supplement 2). Sixty-one percent of the early CDSs
have no known function. Many of the early CDSs are predicted to encode the machinery
for the virus to begin DNA replication. In fact, PBCV-1 encodes seven proteins involved
in DNA replication, recombination and repair that were expressed early including: į
DNA polymerase (A185R), superfamily III helicase (A456L), DNA topoisomerase II
(A583L), RNAse H (A399R), and PCNA (A574L).

A pyrimidine dimer-specific

glycosylase (A50L), a well-characterized DNA repair enzyme involved in pyrimidine
photodimer excision [21], was also expressed early.

Additional PBCV-1 encoded

proteins involved in virus DNA synthesis and DNA recombination were in the early/late
class including, DNA primase (A468R), a 5’-3’ exonuclease (A166R) and a second
PCNA (A193L).

The PBCV-1 genome contains methylated nucleotides, both N6-

methylated adenine and 5-methylcytosine [22]. Therefore, it is not surprising that the
virus encodes three functional DNA methyltransferases that were transcribed early – two
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enzymes that form N6-methyladenine (A251R and A581R) and one that forms 5methylcytosine (A517L).
PBCV-1 DNA synthesis also requires large quantities of deoxynucleotide
triphosphates

(dNTPs)

that

cannot

be

accounted

for

simply

by

recycling

deoxynucleotides from host DNA. By 4 h p.i., the total amount of DNA in the cell
increases 4-fold due to viral DNA synthesis [23]. To guarantee a supply of dNTPs in
non-proliferating host cells, large DNA viruses, including PBCV-1, encode proteins
involved in dNTP biosynthesis: dUTP pyrophosphatase (A551L), thioredoxin (A427L),
thymidylate synthase X (A674R), and cytosine deaminase (A200R) CDSs were
transcribed early. Additional dNTP synthesizing CDSs in the early/late class included
aspartate transcarbamylase (A169R), both subunits of ribonucleotide reductase (A476R
and A629R), glutaredoxin (A438L), and dCMP deaminase (A596R).
Several PBCV-1 CDSs predicted to encode proteins involved in transcription
were also expressed early. These proteins include three putative transcription factors,
TFIIB (A107L), TFIID (A552R), TFIIS (A125L), two helicases, SWI/SNF helicase
(A548L) and superfamily II helicase (A241R), and RNAse III (A464R). The genes for
two enzymes involved in mRNA capping, an RNA triphosphatase (A449R) and a
guanylyltransferase (A103R) were also transcribed early. The products of at least some
of these early CDSs are undoubtedly involved in the switching of virus early gene
transcription to late gene transcription.
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Figure 3. Mapping of the PBCV-1 transcriptome. Blue arrows: early CDSs; green
arrows: early/late CDSs; red arrows: late CDSs. Arrow points to transcription direction.
Shaded areas indicate small transcription CDS clusters that are also conserved in
another chlorovirus (NY-2A), except for the areas marked with asterisks. Middle circle
shows G+C content of the genome. Note that the PBCV-1 genome is linear and a
circular map was generated for illustration purposes only.
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A few PBCV-1 enzymes involved in protein synthesis and protein degradation
were transcribed early including translation elongation factor-3 (A666L), ubiquitin Cterminal hydrolase (A105L), Skp1 protein (A39L), SCF-E3 ubiquitin ligase (A481L), a
zinc metallopeptidase (A604L), and an ATPase (AAA + class) (A44L).
Unlike other viruses, PBCV-1 encodes at least part, if not all, of the machinery
required to glycosylate its major capsid protein [19], including five glycosyltransferases
[24, 25, 26]. Furthermore, glycosylation of the virus major capsid protein probably
occurs independently of the host endoplasmic reticulum-Golgi system [19]. All of the
glycosyltransferase CDSs were expressed early (A64R, A111/114R, A219/222/226R,
A473L, A546L).
The chlorella viruses are also unusual because they encode enzymes involved in
sugar metabolism.

Two PBCV-1 encoded enzymes synthesize GDP-L-fucose from

GDP-D-mannose, GDP-D-mannose dehydratase (A118R), and fucose synthase (A295L)
[27, 28] and three enzymes, glucosamine synthetase (A100R), UDP-glucose
dehydrogenase (A609L), and hyaluronan synthase (A98R), contribute to the synthesis of
hyaluronan, a linear polysaccharide composed of alternating E1,4-glucuronic acid and
E-1,3-N-acetylglucosamine residues [29, 30]. The CDSs for these five enzymes were
expressed early.

3.4. Early/Late CDSs. One hundred (27%) CDSs were classified as early/late, 67 (67%)
of which have unknown function (Supplement 2). This class contains CDSs that were
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expressed before 60 min p.i., but whose transcripts were also present after PBCV-1 DNA
synthesis begins. At least three mechanisms can lead to classification of CDSs into the
early/late class: (i) the CDSs were transcribed both before and after viral DNA replication
begins; (ii) the CDSs were only transcribed prior to initiation of virus DNA synthesis but
complete degradation of their transcripts only occurred after DNA synthesis begins; (iii)
the CDSs encode polycistronic mRNAs, e.g., one could have a dicistronic mRNA in
which one CDS is required for an early function and the other CDS is required for a late
function. To add to the complexity, ~30 transcripts were detected early, disappeared and
then reappeared as late transcripts (these CDSs are marked in Supplement 2). A similar
phenomenon has been reported in transcriptional studies with the bacteriophage T4 [15]
and Red Sea bream iridovirus [31].
In addition to the early/late CDSs described in the preceding section, the most
striking feature of this early/late class was the presence of many genes encoding proteins
associated with genome integration, including 5 GIY-YIG endonucleases (A134L,
A287R, A315L, A495R, A651L) and 4 HNH endonucleases (A354R, A422R, A478L,
A490L). Also, one of the two transposases (A366L) coded by PBCV-1, was expressed
early/late. The functions of these proteins in the PBCV-1 life cycle are unknown.

3.5. Late CDSs. One hundred and thirty-three (37%) of the 360 CDSs were classified as
late CDSs (Supplement 2), 74% of which have no match in the public databases. The
expectation is that most late CDS products are involved in either virus capsid assembly,
DNA packaging, virus release, or are packaged in the virus particles. Indeed, SDS-
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PAGE mass spectrometry proteomic analysis of purified virions indicated that 118
PBCV-1 gene products were detected in the virions (Dunigan et al., unpublished results).
Of these 118 proteins, 83 had their corresponding CDS transcribed late, 29 were
transcribed early/late, while only 6 virion-associated proteins were expressed early.
At least 9 late CDSs are predicted to have their gene products serving a purely
structural role in the virion including the major capsid protein A430L [32] and
A140/145R, which is associated with the unique vertex of the virus [7]. Other putative
structural proteins are A189/192R, A363R, A384L, A540L, A558L, A561L, A622L.
Homologs of all these proteins are present in all of the chloroviruses (Dunigan et al.,
unpublished results). In addition to structural proteins, a DNA binding protein (A437L),
predicted to aid in neutralization of the virus dsDNA, was in the virion and its gene
transcribed late.
Several CDSs encoding proteins with putative enzyme functions were expressed
late and their gene products were packaged in the PBCV-1 virion. Presumably these
enzymes are released into the cell during virus infection and aid in establishing infection.
These proteins include an ATPase (A561L), a superfamily II helicase (A363R), a
SWI/SNF chromatin remodeling complex subunit (A189/192R), and a SET domaincontaining histone 3, Lys27 methyltransferase (named vSET) (A612L).

The vSET

protein is predicted to aid in the rapid inhibition of host transcription during virus
infection [33]. Two site-specific (restriction) endonucleases (A252 and A579L) were
also expressed as late CDSs and their proteins are packaged in the virion. The restriction
endonucleases are involved in host chromosome degradation, which begins within a few
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minutes after virus infection [34]. Thus, PBCV-1 has at least two avenues to inhibit host
transcription and subvert the host RNA polymerase (presumably RNA polymerase II) for
virus transcription: virus packaged restriction endonucleases and a vSET histone 3, Lys27
methyltransferase.
Five of the 8 PBCV-1 encoded Ser/Thr protein kinase CDSs were expressed late
(A34R, A277L, A278L, A282L and A614L). With the exception of A277L, the other
four kinases were packaged in the virion (Dunigan et al., unpublished results). A dual
specific phosphatase (A305L) was also expressed late and the protein is present in the
virion. These results indicate that PBCV-1 has the potential to release several protein
kinase/phosphatase proteins into the cell during infection; these enzymes are probably
involved in regulatory mechanisms.
PBCV-1 encodes five proteins that degrade polysaccharides, and presumably
some of these encoded proteins are involved in host cell wall degradation either during
virus entry or in aiding lysis of the cell wall during virus release. With the exception of ȕ
1,3-glucanase (A94L) that was expressed early, the remaining 4 CDSs were transcribed
late.

The late CDSs encode a ȕ and Į 1,4-linked glucuronic lyase (A215L), two

chitinases (A260R and A181/182R) and one chitosanase (A292L).
Finally, 49 late gene products were not detected in the virion. Fifteen of these
proteins have a putative function, for example a DNA packaging ATPase (A392R) that is
predicted to be involved in packaging DNA into the virion. Interestingly, some CDSs
that were expected to be transcribed early because of their putative involvement in the
DNA replication, were transcribed late. These CDSs encode a replication factor C protein
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(A417L) (RFC), which is similar to one of the two RFCs proteins in Archaea, an ATPdependent DNA ligase (A544R), and a deoxynucleoside kinase (A416R). However, none
of these proteins were detected in the virion (Dunigan et al., unpublished results).

3.6. Aphidicolin treatment. To confirm the early and late classification of PBCV-1
CDSs, aphidicolin was used to block viral DNA synthesis. The drug was added to the
culture 15 min prior to the addition of PBCV-1 and cells were harvested at the same
times after infection used in the previous experiments (20, 40, 60, 90, 120, 240, 360 min
p.i.). Each sample was analyzed using the corresponding infected non-treated sample as
a control.
Expression of 179 (49%) CDSs was inhibited by aphidicolin (Supplement 2). Of
these 179, 14 were expressed early, 57 were expressed early/late, and 108 were expressed
late. This experiment established that transcription of most late CDSs relies on the
synthesis of viral DNA.

In contrast, expression of 181 CDSs was not affected by

aphidicolin. Of these 181, 113 were early, 43 were early/late, and 25 were late. Three
CDSs (A328R, A482R, A464L) were not previously classified as early, early/late or late
because they did not pass statistical tests. However, they were expressed in the presence
of aphidicolin, which indicates that these CDSs might be early. Collectively, expression
of most early CDSs was not affected by aphidicolin and expression of late CDSs was
inhibited by the drug. We have no explanation why 14 early CDSs and 57 early/late
CDSs were affected by aphidicolin nor do we know why 25 late CDSs were not affected
by aphidicolin.
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Figure 4. A. PBCV-1 global expression pattern. B. Distribution of CDSs according to
their putative function and time of expression. CDS products with unknown function are
not listed in this graph.

3.7. Verification of the microarray results. Three independent sets of experiments
support the microarray results. i) Recombinant proteins from 19 PBCV-1 CDSs have
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been biochemically characterized previously and their genes northern blotted to
determine when they were expressed. Sixteen of these results completely agree with the
microarray experiments.

The other three northern analyses were similar, but not

identical, with the microarray analyses. One is a glycosyltransferase (A64R), which
northern analysis indicated is expressed from 45-360 min p.i. [25], whereas the
microarray analysis indicated that the CDS was expressed only between 40-60 min p.i.
The second CDS is a chitinase (A181/182R), which northern results indicate transcription
occurs between 30-360 min p.i. [35], whereas, the microarray analysis showed the
transcript was present from 60-360 min p.i. The third CDS is a dCMP deaminase
(A596R), which northern analysis indicated expression occurs from 30-120 min p.i. [36];
the microarray experiments detected the transcript at 40-60 min p.i. and then again from
240-360 min p.i. This discontinuity in expression has also been observed with a few
other virus CDSs and it has been observed in both northern blots and in the microarray
results (e.g., homospermidine synthase (A207R) [37]). It is important to note that the
microarrays measured relative levels of the transcript and this fact could explain the few
differences mentioned above.
ii) The 46.2 Mb genome of the PBCV-1 host, Chlorella NC64A was recently
sequenced to 9-fold coverage (http://genome.jgipsf.org/ChlNC64A_1/ChlNC64A_1.
info.html). This prompted us to initiate a transcriptome analysis of Chlorella NC64A and
PBCV-1 infected cells by shotgun sequencing cDNA derived from poly A+ RNA using a
new high throughput sequencing instrument. To date, we have two sets of sequences,
one from uninfected Chlorella NC64A and one from cells at 20 min p.i. We compared
the 20 min p.i. viral microarray results with the infected 20 min p.i. viral transcriptome
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sequencing results. Of the 172 CDSs detected by the microarray analysis at 20 min p.i.,
expression of 159 CDSs (92%) were detected in the transcriptome study using a 200-fold
coverage cutoff (Yanai-Balser et al., unpublished results).
iii) Kawasaki et al. (2004) [11] identified 22 immediate-early PBCV-1 CDSs
(expressed at 5-10 min p.i.). Our microarray results indicated that 20 of these 22 CDSs
were expressed early. CDS A689L was not present in our array, and CDS A312L was
classified as early/late and was not detected at 20 min p.i., which is the earliest time point
in the present study. In the later case, the difference could be due to the relative
measurement of the transcript.

3.8. Do late PBCV-1 mRNAs have a poly A tail? Both the microarray results and the
preliminary transcriptome sequencing of PBCV-1 depended on cDNA synthesis using a
oligo dT primer. We mention this issue for two reasons. First, about 20 years ago we
conducted a set of pulse-labeling experiments where PBCV-1 infected cells were
incubated with H3-adenine for 30 min periods [38]. Poly A+ and poly A- RNAs were
separated on an oligo dT-cellulose column and the radioactivity determined. The results
indicated that 22-26% of the radioactivity eluted in the poly A+ fraction from cells
infected from 0-30 min and from 30-60 min p.i. In contrast, 6.1%, 4.5% and 2.5% of the
radioactivity eluted in the poly A+ fractions at 60-90, 90-120 and 120-240 min p.i.,
respectively. Therefore, we suggested that PBCV-1 early mRNAs probably contain poly
A tails and late mRNAs might lack them. However, there are other explanations for
these earlier results, e.g., the pool size of unlabeled adenine certainly increases
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dramatically during infection, consequently, there could be a large dilution effect on the
added H3-adenine compared to the controls. In addition, we now know that PBCV-1
infection leads to rapid depolarization of the host plasma membrane, which causes an
immediate decrease in adenine transport into the infected cell [10]. Both of these issues
undoubtedly influenced our previous results.
Second, a report by Kawasaki et al. (2004) [11] also suggests that there may be a
shift in poly A+ RNAs during chlorella virus replication. Twenty-two PBCV-1
immediate-early CDSs were analyzed and the transcripts gradually decreased in size after
20 min p.i., suggesting weakening or cessation of poly A polymerase activity.
The current manuscript provides evidence that most, if not all, PBCV-1 mRNAs
have a poly A tail because expression of 99% of the PBCV-1 CDSs was detected in our
microarray experiments. Furthermore, many of the CDSs we identified were clearly
expressed late and packaged in the virion.

3.9. PBCV-1 transcription is complex. As mentioned above, we and others have
characterized several individual PBCV-1 gene products. In most of these reports, a
northern analysis was conducted when studying a specific CDS.

The transcription

patterns of ~50% of these CDSs are more complicated than just obtaining a single
hybridizing RNA band of the predicted size at specific times. That is, full-length gene
DNA probes often hybridize to mRNA transcripts that are 40-60% larger than the CDS
itself, suggesting that PBCV-1 might have polycistronic mRNAs. In addition, some
probes not only hybridize to mRNAs of the expected size, but they also hybridize to

87

larger mRNAs at other times in the virus replication cycle. These complex patterns occur
even with ssDNA probes (e.g., the potassium ion channel CDS, kcv) [39]. One difference
between the previous northern analyses and the microarray results is that hybridization to
total RNA was used in the northern analyses and in the research described in this paper
the cDNAs were synthesized from poly A+ RNAs.
We examined four of the CDSs that produced larger transcripts than expected to
determine if expression of their flanking CDSs were identical in the microarray
experiments to the target CDS, possibly suggesting a polycistronic mRNA. A common
expression pattern was obtained for two of the four CDSs. The RNAse III (A464R)
mRNA has a predicted size of 825 nucleotides (nts). However, in a northern blot the
RNAse III hybridizing band is ~1,300 nts. Its two adjacent CDSs are 204 nts (A462R)
and 354 nts (A465R), and like A464R, both of them are expressed early. The combined
sizes of them with the RNAse III CDS are compatible with either a dicistronic or even a
tricistronic mRNA. The other example is the potassium ion channel CDS (kcv, A250R)
that northern analysis indicated has a complex expression pattern, at early times A250R is
expressed as a large message and at late stages as a monocistronic mRNA [39].
However, when the early transcript for this CDS was mapped, the start and the stop sites
were within the adjacent CDSs, so A250R is clearly not a polycistronic mRNA. The
CDSs surrounding the other two CDSs with larger transcripts than expected, fucose
synthase (A295L) and dCMP deaminase (A596R), were expressed at different times than
the target CDS.
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Figure 5. Heatmap showing distribution of selected CDSs according to their putative
functional class. cDNAs from each time point were labeled with Cy5 and the reference
control was labeled with Cy3. Color code represents the log2 (Cy5/Cy3) ratio for each
time point. Each column corresponds to the time point when total RNA was collected
(numbers represent minutes after infection). Each row represents a different PBCV-1
CDS. Recombinant proteins have been characterized for the CDSs marked with an
asterisk.

It is clear that a detailed transcription analysis using a high throughput sequencing
system of PBCV-1 infected cells will be required to precisely determine promoter and
terminator sites, as well as splicing regions of PBCV-1 transcription. This analysis
should include the use of random primers in addition to oligo dT primers, and also allow
the detection of PBCV-1 encoded small RNAs.

3.10. Microarray results with other large dsDNA viruses. PBCV-1 expressed 99% of
its CDSs at some point in the virus life cycle during infection in laboratory conditions.
Similar results were obtained for other large DNA viruses such as vaccinia and
monkeypox viruses in which ~95% of their CDSs are expressed in cell cultures [40, 41].
Transcription analysis using microarrays was also performed with two marine fish
iridoviruses: (i) Singapore grouper iridovirus expressed 97% of its CDSs in cell culture
[42] and (ii) Red Sea bream iridovirus expressed 96% of its CDSs during in vitro
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infection [32]. Therefore, it appears that most CDSs are expressed in these large dsDNA
viruses, even in laboratory conditions.
The temporal categorization of the transcripts in large viruses varies. Different
studies classify virus transcripts in different ways, usually subdividing early CDSs into
more specific categories. For example, Red Sea bream iridoviruses has ~9% of its CDSs
classified as immediate-early, ~43% classified as early, and ~41% classified as late [32].
T4 bacteriophage transcripts are divided into immediate-early (42%), delayed early
(~12%), middle early (21%), and late (~22%) [15]. Poxvirus transcription occurs in the
cytoplasm of the infected cell and is programmed by a virus-encoded RNA polymerase
and time-specific transcription factors to generate three transcription categories: early,
intermediate, and late [43].

Using tiling array technology, a recent study reveals

immediate-early

in

transcripts

vaccinia

[41].

An

additional

microarray-based

classification of vaccinia and monkeypox virus gene expression divided the virus CDSs
into early and late categories only (~50% of the CDSs in each class). The method used in
this later study categorized CDSs according to the time the transcript is first detected, so
the intermediate class (expressed early and late) was not distinguished, implying that this
class was a subgroup of the early CDSs [42]. For PBCV-1, we classified a portion of the
early CDSs as early/late when the transcripts were detected before and after the onset of
viral DNA synthesis.
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4. CONCLUSION
For the first time, a global mRNA transcription profile was conducted for a
chlorella virus. The PBCV-1 life cycle is temporally programmed. This regulation is
controlled by a precise gene expression pattern, where the time of transcription is dictated
by initiation of viral DNA replication, which begins 60-90 min p.i. Early CDSs were
transcribed between 20-60 min p.i, and products of the majority of the early CDSs are
responsible for providing the machinery for viral DNA replication. Late CDSs were
transcribed after 60 min p.i., and most of them were dependent on initiation of viral DNA
synthesis, since aphidicolin blocked the expression of most late CDSs. Products of many
late CDSs serve either a structural role or were packaged in the virion, presumably to aid
in virus infection. Forty-six percent of the early transcripts were still detected after DNA
synthesis begins and were called early/late CDSs, indicating a complex mechanism for
mRNA maturation and degradation. Some of these early/late CDSs may only be
synthesized early, but their transcripts were not degraded until after DNA synthesis
begins. However, this scenario probably does not apply to all early/late CDSs because
several early-late CDS products were packaged in the virion. These CDSs may also be
transcribed as late CDSs.
This study reveals that PBCV-1 gene expression time is independent of GC
content, as well as the transcription direction and CDS location in the genome. It is
anticipated that the temporal transcription map will provide clues to the functions of the
large category of viral proteins whose functions are not yet known and to the events that
must be orchestrated for a successful viral infection.
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5. SUPPLEMENT
5.1. Supplement 1. PBCV-1 50-mer probes' sequences

CDS

Sequence

A002L

TAGATGATTTGAGAAAGTTTGCCGAAGAGTATGCGAATACTGAAATTATA

A003R

CTGGTGAAAGATACACTCATCTACAACGGAACCGTATTTATACCTACGGC

A005R

GCGTAAAGATGCTCATAGAGGCAGGTGCCGGTCTTAACATCGACGGTGAT

A007L

CATCAACAATGAAGGAGCGACACCATTACACTTTGCGTCTCGATATGCAC

A008L

CAATCACTAAAGGGTGTACTGATTATGTTATGTTATTAATCAACGCAGGG

A009R

CGTGATTAAGATGTGTGCTTCGGGAGATCATAGAATGTATAAACTCCCAC

A010R

TCACGTTGTTTTCGACTAACTGGAATGTCCTACAAGTGCGGAGTGGTCTT

A011L

TACAGCAGCAACTATCTCAGATGTGTATAACCAATCGACTACATTAGCAA

A014R

TTTCCTAAATACACTATACATTGGTGCCCAATATAACACGAATTTTAGTA

A018L

CATCAACTTCATTTTTCGGCCTGATGGTGACGGCGGTACAAACAGTGTAA

A025L

CGTTGGAAACTTATTCGCAAACGGAAGCACCATACAACTTTCAAATCTTG

A029L

TAATAACGAACTTGATACCTACCGTTGATATAACGGCTAATGTTCTGCGT

A034R

TCCATGCTCTCAGAGTGTTTTACGATAAGATGAGTGCTGAAGATAAAAAA

A035L

CGCAGTAATAACTTCAAAAGTATCTGGAAAGGTTACCAAGGTTGTATCCC

A037L

AAACTCTTAACTAGTGTGATTGACCAACGAGGTATTTTTTATTTCTTATA

A039L

TGAAAACGATCTTACACCCGAAGAAGAAGCTGCTGCTCTTGCAGAACATT

A041R

AACATTCTAAAAGATCCGAAGGATAAATCTTGGTACAATGGGTTGAAAAA

A044L

TCGGATTACTACACACCAGCAGAAGTGTCTCAGATCATCCTCAAAAATAT

A048R

GCGTCTTGAATAGGATAAATATTCTCATGGATACATATGATATTACGCAT

A049L

ATACAAAAATCGAATATCCCATACGAAAATACCCTGGTGACTTCATTTAA

A050L

AAAAATCGCTATGAAGCCAAGTTTTTACAGGTTCACGAAAGCTAAAACCA

A051L

ATGTGATAAATATTCACGATGATAAAGTTACTTTTTACCACGATCACCAA

A053R

CTTAAAAATATTGCAGATACAACCATCGAAAACCTAACTTCAGCATTCAA

A057R

GACCATCCATACTTAGATTATACTCAGGATAATGCGAATGTGAAACCTTC

A060L

GTCTTCCGATGGATAGGAGTTCAATCATTGATACAGTACCATTTCCATAG

A061L

ATTTTTTCAACATCGGAAACGGAAAGACTGCCGCAATCATAAAAAAATAA

A063L

TGGTTCGTTTCTAAACTCAATGTGGATGTGCCGAAAATCTTCCACTCGTA

A064R

GTAGAGGATATACCTCATTTAGAATGGTTAGAAATTCTGGCAAATGAAAT

A067R

GCTGACATCCGACGGACAGCAGTTCAATGTGACTCTGCCACATGCTCTCA

A071R

CGATTGTGTACTTTGGGATAGCCGAGGGAAAAACTTGGAATGTAATTTGA

A075L

AAGAATTTCCCGGAAGAACGGCAAAGGATCGTTGATTTATACAGTGATAA

A077L

TTATGGAAACATTCCGTTATCAAGGTATTGTAACAACGGGTTTTATGTTC

A078R

TGGTGGTGTTGATCCTGAACCTGTTGATCTTAAAGGTTATACGAAATATA
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A079R

AAAGATGATATCCACACTCCTGCTCCCATTGGTAATATATCAGTCGTTGG

A081L

GTTGAAGCGGCGAGCGTAATAATAGAAGACAACGACGAAACTATCATTTT

A084L

ATGACACGAGCACTCGATTTCATAGATGCAGCAGAAGACAGGTTCCCGTT

A085R

AGAAACTTTGCACGCAGGACTTCCCGTGAAAAGTGGAGAAAAAATCATCG

A087R

TAAACACTCCGAACAAGGTGTATGGTCGCACATGGATTCGAGCACATTTC

A088R

ATTACAAGTTGGAGGTTGCAAATGCTTCTGGTGACTATGATAATGAATAT

A089R

GAGGTGAGAAGATTGGGTTTACTGCGAAGAGTAGCTTGAAGTCAATGGGT

A090R

TCCTTGTATACCTAAAAGGAAAACACCCAACTTTCATATTAGAACATATT

A092/93L

AAACGTGCCTCGAATGAAGCCCTCAAACTCGCGTTACAGATGTATGTTAA

A094L

CTGATGCACCTTACAACCGACCTTTTTATATTATTCTGAATACATCTATC

A098R

TTCTGTATGATTCCGGCCAGGATTACTGCAATGATGACGCTTTGGGACAT

A100R

AATTTTCTCCGATAATTCACACTATCCCGATGCAACTGCTTTCGTATTAC

A103R

TCCAACTATCATCAAGGACCATCTCAAAAAGGCCAATGCTATTTATCATA

A105L

AATAAATGGTTCAGATATGACGATGAAGTTGTTACACAAATTTATGATAT

A107L

TCTCAAACGAAGACATCAAGAAGCTACGCCGGGATAGCAACAAAATGATT

A109L

CAAATGAAACATAAATTCCTACAGAGAGATGAAATTCGTCAAATTGAACT

A111/114R

CCGTGGATAATCAACGCGGATTATATCTCATATCTAGACGATGATAATAT

A118R

CCAGATGACTACGTTATTGCGACTGGACAGACGACGAGTGTCCGTGAATT

A121R

GGTCAAAACCATCATTTACAGACGCTCTTAAAGTAACTGAAAAAAAAATA

A122/123R

TGCACTAATTTTAAGAGGTATTGGAGGTACAAACACTGTTAATCTGTTCA

A125L

TATAAAAAACTTCGTAAATTCAAAACCGTGGGAAGTATGTCCCGAAAAAT

A127R

AGAACCCATTCTCATAAAGAACGCTGGACTATTCGCACATAAACGAGGCT

A129R

ACGATACTCTCAGGCTGTTTCGTCGATACGAGAACTCCTTGTGAATCCAA

A130R

CACCTCCGTTTTTATTTTCGATACTCGTGGCAATTGGATGCGCTGCAATA

A131L

TTTACGAACAACTGGAAGCTCTGAAGACTATTTCAACGCTCCAGATTAAC

A133R

TATGCTCGTTAAACAACACATACACAGGTATAATAAGAACTATACATATT

A134L

CTATTTACAAAGATTTCCCGATCATCAAGAAGACTTCGACTTCCTCTTAA

A135L

CGTCACTCTTTTCTTTACTACTTTTTTCACAGGAGCCATTGCACACACCG

A137R

TTCGCGCCAATAGATATAAGAGAGCATTCATCTCTCCCGTAATTCGACCA

A138R

TTCTTATAACATTAATAGTCCAGTAGAAATGGTATGTAAACCTCGTAAAC

A139L

CAGTTGGTAGAACTCACACCTAAACTCAAGGAACAAATAGAATGTAAATT

A140/145R

GTGAAACCCACGGCACCCGTTGGAACCATCATTATCGCAGCGAAGGTGAC

A148R

TGGTGCTAAAGAATCTACCCGGACGTTTAACCAAGAAGGTCATTGTTTGA

A150L

CGACACACGGTGTCAACTGATGTAATCTCTAAATACAAAAAGAAAGTTAA

A151R

ACCATAACGCCAAGTATTGTTGGAGTTATCTCTGGACCTTTTTTGCTCAA

A153R

AAGAAAAAATTGAAGAGAAAATGGAATCAATGTTCATAGATGAGGACTAA

A154L

TGGATATGGCAACATTCCGTGCCCCGTAAGAACTCAACTCAAATACGAGA

A157L

AGGGACAAGGAGTCCGAAGTTGTGAAGGGCGTTGAGAATTCCCAAGTGTA

A158L

CTACAAGCGGTTTTGACAACGGAGAACTTCCTGATGTGGTAGATGATGTT

A161R

TCCCGATATTATTAAGAAGAAGAAGAGGGCAAAGCGCAATAGCAAACTGA
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A162L

ACCAAAAACACATTCACCAGATGATCTAGAGAAATATGAAGCCGAGGGAT

A163R

TGAACTTGTAGAATTTATGCCTACCAATAATAGTAGTATACGAGACAATT

A165L

GAAGTGGAATCTTTGAAAATGGTGATAGATACCAACGGAAAGAATATTAA

A166R

CGACGTGCCAAGAGAAGAATACGTCAGAGAACTTGAAGACACGGACGATT

A168R

TGGTCAATGACACCCGCGCAGAAAATGATTACACCTACAATTCCAGATGT

A169R

ATGTGGATACAAACCATCGTGCCGTGTATTTTGACCAAGTGGAACGTGGG

A171R

CTTGGTATTTTACACTCGGAAAAACAGTACCTATTCCAGAAACAACCATA

A173L

AATTTTTCCAGAGTCTCATCGTCACAGCGACGAAAGACAAATTTTCAAAA

A175R

GATGCGCGACGCTTAGTGTTTTTAGTCGGAGCCATATATTTTTACCAAAT

A177R

AAGGTTGTTGATTCCGCAGTTGGGTATGTGAAAGACGCAATAATAGATGC

A180R

GCGAGTATGTCGAAAGGTAAAGGAAATGTCAACGTGATTTACACAAATAT

A181/182R

AGCAGCGATCAGTGCCGCTACTGCAACGAAGAAGCAGTGTGATGACTTGG

A185R

GGATACAAGAACGAGTGCCAACCGCATCTTCACGTAGCGAACAAAATTTA

A189/192R

AAATCACCTTCACCGTCTCGTTCGGCTATAAGAACACCAACTGGGAAAAC

A193L

TGTCGTCTGCTGTAGAAATTTACTTGAAGGAAAGTTACCCACTTATTTTG

A196L

TTGTTTTTGATTTCTTGGATCGTGTTTTTCTCCATATTGTATGCCCTTAA

A199R

TCTAACAGCGGAAACCGTGATGATCACAGCTTCTCTAGCAGGTCCTGGGT

A200R

AATAATTTCAGAAGGGCATAATCACACGAGGAAGCAAATAGGAACATTTT

A201L

GACGGAGGTGTGTTTTATAAGTTTGCCAAAGGAGGAGTTTGGGTAACAGC

A202L

ATTGTTTTAAGTGGCTTCACGAAAAATATGGAAATGTAGAACCTGATGGG

A203R

TAGAAAATATTGATGAAACACCGCTCGCGGAATTCATTCCAGATTTTGTA

A205R

TCGCAAAATTTATAGAGGAAAACGCGGTGGTGAGTTTGTAATTTCTGATA

A207R

CCAGCTTCTCAGAGATGTCCCGGATGATGAGGAATATGTACCATCTGTAT

A208R

GATGGTGTCAGGGTAGACCTAACAAAAGTGGAATTTGAAGTTGCTGATGA

A213L

ATTCCTACGGATATTTATCAGAACTCTGGTCGTGTTTCTCTGAAAGAATT

A214L

TTGCGGATAGTCTATCTTCTGGCGAGACCAAGGTGTCTCTGTCTATCAAG

A215L

AGAATCAGGTAGCATACTTCACGAATTTCCAAATGAAGAAATACGAATGA

A217L

GATAATAATAGGAGAAATGCTGTCAAAACGTATAGGTTATGTTGAGGGTG

A219/222/226R

CAGACATTGTCTTCCATTTGTGGTCTATTACCGTCAATCATAAGATTTCT

A227L

TTTGGTTCCAAACTTCTATCAAGATTTACCACTGGTACACAGAAAGTTAC

A229L

CTTCGTATGTTCTCAGGGATAATATTGCTTTTTGTTCTCTCGTAATTTAA

A230R

AAATTGTTCGCATATGGTATAGACATCGAAAACAAAATCATCATTCTATT

A231L

AAAGAAAGAAACTCGAAGCCTTAAAAAAGAAAATACAAACTCGGAAATAA

A233R

CCAACTTCCAAAAAATTAGTGACTACGAAATGTGGGAGCATTATACTTAT

A234L

AAGGGATTCAAACAATATTTCCTTCGCCAGGACAACGGAGACGTTCAATT

A237R

GGAATGGAGGTCTGCGAAGATAGTTTGGGAGCCGTCTCTAAGCAATGTCC

A239L

GGACTGCCAAGTTGAAGGCCGTAGGAGCTGCCATCAATGATTTTGCATAT

A241R

CAAAAACAACATTTTAGAGGAATTTTGAAAACTTCATCGCTTTACATTTA

A243R

AAAGGGTTTGCAGCTTTGAGAAATCTAGAGATCCATGTTCATCAGATATA

A245R

AGGAAAACGAATCGGATGCGCTGTTATAGGATATGCCAAAGAAAACTTTT
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A246R

AGGTGGAATAAGTAAAAAGGATGTGAGAATGACATATCATTATTATGCAC

A247R

ACAACGATGGAAATTTGCCGGATGACCTAACGTCGGACAAACAAATTATT

A248R

GAGACGGATGAAAATTGGAGAACTTTTTGAGCACCCATTCATGATTCTTA

A250R

AACTTCTCTGTTGCAAACCCGGACAAAAAGGCATCATGGATAGATTGTAT

A251R

CCGCAGTGGGAAATGATGTTGAAGAATATCTTTTCTTTGTATATATTGAA

A252R

AAAAGATTAGGAGAGTTCCAGATTCACACATCCAGAAGTTGTATTAAATT

A253R

AAAAATATGTTGGCGAGAATTGCAAAGGAACGCAAAACTTCTAAAGAAAA

A254R

GTACATACTATTGATGATGCCGTATATATTGTATCAGGAGGATTTGGTGA

A256L

GAATCTCTAAAAGAAGTAAAACCTATTGCTCCAAGTGAATATGAAGAATT

A257L

GGCAGTACAACTTCAAAAACAACTAAAATAAATTCATCTGTATTTACATT

A259L

TTCGAAACAAAATATTCGGCTCGGGAAATGAGAGACGCAGGAGGGTCGTG

A260R

ACTCGTTCCCTACTCGGTAACCGACGCCGCCGAAACGATGCTCAAACTCG

A261R

CCTCCAATATACAAACCATTGTTAGAACGAGACATAAAAAATGTAGATAT

A262L

GATGGAGAAAACGGTGGAAAACAGTGCAAGTACTATCCATGATTTTTATA

A263L

AGTTGTGAACGTGGTAAAACCACAGGGATACAAACCAGAATTTGTAAACC

A265L

TCATTGGCTCAGATGAAATCCGGGAATTACACGCAAGGTGGTTTGAAATT

A267L

CTCGAACTTACAACTGATGACTGGGAACAACTTATCAAAGGAGAATGTGC

A271L

TTGACGAGGAATTCAACACTCATTGGTTTAACGACCCGCTGACACGCCAT

A273L

CGTTAAAAATAATAGCGTCTCAACAACAAGAGATAAAATTGTTAGAGAAA

A274R

TATCAACATACACACTGTATGATGGAGAGTTAAATTATGATAGTTTTCAC

A275R

TCGTTTCAAGAGCTGTAGATGCCGTCAAAAAAGAGATACGACATGCGAAT

A277L

TCCTCAACCACGCGGTGTTTCAACCATTCGCATGTCGTATCTCTTTTTTG

A278L

ATAGTAAGAAACTTACTCCACCAACTGAAGTAGATGCTAAAAAACGCAAA

A282L

CAATTACACGAATAGCGTAGCCCAAGCCAGAGATTATGGATGGTACAACC

A284L

GTTGTTCCATGTTTTAAATAATTTTGATATTCCAAAAGGAGTAGTGGCGT

A286R

TAAACTCTGTGAAAACGGTTCCTCATGGTAACGATTATATGTATCTTTAT

A287R

AGAAACGAAGAAGAAAATTAGTGAAAATAATCCTAATTCAAAGATAGTGT

A289L

CTCTCACCGACCGAGTTGATGAAAAATACATCCCAACACAAACCGACATT

A292L

GCTGTACACTTTGGGCAAACATCTTCAAAGAAGGAAACGTTGGGCTGAAA

A295L

ATCTACGATACTTATATGCCCGATGGAACTCTGAAAAAACTCATCGACTC

A296R

ATTAAGGACCAGAGAAGCTAAAGTAGAAAGGCGTCGGTTGCAAGCAGAAG

A297L

TGGCTATTATTTTCATCCGTTACGAGAGAAATACTGCAAAGTTTATTTAA

A298L

TGAGAGATGACCTGGTAAAGAATCTACATATCAAAGGATTTCACAGGAGG

A301L

CGCTCTAAATGGTAATGTTGAATATATCAACCAACTACTTGCGGATCTAT

A304R

ACATACACGAAATAACCCGACATATACAATATTCCGAAAATTATCTATTA

A305L

AAAAAATACAAAAAACACAAAAAACACGAAGAAAAGCAAGAATCTTAAAT

A306L

GTTACACGAAGATGATCCAGAAGTATGGTTTGACTACATGAGCGAGGAGC

A308L

TCGTAGTAGAAGTCGAATGCCTTGATGACGAGTGTGTAGTCGTAAATTAT

A310L

GTGGCAGTACAATTACGCAGAATGGTCGTGTTCTCGGTGGAACGAGATAA

A312L

TCTCGAAGTGAGCGACGAAGACGATGCCCGCGTAGCTCAAAACTTCCTTT
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A313L

AAATTTACGAGAGTATCACCACTGGAAAGTGCATGATGTGTGGGACAATA

A314R

ACTGGTATTATATTGATTGCTACAAACGAATTAACATATAATCGCCCTCG

A315L

TTCATGGTGGTATAGCGAGTTGTGCTCGTGGTGATAGAAATTCTGCTTAT

A316R

GAAAGAAGATTTATTATTCCCGGAATTACCAACTACAAATATAGCACCTA

A318R

ATTGTAACGCTGACATAGAACCGATGGCCGGTGGTTATGGAGCTAAATAT

A320R

TCGAAACCCTCAAGAGAAAATACACAGCGGAGATGAATAAAATTAAGTAA

A321R

GGCGTCCTTGGGTATTTACTCGAAGCCGCTGGAAAACCAGAACTTGCGAA

A322L

AACAATTTTACACACCTGTTATTCCACAAAACCCTATACAACTTCAGTGA

A324L

GAGTTTTCATCACCGGAGGATACAACTGTAAAGGTTGTTAAAGGAAGTGC

A326L

TATGAAATATAAAAACATAGGGACGAACCTCATAGAAAAATCGGAGCTTG

A328L

ATGATTACTACATGTTATACCCGGTTAGGATGTATAAACGATACAAAATA

A329R

GATGGTTCTATCTGTAGCCATTAACGCGATAATAGATATCATAGACGAAG

A330R

TCTTTAATAATGTCAGGAGGAAAACAACTCTTTTGTGTCTAAATAAAATA

A333L

AGATATGAGAGCGTGTGGAGAACCTGGTGCTGTACCCGAAGAATTTTGGA

A337L

TAAGATGGTGGCAGAAAGCATCAAGGAAGAATTCAACTTTGCTCATGTCC

A339L

TCGTCATCAGATAGGTTGAGTATTATGAAGTCGTGTCTTGGGTGGGTAAG

A341L

CACGAGGTTCGCAGGTCTATTTTCGACCTAATCGGCTCGTTGTTCAAGAA

A342L

GGAAACGGAAGCAACTACAAGCGCAAAAAAACAAGCAACAGAGGAAGTGA

A348R

CTACCGGCAAGAGGATGTTCAGAAATCCTAAAATTCACAATGATTTTAAT

A349L

GATTACCGCGCATTCCTCCAAAAGAACGCGAAGGAGGTCGAAAAAACTGT

A351L

ACGAGACGCAACAAGAAGATAGAGGAATATGCGTTGGTAGGAATTGATAT

A352L

CACACAGGGCAGCTCCCTGAAGAACGCGAACTACGATCTCCGCGCTGACC

A354R

AAATGTGTATCTTATATTGATGGCGTAGAAGAAAAAGAACACAATAGTCT

A357L

TGTGATAAATGCGTCTAGGGAAAAACGCACGAGTGGAACGAATTTCTCGG

A360R

TCGTAGATAACGGTAAAACATCCTTAAAAAGAATGAGCGAAGTTCGGTAA

A361R

CTTTGTCAAAGGGATGGAAGAACGACTCAAACCAATCATACAGCTCAAAA

A363R

TGACAAGTTCGAGAAAAATAAGATCATCAGGAAGCCCGAGGGATGTCGTG

A366L

AAAATTGTAGGAAAATTCGAAGAACACACTGAGACAGAATTAAACAATAT

A368L

TGATGACGATGGTTGGGACTCCGAAGACTATGATCCCGAAGAATGGTATT

A373R

ATTCGCAAAAGATTCAACGTAAAGAAACCACGAAAATTTCTAAATCATTT

A375R

GTAAAAAATACTATGGAACTACGAAGGATAGGTTTTATTCGTTTAGTCAA

A378L

ATCTTGTCCTCGTTTCCAAAAATGGAATGGAAGTAAATGCGAATGTGATT

A379L

AATAATACTCCTCGCAATATGAATAATACACGGACCGCAAAGAAATCAAC

A382R

TGTTTATTTGACGTACAACCCGCAGATTTCATTGTTCAAGAGAAGTATAA

A383R

TGGGAACTAATAATACCATTGAAATTTTTTTGCTGCAAACGGAACACAGG

A384L

GCGCCGAAACTGCCGGAAAATGTAGCGGTAAAGAAGGAGGTGAACCATAT

A390L

ACGAATGTGAGTACACAACTCGACAAAGATGGAAAGGAACTTGGGTATGT

A392R

TTCCAAAGAAAGGAAAAGGGATGATGACTCTGATGATGAAGCCGATAACG

A394R

ATAGATGACACGGAGCAATTTCCCGACATGGATTGTGTATCTACGAAAGA

A395R

GATTTTCAGGACATATAGACCTTGGTGATTTCGGACGCACCGCGATTTGT
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A396L

CAAATTCTGATAACACATATTTTTACTACCTTGTACTTCTTTCCGTAATC

A397R

ATAATGAGGAATATCCATTATTCATAGTAGTACACGAACTACATGAAGAA

A398L

ACTCTCAGGTCTCGGACTTAAAGCAGCGACACTTTTAGCACCGCGCATCG

A399R

AGTTAAGGCGCACAGTGGAAATATTGGAAACACATTTGCTGATAAACTTG

A400R

AAGTGGTCGTAAAACCAACATTGTCTTGCCGTGTTCAAAAAACGAAATAA

A401R

GTAAAACAAAAAATCGCTGCTGGAAGTCAAGAAGATATTCGTCAAATGGG

A402R

TATGGAAAACCTATTTACGCAGATGCCAACCTACAATGTTCTAAAAGTGC

A403R

CGTTCGTTTTGGTCCTGTCCTTGATGAAGCAACGTTCAAAGAATATCAAC

A404R

GTAGAAGAAGTCGTAGAAGATTATGAGGATGACGAGGTCGTAGAAGAAGT

A405R

GGAGTTGTATCTGTTGTTTTCATTATAGCACTAAAAAACGCCAAAAATAT

A407L

CTGTAACAACTGCCGCTCCAGATCTCACGGCGTTTGGTCAGTTTTTGTAT

A408L

AGAAGACCAAGGATTCAAAATCCGGGAAGAAGCACCGCAAACATAAATAA

A410L

GAATCTATGATTCCCTATGCGGAATATGTAGCCAACCGTGACGAGACTAT

A411R

GTTGTCATGGATTTGATGAAAAATATAATACCTCCAAATACATCTCAGTT

A412R

ACGAAGTAACACCAAATAATGAAAATAAATTTCTATTCCTTGACGACGAA

A413L

CACCTTTAAAAGAACGTCGTGTAAAACCTATTGTTAAAATTGAGGAACCG

A414R

GCCTATTCGTACATTCGATTGTTTTCGGTCTTCTGACGTACATATACCTG

A416R

CAATAAAATTTATAGACGCTAGTAAAAACGAAGATGAAGTCGAGGAAGAT

A417L

AGAGCCGAGAACGGGCTGCCATTTCTAGATGTTTTAGAGTTGTCGTATGT

A420L

TCAATGTCTTGCAACCATATTCTTGATAATAATGGAGATTAAAAGAAATT

A421R

AACTTGGTTCAGCCGCGATCTTAATTATGGAAAAGCGAATAGTAAGATAT

A422R

ACATATAGGACCGAATAATATAGGTTGCACCGCTTACGCAAACTACACTC

A423R

ATGTTCAGGAAATAGGGAAAGAAGTTATTGAAAAATACAAAACATTAGAT

A424R

AATAACGGGAATAATAAAGGGAATAATAGCGTCAAGAAAAACAACGTCAA

A426R

CTTTACAAAATCATCTCGAAAAGTGTTCTACTCCAGAACTCGTTCATCTT

A427L

GTATGAATGGTCTAAAGGAATATGACGAATTTATTGAACTCGTAAAACCT

A428L

TAGCAGAACCAGAGTACCACCCAGAATCTTCTCTAAATTATTTTAACAGA

A429L

CTAATGTCATATTCAGCTCAATCTAAGGTTTACACTATTTTGATGTCTTT

A430L

GCCAAAAATTACAACGTCCTTCGCATAATGAGTGGCATGGGAGGCTTAGC

A431L

TGAACACTACGATGGAAGGAAAAATGTCAAGGTGGAAGTTATCTAGGAAA

A432R

CAAAGTATTGGTTCTCACATCACACCCGTAAACGAGTATATGGTATCTAA

A435R

GGGCGAGCTTAGATCCGTTACGGCCGCGTACGAATTCGCCTCCACGAGGG

A437L

TGATCGCCGGTAAACCCGTGAAGATCGAGAAAGAATCCAAGGCGAAGTTC

A438L

GTTTTAACATTTCCTCGTGTGTATAATGGTTCGCGTTTAATTGGTGGTTG

A439R

TTCTCCTTATGCCTTTCATAATGATTCACTGGATTCTGTTGGATGATACG

A440L

GGGAGAGAGAAGACGCCTCAAAATACACTTAAAACTCTCGACAATGCCCA

A441L

AGTTCCGCGAAAAGATTGCCGACTACGGTTTCGAGCCACTTATGGATAAA

A443R

TGATCAGAAATCTAGGAACTCTGTTGTCATGGTCTGTGAGTAAAAAGTAA

A444L

TAAAGCTCGTGGTCAGCAAGCATCCGATAGTCTAAAGGGTTTCTTCGAGA

A445L

ATCGCAGATGCAAAAAAGATTGCGCGTTATGGGTTTGCAATGTTTCTCCT
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A448L

CCGTCCTGAAAAACGAGATGCCTGTTTACGTTGTTGATGCCGAAAAGAAC

A449R

GCGACCGACAGAGACTGTGAATCCACGTATGAGATCGAAGTTGAATTGTA

A450R

AGGATTTGTTGACCGTGCTGTTGACGCTGTGAAGACTGAGATTCGAAATG

A452L

AGATGATACTGAAATGGCGATAGAGACCATTACAAAAGCTGGAGAAAAGT

A454L

ACAGCAAACACCACACTCAACTACCCATGCGTTCTCTAAACGAACCACCC

A456L

AGTTCATCCAAGGGTTGTCTCTAAAATCTGCAAAGGCAAAGGATGCCAAT

A462R

AATATTTGTATTCGTTTCATAATGGACACTCCTCAAACACGCCTCAGCCC

A464R

GAAAATTTCAACAGGAACTGGAAAATCCCGCAAAGATGCAGAGCAAAATG

A465R

CGTCAGTATGGTTGATGATCCATTTATCCGCATTACGTTATCCTAAAAAC

A467L

AACTCGAAGGATTTGTTGACTTCATAACGAGGATTGTGTATGACGAGAAA

A468R

CCTAAGAAACTCATAGAAGAATTATTTCCAGAAGAGGTTGATGATAAATC

A470R

ATACCGAGGAGGCCGGGACTTCCGCTTCATGCAGTTGAAAAAATCTTTGA

A471R

GAACAGGGAGATAAAAGAAGAGAATTGTCAAAAGCTGCGATCAAACGTTG

A473L

TTTTTTGACAACCGTCAACACATTCATCTCTCTACCTTTTATTTGTAACA

A476R

AGCTCATTTCGCTTCAAGGGAAGACCAACTTCTTCGAAAAGCGTGTCAGT

A478L

ATATTAGAGACGGTGCTCTACGGCGAAATATTCAATTCGACCTCACGAAA

A480L

AATGCTGTTCAGTTATTTTGCCGCATACCAACTAGGGAAAATGCAAGAAA

A481L

ATATTGCACAAGAAGTCGAACGCAGAATTAACAATACCGAACACGAATAA

A482R

CTGAAACTCAGACGACCCAAACCAATGACCAAGGGAAAAGCAACTCTTGA

A484L

TATTTACCCTGGGACGATGAGTTCCGCATTCGAAGCTAGAAATTATAGAG

A485R

AGGAGACGCTGTAAGAAGAATGGAAATCATCAAATTGGCATTACAAAATT

A486L

TTGGTAAAGTCATTTCCCACTGAGTTTGACGATAGTGAGAAAATTATGTG

A488R

CCGTTAGAGAACTTCTGCCCATAGAGCAAATTCTCAGGGCATATCTTGGA

A490L

CAGAAGATTTTGTGAGAATTATAACCAATGAAGAATGCTTTTACTGTGGG

A491R

CAACAAGTACGCAGAACCTGGTGAAAAGAATGTTGGTAGAAACTTTTTGA

A492L

TTTCCGTTCGACGACCACGAGGACAATGCAGAAAGATTTTGTGATTTATA

A493L

TGTTCCCGGTTGACAACCATAAGGAAAACGCAAAGAAGTTTTCAGCATTG

A494R

AAAAATTTACACAACCAAGACGTAATATGGAAGAAAATATGTAATGACTT

A495R

AAAAAATGAGCGACTCAAGAAAAGGTGGAAATAATCCGAGAGCAAGACCG

A497R

AGCATCTTGAAGATGGTGTTTGGAAACTGGAAAATTCTGTTGTGCGTTGC

A501L

TGACAGCCTCAAGGAATATCTTGTATCTGTTGCAAAGTTTGTCGCCGTAG

A502L

GATGATTTGGCATCATTGTTTTCAAAGAGACTCTTACCAGATATAATCCC

A503L

GTCGTAGGTCTCAAATTTCATCTAAAGGTAAAGAAAAACATTCGCTTTCC

A505L

GGTAATGGTCTATATCGGAAACTCAATGATTTTAAATTTCAAAATACTCT

A512R

GTTGACAATGTGATTGATTTTGATGTGTCTATGATGCCTGGTCGTACTAA

A517L

CATATAAAACATCCTACACGTTCTCCTGAAAATATCACTTTAACACCGAG

A519L

CTCAAATGGTTGGTATTCGCGTTCGTTTTAGGATTTGTGTTACATTATAT

A520L

TATTACGACAGAAATGGTCTCAAGAAGTTTATCGCGGAACAAGGTTCTAA

A521L

GTCCCGATCTATCATCAGTGACGATGTTCAACCCATTTGCCAAGAAATCT

A523R

CAGATGATTGATGTTCCTCTCGCAGCGGCAAAGACATCTTTCATTGCTGG
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A526R

CACCTTCTCGGTTGTTCGATAGGTCCGATGGTGTAAAATATGTTAGATAA

A527R

ATATCAACGTCAATCGCCTCGTGCTTAATTATATTCGTTCATTCCAATAA

A530R

GTGAAAATGAGGCATCCTTCGTGGTTTTGTGTGATCCCAAAAAGGTGCTC

A531L

AAGAGAAGTATTCAGGTCCTCAAACCGTATTCACGGAAACTCCTAAGCTC

A532L

GGAAAAAAGGCCGAAAAGTTCAACGACGCCTATTACGGTGTTCCATCTAC

A533R

CGTATTACCGCGTCAGGACCTTTTACTCTTCTTGGTAGCACAGGTACTAT

A535L

TCGGATGACGAAGAGGACATCATTCCAAAGAACATAAACATAGAAAAAAT

A536L

TGAAACTATATCGCCCAGATATCACCAGAGTACCAGACGATGAGTGGGAC

A537L

TCTATACTGAACGACGACCCGGAAGAAATCTTAGACCCAATTGTAGAATT

A539R

GATACTATGCTATCCGAAGAAGAATTTCAAGCCATCAGACGGCTTTTGTA

A540L

AGTCTCTTGAAACTCTAGAAGAACGTGTGAAATTATTAGAATCCCGGTGA

A543L

AATTCTACACTTGTAGGGCATACGCCGGGTACACAATGCAAAACACGGAA

A544R

TAAAATGGTGAAATTCAAATACTTCGAAATGGGTTCCAAAGATTGCCCAA

A546L

CCGAGGAAAAGGTTCGCTTTTTGTGTAATAGTCATCTTGATTCAAAATTC

A548L

GAACCTACAGGTGGCAACTCGTGTGTTTATCAATAGTTTGTCGTGGAATG

A551L

TTCTACAGGTATTTCTATTCGCGTTCCAAATGGGACATATGGTCGAATTG

A552R

TGGAAATAGCACATGGTTACCTAACAAATAGCTGGAGATTGTGTATTTGA

A554/556/557L

GGTCATAATATTCCTTACCTTCCTAATAGTACACCCGCGCATTTCAAAAG

A558L

AAACGAATCTCCACGGGCAGTATACCACATCAAATAGCACATTCGTGACG

A559L

CAAAGTAGACTCTGTTAAGAAGGTGTGGACAAAAAGGATGGCAGAATATA

A561L

AAGAGAAATGCGTGGAATAACATCAAAATTGGTCTTAAATTAAATACGAT

A564L

TGTGGGACGTGTAAACCAGAAGACGCAGTTAATGTCGTATCAAAGAAATG

A565R

AAGAAGAATGGAGGTCCTTTGAATTACGGAGACACATTATACTTGAAGTT

A567L

AAACAAGATGTAAACCGCCGCGATTTTGCTACTGAACTTAATAATTCATT

A568L

TGGTTTTTTCATGTTATTATTACAGGAGTATTGACAACATTTATCGTTAT

A570L

AAGTTGTAGATACGCCAGAAGAAGAAGTTATAGAACATGAAGAAGCTTAA

A571R

CTTGCAAAAAATAAAGCATCTGTCGTGAAAAATATGACCAAAAAAATGTA

A572R

CGAGGTCCCATGTTCTTCTGTGAGCTTTTATGGCCTTACAAAAGACGATT

A574L

TAAGCGAGTCGTAATAAAACTACTCGATGATCAACCGGGTATTTTTGAAT

A575L

GTGTACCCTTATAATTTCATTTGCGCTAACGAAAATATGTTGAGGACGAG

A577L

ATGATACAACAAAAGCAGAAAGCCAAAAGGAAAACTGTTCATTATAAATA

A579L

TAAAACCAAGTGGTCAGTGGACGACGAAATTAGGAGAACATATAGCAGAG

A581R

AATTCAAAGAAACCAGGTTCTACAACAACTGAAATTATTGTTATCAAAAT

A583L

AATATGCGGATTAGCAGTCTCACACTGGAACGTGCGACAGAATTGGAACG

A590L

AATATTTATTGGATGGTTTTGCAATTTTGGAGGCAATAGAAACGATATTA

A592R

CGTATATCGATTTTGATTACGATAACTATGACGAAACTCTAGTTTTTTAA

A594R

CGATTCAACTTCAACGCATCTCCTTCTTCCGGGCCATTCAAGTCTATTTT

A596R

TTTCAAATGAAATGTTTGATGAATGTGGAATAGAAGTCGAATACCTATGA

A598L

TGTTCAAAAAACCGAGTGACGAAATAATCTTCAAATGGTCTTTGGCAACG

A601R

GACAAAAAGAGGTGACCCGAGTGTTTATCTACCGTTGATCACGAGCATAT
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A602L

GCGTCACTGATGCAGTCCGCAAAATCCCTCAAGTTTCTTCAAAAATCCTC

A603R

ATGTCCGTAGGTTCATTTACTCTCTCATTGGGAAAAAAGGTTCATTCGTT

A604L

ACATATTGTGAAAATTACAAGAGAATATACTCAAAATCAGGCGATTTTAA

A605L

CATTTCCAAAGCTCACGCCAACCAAGATGAGGTACGTTAATCTAATGTAG

A607R

ATACTCCAATTCATTTATTTCTACGCTTTATACAACGCCCTTCCCTGACA

A608R

CACGTTTTTTACACACGAAAAGGTATTCATTTAGAAAGAGAAATCATTAA

A609L

AGAGTTCCCGTTGAACATCGCATTCTCTTTGGTAAAAAATTAATCACACG

A612L

CAATGGCTCTTGGTTTTGGTGCAATTTTTAACCATAGCAAAGACCCTAAC

A614L

TGTGCTCGTATTGGAAAAAAATGCGGTCCTAAAGGAAGATGTGTCAAACT

A617R

CCAAACATTAAGAGACTCGAAAATAAAAGAGTGACGAGTGGAAACTTTAG

A618L

ATATTCGTCAACAGCGAAGGCAGCACTGTGTCCGACATTCTCACACGTAT

A619L

GAAAACCATTATAAAAGAACAGAAGGAAAAACCAAAACGAGTGTTCATTG

A620L

TTGTTTGAAAACAAGAAGGAAAATTTCACTACCGGAAAAAGTCTGACTAA

A621L

ATAAAAACATAGAAAACTCTATCATTGCCTCTATAATGCTTCAATCAAAT

A622L

TCAGATTTATGCTCCCAACTTTAACATCCTGCGTATCGCTGCTGGAATGG

A623L

AACATCGTTTGATGGAATCTCATTCATGTCCCACTTTACAGGCAAAAGAA

A624R

TCTGAAACGACGACAAACTTCAAAGCGTTCCTATTGGGTTTTCTGGCATA

A625R

TAATGTATGCGACCGCGATATTCACGCCGCCCGCAACATCCTCTTGAAAT

A627R

AGTTATAGGAAGACAAGTGCGTCGTCCAGTCAGTCGTCAAGTTAGAAAAC

A628L

GTTTGGCTGTTTTACTACCCAGAATACATTAACTTCTCTCAGTACTCACA

A629R

AAACAGCCTGGGACCTTTCCATGAAAAGTGTGATTGACATGGCGGCAGAC

A633R

CTGTATTGTTCACAAAAGGTTCCCGAAAGATGGAAAAATAGTGACGGGTT

A634L

GCTAACTGGGAACCATACGAAAAATATCTTAATAAGGGTGATAAAGTTGA

A635R

ATTCATCGTGGGAATTTACGCAGTGTGGCTGAGCTGGAGCTGCTCAAAAG

A636R

AAGTTTTTTAAGACAGGAGAAAGCACCAAGTGTCACGTCAATACGTCAAT

A637R

AACTCATTATGAAAGAATTCGGTGTTTTCTTCGACAAGGCAAAACGATTT

A638R

GTGATATGTTCATCACTGAAGAGGAAGCCACGGGAGTCGTAAATTCAGGT

A642R

AAGAACTTTATGGAATCAAAAACCTTAACGAATTTCCACCGCAGGTTATA

A643R

AGGTAGCTTGAGGGTGCCATATAGCCGTAAGTCAATGAGAAGACCAGGGT

A644R

ATGCTTGAAGCAAATTCTTCCCGGCGTTCGCGCATACGCACTATACGTCA

A645R

AAGGCCGAAAAAAACGGGCTGCTTTCAATGGATAAAAATATACCACTGAT

A646L

TAGAAAAGTATCCCTTTCTCCGAGAAGTTAATACACTCGTATACAAAGGA

A647R

AATTTGGGAGGACGACAAATACCGACATCAGGAAACTAAAAACAAGATAT

A649R

GATGGAGATACTCGCACGGTTATTTATAGAGCACTACAATCGCCACAGTT

A651L

AAATGTGCAAGAGGTAAAAGAAAAACCGCGTATAAGTTTCGTTGGTCATA

A654L

ACTTCTCAAAAAAACTATTGAAGAATCATCTTCACATGGGTTCAAGTATA

A656L

CCAGATTATTCGAAAATATTACCAAAGAGAACTAGTGGTAAAGTGATCCC

A658R

GAGTATATTGTGCAGACGTGGTTCTTGGGTTGTTGTAAACGAAGATATCA

A659L

TTCCGAATTAGACCATGTTGATGAAAATGAGGTGGAAGAGGAAGAAAATT

A662L

TAAACAAGACCATTGTGAATCAGATTTTTTTTGCACCCATCAACATTTCT
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A664L

AGGCCATTAGAACTCGTGTCAATTGCTCGTGTACAAGAAGAAGAACTTAT

A665L

TGTAGGAGAAATTTTATCGCCTATGATGAAGGACTCGGAACTTACAGTAT

A666L

TGAGGAAGGCGCGTGGTGAAGAAGTATCTGACAGCGATGAAGACTACTAA

A672R

TGAACGGAAAACTGGGAATATACCCTGAAGCAATTATAAATGACACATAA

A674R

CAAGGTTTATTCTTCCTCTGAGTACACCAACTACTATTTACATGTCGGGT

A676R

TAACTGAACTTTATGGAATTCGCTACGGTTATACGTTCGGAAATGATTAA

A678R

TTGGTGGGACATACTTGATAGGAACTACTATTTTCCTTGCTCCTGATTTC

A682L

ATAAAAACACTCATCGAAGCAGGTGGTAACATCAACGCCGTCAACAATTC

A683L

CACACCATGTGCTAGTTATGGCACTGCTACTGCTGGATGCAATGTTCTGA

A686L

TTTGTTATCATTCCCAAGGGTACAGAAGTCCATATGAAATATGTTAATCT

A687R

CCCGTTCAAGATCGAAGAGAGTGACTTGAGACGAGCTTTGGAATCCGTGT
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5.2. Supplement 2. List of PBCV-1 CDSs with expression profile

RefSeq
(NCBI)

Expression
timec

Expressed
with
aphidicolin

A002L

NP_048350

E

Yes

Unknown function

Uncategorized

A003R

NP_048351

E

Yes

Unknown function

Uncategorized

A005R

NP_048353

E

Yes

Unknown function

Uncategorized

A007L

NP_048355

E

Yes

Unknown function

Uncategorized

A008L

NP_048356

E

Yes

Unknown function

Uncategorized

A009R

NP_048357

E

Yes

Unknown function

Uncategorized

A010R

NP_048358

L

No

Unknown function

Uncategorized

A011L

NP_048359

L

No

Unknown function

Uncategorized

A014R

NP_048362

L

Yes

Unknown function

Uncategorized

A018L

NP_048366

L

No

Unknown function

Uncategorized

A025L

NP_048373

L

No

Unknown function

Uncategorized

NP_048377

L

No

Unknown function

Uncategorized

NP_048382

L

Yes

Ser/Thr protein kinase

Signaling

CDS

A029L
a

A034R

COGd

Putative function

A035L

NP_048383

L

No

Unknown function

Uncategorized

A037L

NP_048385

E

Yes

Unknown function

Uncategorized

A039L

NP_048387

E

Yes

SKP-1 Protein

Protein Synthesis, Modification, and Degradation

A041R

NP_048389

L

No

Unknown function

Uncategorized

A044L

NP_048392

E

Yes

ATPase (AAA + class)

Protein Synthesis, Modification, and Degradation

NP_048396

EL

Yes

Unknown function

Uncategorized

A049L

b

NP_048397

EL

Yes

Glycerophosphoryl diesterase

Lipid Metabolism

A050L

a

NP_048398

E

Yes

Pyrimidine dimer-specific glycosylase

DNA Replication, Recombination, and Repair

A048R

A051L

NP_048399

L

No

Unknown function

Uncategorized

A053Ra

NP_048401

E

Yes

D-lactate dehydrogenase

Sugar Metabolism

A057R

NP_048405

E

Yes

Unknown function

Uncategorized

A060L

NP_048408

N/A

N/A

Unknown function

Uncategorized

A061L

NP_048409

L

No

O-methyltransferase

Miscellaneous

A063L

NP_048411

L

No

Unknown function

Uncategorized

A064R

NP_048412

E

Yes

Glycosyltransferase

Sugar Metabolism

A067R

NP_048415

E

Yes

Unknown function

Uncategorized

A071R

NP_048419

EL

No

Unknown function

Uncategorized

A075L

NP_048423

EL

Yes

Unknown function

Uncategorized

A077L

NP_048425

E

Yes

Unknown function

Uncategorized

A078Ra

NP_048426

E

Yes

N-carbomoylputrescine amidohydrolase

Miscellaneous

A079R

NP_048427

E

Yes

Unknown function

Uncategorized

A081L

NP_048429

E

No

Unknown function

Uncategorized

A084L

NP_048432

E

Yes

Unknown function

Uncategorized
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A085Ra

NP_048433

L

No

Prolyl-4-hydroxylase

Protein Synthesis, Modification, and Degradation

A087R

NP_048435

E

Yes

HNH endonuclease

Integration and Transposition

A088R

NP_048436

E

Yes

Unknown function

Uncategorized

NP_048437

EL

Yes

Unknown function

Uncategorized

NP_048438

EL

No

Unknown function

Uncategorized

NP_048441

EL

No

Unknown function

Uncategorized

NP_048442

E

Yes

Beta-1,3-glucanase

Cell Wall Degradation
Sugar Manipulation

b

A089R

A090R
A092/93L
A094L

b

a

a

A098R

NP_048446

E

Yes

Hyaluronan synthase

A100Ra

NP_048448

E

Yes

Glucosamine synthetase

Sugar Manipulation

A103Ra

NP_048451

E

Yes

mRNA guanylyltransferase

Transcription

A105L

NP_048453

E

Yes

Ubiquitin C-terminal hydrolase

Protein Synthesis, Modification, and Degradation

A107L

NP_048455

E

Yes

Trancription factor TFIIB

Transcription

A109L

NP_048457

EL

Yes

Unknown function

Uncategorized

NP_048459

E

Yes

Fucosyl-Glycosyltransferase

Sugar Manipulation

NP_048466

EL

No

GDP-D-mannose dehydratase

Sugar Manipulation

No

Unknown function

Uncategorized

A111/114R
a

A118R

A121R

NP_048469

A122/123R

NP_048470
NP_048471

L

Yes

Unknown function

Uncategorized

A125L

NP_048472

E

Yes

Transcription factor TFIIS

Transcription

A127R

NP_048475

L

No

Unknown function

Uncategorized

A129R

NP_048477

EL

Yes

Unknown function

Uncategorized

A130R

NP_048478

EL

Yes

Unknown function

Uncategorized

A131L

NP_048479

E

Yes

Unknown function

Uncategorized

A133R

NP_048481

E

Yes

Unknown function

Uncategorized

A134L

NP_048482

EL

No

GIY-YIG endonuclease

Integration and Transposition

A135L

NP_048483

L

Yes

Unknown function

Uncategorized

A137R

NP_048485

E

Yes

Unknown function

Uncategorized

A138R

NP_048486

EL

Yes

Unknown function

Uncategorized

NP_048487

L

No

Unknown function

Uncategorized

A140/145R

NP_048488

EL

No

Unknown function

Uncategorized

A148R

NP_048496

L

No

Unknown function

Uncategorized

A150L

NP_048498

E

No

Unknown function

Uncategorized

A151R

NP_048499

E

Yes

Unknown function

Uncategorized

b

A139L
b

EL

A153R

NP_048501

EL

No

Superfamily II helicase

Transcription

A154L

NP_048502

EL

No

Unknown function

Uncategorized

A157Lb

NP_048505

EL

No

Unknown function

Uncategorized

A158L

NP_048506

E

No

Unknown function

Uncategorized

A161R

NP_048509

E

Yes

Unknown function

Uncategorized

A162L

NP_048510

E

No

Unknown function

Uncategorized

A163R

NP_048511

EL

No

Unknown function

Uncategorized

A165L

NP_048513

EL

No

Unknown function

Uncategorized
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A166Ra

NP_048514

EL

No

Exonuclease

DNA Replication, Recombination, and Repair

A168R

NP_048516

L

No

Unknown function

Uncategorized

A169Ra

NP_048517

EL

No

Aspartate transcarbamylase

Nucleotide metabolism

A171R

NP_048519

E

Yes

Unknown function

Uncategorized

A173L

NP_048521

E

Yes

Patatin-like phospholipase

Lipid Manipulation

A175R

NP_048523

EL

Yes

Unknown function

Uncategorized

A177R

NP_048525

EL

No

Unknown function

Uncategorized
Miscellaneous

A180R

NP_048528

E

Yes

Fibronectin binding protein

A181/182Ra

NP_048529

L

No

Chitinase

Cell Wall Degradation

A185R

NP_048532

E

Yes

DNA Pol

DNA Replication, Recombination, and Repair

A189/192R

NP_048536

L

Yes

SWI/SNF chromatin remodeling complex

Transcription

A193L

NP_048540

EL

No

PCNA

DNA replication, Recombination, and Repair

A196L

NP_048543

L

No

Unknown function

Uncategorized

A199R

NP_048546

L

No

Unknown function

Uncategorized

A200R

NP_048547

E

Yes

Cytosine deaminase

Nucleotide Metabolism
Uncategorized

A201L

NP_048548

EL

No

Unknown function

A202L

NP_048549

EL

Yes

Unknown function

Uncategorized

A203R

NP_048550

L

No

Unknown function

Uncategorized

A205R

NP_048552

L

No

Unknown function

Uncategorized

A207R

NP_048554

EL

No

Ornithine/Arginine decarboxylase

Miscellaneous

A208R

NP_048555

E

Yes

Unknown function

Uncategorized

A213L

NP_048560

EL

Yes

Unknown function

Uncategorized

NP_048561

E

Yes

Unknown function

Uncategorized

a,b

A214L
a

NP_048562

L

No

Beta and Alpha 1,4 linked glucoronic lyase

Cell Wall Degradation

A217Lb

NP_048564

EL

No

Monoamine oxidase

Miscellaneous

A219/222/226R

NP_048569

E

Yes

Glycosyltransferase

Sugar Manipulation

A227L

NP_048575

L

No

Unknown function

Uncategorized

A229L

NP_048577

L

Yes

Unknown function

Uncategorized

A230R

NP_048578

L

No

Unknown function

Uncategorized

A231Lb

NP_048579

EL

No

Unknown function

Uncategorized

A233R

NP_048581

L

No

Unknown function

Uncategorized

A234L

NP_048582

EL

No

Unknown function

Uncategorized

A237R

NP_048585

L

No

Homospermidine synthase

Miscellaneous

A239L

NP_048587

E

Yes

Unknown function

Uncategorized

A241R

NP_048589

E

Yes

Superfamily II helicase

Transcription
Uncategorized

A215L

a

A243R

NP_048591

EL

No

Unknown function

A245Ra

NP_048593

L

No

Cu/Zn-Superoxide Dismutase

Miscellaneous

A246R

NP_048594

L

No

Pathogenesis-related protein

Miscellaneous

A247R

NP_048596

E

No

Unknown function

Uncategorized

a

NP_048597

E

Yes

Ser/Thr protein kinase

Signaling

a,b

NP_048599

EL

Yes

Potassium channel protein

Signaling

A248R
A250R
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A251Ra

NP_048600

E

Yes

Adenine methyltransferase

DNA Restriction/Modification

A252Ra

NP_048602

L

No

DNA restriction endonuclease

DNA Restriction/Modification

A253R

NP_048604

E

Yes

Unknown function

Uncategorized

A254R

NP_048605

L

No

Acetyltransferase

Lipid Manipulation

A256L

NP_048607

EL

Yes

Unknown function

Uncategorized

A257L

NP_048608

E

Yes

Unknown function

Uncategorized

NP_048610

E

Yes

Unknown function

Uncategorized
Cell Wall Degradation

A259L
a

A260R

NP_048613

L

Yes

Chitinase

A261R

NP_048615

EL

Yes

Unknown function

Uncategorized

A262L

NP_048616

L

Yes

Unknown function

Uncategorized

A263L

NP_048617

L

No

Unknown function

Uncategorized

A265L

NP_048619

EL

Yes

Unknown function

Uncategorized

NP_048621

E

No

HNH endonuclease

Integration and Transposition

NP_048625

EL

Yes

Lysophospholipase

Lipid Metabolism

NP_048627

L

No

Unknown function

Uncategorized
Uncategorized

A267L
A271L

b

A273L
A274R

NP_048628

EL

No

Unknown function

A275R

NP_048629

E

Yes

Unknown function

Uncategorized

A277La

NP_048631

L

No

Ser/Thr protein kinase

Signaling

A278La

NP_048632

L

No

Ser/Thr protein kinase

Signaling

A282L

a

NP_048636

L

No

Ser/Thr protein kinase

Signaling

A284L

a,b

NP_048638

EL

Yes

Amidase

Miscellaneous

A286R

NP_048640

L

No

Unknown function

Uncategorized

A287R

GIY-YIG endonuclease

Integration and Transposition

NP_048641

EL

No

a

NP_048643

EL

Yes

Ser/Thr protein kinase

Signaling

A292La

NP_048646

L

No

Chitosanase

Cell Wall Degradation

A295La

NP_048649

EL

No

Fucose synthase

Sugar Manipulation

A296R

NP_048650

L

Yes

Unknown function

Uncategorized

A297L

NP_048651

L

Yes

Fructose-2,6 biphosphatase

Sugar Metabolism

A298L

NP_048652

E

No

Unknown function

Uncategorized

A301L

NP_048655

E

Yes

Unknown function

Uncategorized

A304R

NP_048658

L

Yes

Unknown function

Uncategorized
Signaling

A289L

A305L

NP_048659

L

No

Dual specificity phosphatase

A306L

NP_048660

EL

Yes

Unknown function

Uncategorized

A308L

NP_048663

E

Yes

Unknown function

Uncategorized

A310L

NP_048665

L

No

Unknown function

Uncategorized

A312L

NP_048667

EL

Yes

Unknown function

Uncategorized

A313L

NP_048669

L

No

Unknown function

Uncategorized

A314R

NP_048670

L

No

Unknown function

Uncategorized

A315L

NP_048671

EL

Yes

GIY-YIG endonuclease

Integration and Transposition

Yes

Unknown function

Uncategorized

A316R

NP_048672

L
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A318R

NP_048674

L

No

Unknown function

Uncategorized

A320R

NP_048676

L

No

Unknown function

Uncategorized

A321R

NP_048677

L

No

Unknown function

Uncategorized

A322L

NP_048678

L

Yes

Unknown function

Uncategorized

A324L

NP_048680

L

No

Unknown function

Uncategorized

A326L

NP_048682

L

No

NTP pyrophosphohydrolase

Nucleotide Metabolism

A328L

NP_048684

N/A

Yes

Unknown function

Uncategorized
Uncategorized

A329R

NP_048685

L

No

Unknown function

A330R

NP_048686

EL

No

Unknown function

Uncategorized

A333L

NP_048689

EL

No

Unknown function

Uncategorized

A337Lb

NP_048693

EL

No

Unknown function

Uncategorized

b

NP_048695

EL

No

Unknown function

Uncategorized

NP_048697

E

Yes

Unknown function

Uncategorized

NP_048699

EL

No

Unknown function

Uncategorized

NP_048705

E

Yes

Unknown function

Uncategorized
Uncategorized

A339L
A341L
A342L

b

A348R
b

NP_048706

EL

No

Unknown function

A351L

NP_048708

E

Yes

GIY-YIG endonuclease

Integration and Transposition

A352L

NP_048709

L

No

Unknown function

Uncategorized

A354R

NP_048711

EL

No

HNH endonuclease

Integration and Transposition

A357L

NP_048714

EL

Yes

Unknown function

Uncategorized

NP_048717

L

No

Unknown function

Uncategorized

A361R

NP_048718

EL

No

Unknown function

Uncategorized

A363R

NP_048720

L

No

Superfamily II helicase

Transcription

A366L

NP_048723

EL

No

Transposase

Integration and Transposition

A368L

NP_048725

E

Yes

Unknown function

Uncategorized

A373R

NP_048730

EL

Yes

Unknown function

Uncategorized

A375Rb

NP_048732

EL

Yes

Unknown function

Uncategorized

A378L

NP_048735

L

No

Unknown function

Uncategorized

A379L

NP_048736

E

Yes

Unknown function

Uncategorized

A382R

NP_048739

L

No

Unknown function

Uncategorized

A383R

NP_048740

L

Yes

Unknown function

Uncategorized
Uncategorized

A349L

A360R
b

b

NP_048741

EL

Yes

Unknown function

A390L

NP_048747

L

No

Unknown function

Uncategorized

A392R

NP_048749

L

No

ATPase (DNA packaging)

DNA Replication, Recombination, and Repair

A394Rb

NP_048751

EL

No

Unknown function

Uncategorized

A395R

NP_048752

EL

Yes

Unknown function

Uncategorized

A396L

NP_048753

EL

No

Unknown function

Uncategorized

A397R

NP_048754

E

Yes

Unknown function

Uncategorized

A398L

NP_048755

L

No

Unknown function

Uncategorized

No

Rnase H

DNA Replication, Recombination, and Repair

A384L

A399R

NP_048756

E
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A400R

NP_048757

EL

Yes

Unknown function

Uncategorized

A401R

NP_048758

EL

No

Unknown function

Uncategorized

A402R

NP_048759

L

No

Lipoprotein lipase

Lipid Manipulation

A403R

NP_048760

EL

Yes

Unknown function

Uncategorized

A404R

NP_048761

L

No

Unknown function

Uncategorized

A405R

NP_048762

L

No

Unknown function

Uncategorized

A407L

NP_048764

L

No

Unknown function

Uncategorized
Uncategorized

A408L

NP_048765

EL

No

Unknown function

A410L

NP_048767

E

Yes

Unknown function

Uncategorized

A411R

NP_048768

L

No

Unknown function

Uncategorized

A412R

NP_048769

E

Yes

Unknown function

Uncategorized

A413L

NP_048770

L

No

Unknown function

Uncategorized

A414R

NP_048771

L

No

Unknown function

Uncategorized

A416R

NP_048773

L

No

Deoxynucleoside kinase

Nucleotide Metabolism

A417L

NP_048774

L

No

Replication factor C

DNA Replication, Recombination, and Repair
Uncategorized

A420L

NP_048777

L

No

Unknown function

A421R

NP_048778

L

No

Unknown function

Uncategorized

A422Rb

NP_048779

EL

No

HNH endonuclease

Integration and Transposition

A423R

NP_048780

L

No

Unknown function

Uncategorized

A424R

NP_048781

L

Yes

Unknown function

Uncategorized

A426R

NP_048783

L

No

Unknown function

Uncategorized

A427L

NP_048784

E

Yes

Thioredoxin

Nucleotide Metabolism

A428L

NP_048785

EL

Yes

Unknown function

Uncategorized

A429L

NP_048786

E

Yes

Unknown function

Uncategorized

A430L

NP_048787

L

Yes

Major capsid

Structural Protein

A431L

NP_048788

E

Yes

Unknown function

Uncategorized

A432R

NP_048789

L

No

Unknown function

Uncategorized

A435R

NP_048793

E

Yes

Unknown function

Uncategorized

A437L

NP_048794

L

No

DNA binding protein

DNA Replication, Recombination, and Repair

NP_048795

EL

No

Glutaredoxin

Nucleotide Metabolism

NP_048796

E

Yes

Unknown function

Uncategorized
Uncategorized

A438L

a

A439R
A440L

NP_048797

E

Yes

Unknown function

A441L

NP_048798

E

Yes

Unknown function

Uncategorized

A443R

NP_048800

E

No

Unknown function

Uncategorized

A444L

NP_048801

L

No

Unknown function

Uncategorized

A445L

NP_048802

E

Yes

ABC Transporter

Miscellaneous

NP_048805

L

No

Protein disulfide isomerase

Protein Synthesis, Modification, and Degradation

A449R

NP_048806

E

Yes

RNA triphosphatase

Transcription

A450R

NP_048807

E

Yes

Unknown function

Uncategorized

Yes

Unknown function

Uncategorized

A448L
a

A452L

NP_048809

E
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A454L

NP_048811

EL

Yes

Unknown function

Uncategorized

A456L

NP_048813

E

Yes

Helicase -Superfamily III

DNA Replication, Recombination, and Repair

A462Rb

NP_048818

EL

No

Unknown function

Uncategorized

a

NP_048820

E

Yes

RNAse III

Transcription

b

A465R

NP_048821

EL

No

Thiol oxidoreductase

Protein Synthesis, Modification, and Degradation

A467L

NP_048823

EL

Yes

Unknown function

Uncategorized

A468R

NP_048824

EL

No

Archaeo-eukaryotic primase

DNA Replication, Recombination, and Repair
Uncategorized

A464R

A470R

NP_048826

L

No

Unknown function

A471R

NP_048827

L

No

Unknown function

Uncategorized

A473L

NP_048829

E

Yes

Glycosyltransferase

Sugar Metabolism

A476R

NP_048832

EL

No

Ribo. Reductase

Nucleotide Metabolism

A478L

NP_048834

EL

Yes

HNH endonuclease

Integration and Transposition

A480L

NP_048836

L

No

Unknown function

Uncategorized

A481L

NP_048837

E

Yes

SCF-E3 ubiquitin ligase

Protein Synthesis, Modification, and Degradation

NP_048838

N/A

Yes

Unknown function

Uncategorized
Uncategorized

A482R
b

NP_048840

EL

No

Unknown function

A485R

NP_048841

L

No

Unknown function

Uncategorized

A486L

NP_048842

E

Yes

Unknown function

Uncategorized

A488R

NP_048844

L

No

Unknown function

Uncategorized

A490L

NP_048846

EL

No

HNH endonuclease

Integration and Transposition

A491R

NP_048847

L

No

Unknown function

Uncategorized

A492L

NP_048848

E

Yes

Unknown function

Uncategorized

A493L

NP_048849

E

No

Unknown function

Uncategorized

A484L

A494R

NP_048850

EL

No

Unknown function

Uncategorized

A495R

NP_048851

EL

Yes

GIY-YIG endonuclease

Integration and Transposition

A497R

NP_048853

L

No

Unknown function

Uncategorized

A501L

NP_048857

L

Yes

Unknown function

Uncategorized

A502L

NP_048858

L

No

Unknown function

Uncategorized

A503L

NP_048859

E

No

Unknown function

Uncategorized

A505L

NP_048861

E

Yes

Unknown function

Uncategorized

A512R

NP_048868

E

Yes

Unknown function

Uncategorized
DNA Restriction/Modification

A517L

NP_048873

E

Yes

Cytosine methyltransferase

A519L

NP_048875

L

No

Unknown function

Uncategorized

A520L

NP_048876

L

No

Unknown function

Uncategorized

A521Lb

NP_048877

EL

Yes

Unknown function

Uncategorized

A523R

NP_048879

L

No

Unknown function

Uncategorized

A526R

NP_048882

L

No

Unknown function

Uncategorized

A527R

NP_048883

L

No

Unknown function

Uncategorized

A530R

NP_048886

L

No

Cytosine methyltransferase

DNA Restriction/Modification

No

Unknown function

Uncategorized

A531L

NP_048887

L
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A532L

NP_048888

L

No

Unknown function

Uncategorized

A533R

NP_048889

EL

No

Unknown function

Uncategorized

A535Lb

NP_048891

EL

No

Unknown function

Uncategorized

b

NP_048892

EL

No

Unknown function

Uncategorized

A537L

NP_048893

E

No

Unknown function

Uncategorized

A539R

NP_048895

E

Yes

GIY-YIG endonuclease

Integration and Transposition

A540L

NP_048896

L

No

Unknown function

Uncategorized
Uncategorized

A536L

A543L

NP_048899

L

No

Unknown function

A544R

NP_048900

L

No

ATP-dependent ligase

DNA Replication, Recombination, and Repair

A546L

NP_048902

E

No

Glycosyltransferase

Sugar Metabolism

NP_048904

E

Yes

SWI/SNF helicase

Transcription

NP_048907

E

Yes

dUTP pyrophosphatase

Nucleotide Metabolism

A552R

NP_048908

E

Yes

Transcription factor TFIID

Transcription

A554/556/557L

NP_048910

E

Yes

ATPase (PP-loop)

DNA Replication, Recombination, and Repair

A558L

NP_048914

EL

No

Unknown function

Uncategorized

A559L

NP_048915

L

No

Unknown function

Uncategorized
DNA Replication, Recombination, and Repair

A548L
A551L

a

A561L

NP_048917

L

Yes

ATPase (DNA repair)

A564L

NP_048920

EL

Yes

Unknown function

Uncategorized

A565Rb

NP_048921

EL

Yes

ATPase (Chromosome segregation)

DNA Replication, Recombination, and Repair

A567L

NP_048923

EL

No

Unknown function

Uncategorized

A568L

NP_048924

E

Yes

Unknown function

Uncategorized

A570L

NP_048926

L

Yes

Unknown function

Uncategorized

A571R

NP_048927

L

No

Unknown function

Uncategorized

A572R

NP_048928

L

No

Unknown function

Uncategorized
DNA Replication, Recombination, and Repair

A574L

NP_048930

E

Yes

PCNA

A575L

NP_048931

E

Yes

Unknown function

Uncategorized

A577L

NP_048933

L

No

Unknown function

Uncategorized

A579La

NP_048935

L

No

DNA restriction endonuclease

DNA Restriction/Modification

a

NP_048937

E

Yes

DNA methyltransferase

DNA Restriction/Modification

A583L

a

NP_048939

E

Yes

DNA Topoisomerase II

DNA Replication, Recombination, and Repair

A590L

b

NP_048946

EL

No

Unknown function

Uncategorized

NP_048948

EL

No

Unknown function

Uncategorized

A581R

A592R
A594R

NP_048950

E

Yes

Unknown function

Uncategorized

A596Ra

NP_048952

EL

Yes

dCMP deaminase

Nucleotide Metabolism

A598L

NP_048954

EL

Yes

Histidine decarboxylase

Miscellaneous

A601R

NP_048957

EL

No

Unknown function

Uncategorized

A602L

NP_048958

E

Yes

Unknown function

Uncategorized

A603R

NP_048959

E

Yes

Unknown function

Uncategorized

A604L

NP_048960

E

Yes

Zn metallopeptidase

Protein Synthesis, Modification, and Degradation

NP_048961

EL

No

Unknown function

Uncategorized

A605L

b
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A607R

NP_048963

E

Yes

Unknown function

Uncategorized

A608R

NP_048964

E

Yes

Unknown function

Uncategorized

A609La

NP_048965

E

Yes

UDP-glucose 6-dehydrogenase

Sugar Metabolism

A612L

a

NP_048968

L

No

Histone H3, Lys27 methylase

Transcription

A614L

a

NP_048970

L

No

Ser/Thr protein kinase

Signaling

a

A617R

NP_048973

EL

Yes

Ser/Thr protein kinase

Signaling

A618L

NP_048974

L

Yes

Unknown function

Uncategorized
Uncategorized

A619L

NP_048975

L

No

Unknown function

A620L

NP_048976

L

No

Unknown function

Uncategorized

A621L

NP_048977

L

No

Unknown function

Uncategorized

A622L

NP_048978

L

No

Unknown function

Uncategorized

A623L

NP_048979

E

No

Unknown function

Uncategorized

A624R

NP_048980

L

No

Unknown function

Uncategorized

A625R

NP_048981

L

Yes

Transposase

Integration and Transposition

A627R

NP_048983

L

Yes

Unknown function

Uncategorized
Uncategorized

A628L

NP_048984

E

Yes

Unknown function

A629R

NP_048985

EL

Yes

Ribo. Reductase (Large subunit)

Nucleotide Metabolism

A633R

NP_048989

L

Yes

Unknown function

Uncategorized

A634L

NP_048990

E

Yes

Unknown function

Uncategorized

A635R

NP_048991

L

Yes

Unknown function

Uncategorized

A636R

NP_048992

L

No

Unknown function

Uncategorized

A637R

NP_048993

E

Yes

Unknown function

Uncategorized

a

NP_048994

E

Yes

Agmatine iminohydrolase

Miscellaneous

b

A642R

NP_048998

EL

No

Unknown function

Uncategorized

A643R

NP_048999

L

No

Unknown function

Uncategorized

A644R

NP_049000

L

No

Unknown function

Uncategorized

A645R

NP_049001

E

Yes

Unknown function

Uncategorized

A646L

NP_049002

N/A

Yes

Unknown function

Uncategorized

A647R

NP_049003

E

Yes

Unknown function

Uncategorized

A649R

NP_049005

E

Yes

Unknown function

Uncategorized

A651L

NP_049007

EL

Yes

GIY-YIG endonuclease

Integration and Transposition
Lipid Metabolism

A638R

A654L

NP_049010

E

Yes

N-Acetyltransferase

A656L

NP_049012

E

Yes

Unknown function

Uncategorized

A658R

NP_049014

L

No

Unknown function

Uncategorized

A659L

NP_049015

L

No

Unknown function

Uncategorized

A662L

NP_049018

EL

Yes

Unknown function

Uncategorized

A664L

NP_049020

E

Yes

Unknown function

Uncategorized

A665L

NP_049021

E

Yes

Unknown function

Uncategorized

A666L

NP_049022

E

Yes

Translation elongation factor -3

Protein Synthesis, Modification, and Degradation

Yes

Unknown function

Uncategorized

A672R

NP_049028

E
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A674Ra

NP_049030

E

Yes

Thymidylate synthase X

Nucleotide Metabolism

A676R

NP_049032

L

No

Unknown function

Uncategorized

A678R

NP_049034

L

Yes

Unknown function

Uncategorized

A682L

NP_049038

E

Yes

Unknown function

Uncategorized

A683L

NP_049039

EL

Yes

Cytosine methyltransferase

DNA Restriction/Modification

A686L

NP_049042

E

Yes

Unknown function

Uncategorized

A687R

NP_049043

E

Yes

Unknown function

Uncategorized

N/A

Unknown function

Uncategorized

A689L

NP_049045

N/A

a

Recombinant proteins have been characterized for these CDSs

b

Non-continuous transcription was detected for these CDSs

c

E = Early genes; EL = Early/Late genes; L = Late genes; N/A = Not Available

d

COG = Cluster of Orthologus Group
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CHAPTER III
PUTATIVE GENE PROMOTER SEQUENCES IN THE
CHLORELLA VIRUSES

1. OVERVIEW
Chlorella viruses (Family Phycodnaviridae, genus Chlorovirus) are large,
icosahedral, plaque-forming, dsDNA-containing viruses that infect and replicate in
certain isolates of chlorella-like green algae. The 330-kb genome of the prototype virus,
Paramecium bursaria chlorella virus 1 (PBCV-1), was sequenced and annotated more
than 10 years ago [1]. The virus contains 366 putative protein-encoding genes and a
polycistronic gene that encodes 11 tRNAs [1, 2]. Approximately 40% of its predicted
gene products resemble proteins of known function and many are unexpected for a virus.
Currently, three species are included in the genus Chlorovirus: i) Viruses that infect
Chlorella NC64A (NC64A viruses), ii) viruses that infect Chlorella Pbi (Pbi viruses) and
iii) viruses that infect symbiotic zoochlorella in the coelenterate Hydra viridis [3].
Chlorella NC64A and Chlorella Pbi are normally endosymbionts of the protozoan
Paramecium bursaria, but they can be cultured independently of the protozoan. The
current study involves three chlorella viruses whose genomes have been sequenced:
viruses PBCV-1 and NY-2A [4] are NC64A viruses with 330-kb and 369-kb genomes,
respectively, and virus MT325, a Pbi virus with a 314-kb genome [5].
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PBCV-1 infects its host by attaching rapidly to the external surface of the algal
cell wall [6]. Attachment occurs at a unique virus vertex [7] and is followed by digestion
of the cell wall at the attachment point. Following host wall degradation, the PBCV-1
internal membrane presumably fuses with the host membrane, which leads to the entry of
virus DNA and probably associated proteins into the host. An empty capsid remains on
the host surface. Circumstantial evidence suggests that the infecting PBCV-1 DNA, and
DNA associated proteins, rapidly move to the nucleus to initiate virus transcription [2].
Support for this hypothesis includes the fact that neither PBCV-1 nor any of the chlorella
viruses encode a recognizable RNA polymerase or RNA polymerase subunit.
Furthermore, RNA polymerase activity was not detected in PBCV-1 virions (Rohozinski
and Van Etten, unpublished results). Consequently, assuming that the infecting viral
DNA moves to the nucleus, it must FRPPDQGHHU RQH RI WKH KRVW¶V 51$ SRO\PHUDVHV
(probably RNA polymerase II) to initiate viral transcription [2]. Therefore, the host
polymerase(s), possibly in combination with a virus protein(s), must recognize some
virus DNA promoter sequence(s) to initiate transcription. This process occurs rapidly
because early PBCV-1 transcripts can be detected within 5 to 10 min post-infection (p.i.)
[8]. Virus DNA replication starts 60 to 90 min p.i., followed by transcription of late virus
genes. Nascent virus capsids begin to assemble in localized regions of the cytoplasm,
called virus assembly centers, at 2 to 4 hr p.i. By 5 to 6 hr p.i. the cytoplasm contains
many progeny viruses and by 6 to 8 hr p.i. the cell lyses and releases progeny viruses
(~1,000 particles/cell).
Thus, PBCV-WUDQVFULSWLRQLVWHPSRUDOO\SURJUDPPHG*HQHVGHILQHGDV³HDUO\´
are transcribed within 5-60 min p.i.; some of the earliest transcripts form in the absence
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of de novo protein synthesis [8] (Yanai-Balser et al., unpublished results). Transcripts of
JHQHVGHILQHGDV³ODWH´EHJLQWRDSSHDU-90 min p.i.; their appearance probably requires
translation of early viral genes. However, some early gene transcripts can also be
detected in later stages of infection. The PBCV-1 genes are not spatially clustered on the
genome by either temporal or functional class.

Therefore, temporal regulation of

transcription must occur via cis- and possibly trans-acting regulatory elements.
The purpose of the current study is to identify conserved DNA sequences that
might be involved in activation and regulation of viral transcription by using
bioinformatic procedures. We identified three conserved nucleotide sequences that appear
within 150 nucleotides of the ATG translation start codon of many virus open reading
frames (ORFs). One of these motifs is associated predominately with early viral gene
transcription and is likely to serve as a promoter for early genes.

Figure 1. Genomic locations of homologous genes between NY-2A and either PBCV-1
or MT325. When a homologous gene is detected between NY-2A and another genome a
line is drawn. If the gene is transcribed in the same direction the line is blue. If the gene
is transcribed in the opposite direction the line is red.
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2. MATERIALS AND METHODS
2.1. Bioinformatics. The genome sequences and annotations for viruses PBCV-1, NY2A, and MT325 are available from GenBank under accession numbers U42580,
DQ491002, and DQ491001, respectively. The same material is also located at
http://greengene.uml.edu. For this study, the promoter region was defined as the region
encompassing 150 nucleotides upstream of the ATG translation initiation codon and 50
nucleotides downstream of the ATG translation start codon.
AlignAce software [9] was used to identify conserved motifs in the promoter
regions of the 366 PBCV-1 genes. Three conserved sequences were initially identified
(Fig. 2). Two of the sequences were 10-mers and one was a 12-mer. These sequences
were optimized and shortened (from each end) one base at a time by trial and error to
generate the highest ratio of sequence hits in the promoter region relative to total
sequence hits in the PBCV-1 genome (Table 1). The PBCV-1, NY-2A, and MT325
genomes were then searched for the occurrence of the three optimized sequences under
complete stringency; the locations of the sequences within the promoter region were
identified for each gene. The position of each sequence was then plotted with respect to
the ATG translation initiation codon (Fig. 3). In addition, the PBCV-1 genome was
searched for the three conserved sequences allowing one nucleotide mismatch and
plotted.

2.2 RNA isolation. Infected chlorella cells (m.o.i. of 5) were collected at 20, 40, 60, 90,
120, 240, and 360 min p.i. Cells were disrupted with glass beads in the presence of
Trizol (Invitrogen, Carlsbad, CA) and RNA was isolated using the Absolutely RNA
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Miniprep kit (Stratagene, LaJolla, CA), according WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV
RNA integrity was verified in denaturing 1% agarose gels where intact host cytoplasmic
and chloroplast rRNAs were visualized.

Figure 2.

AlignAce results for the three conserved nucleotide sequences that

frequently occur in the virus PBCV-1 promoter regions. The black line indicates a
potential groove of DNA.

2.3 Microarrays fabrication and hybridization. A microarray containing 50-mer
oligonucleotide probes representing each ORF in the PBCV-1 genome was constructed
by MWG Biotech (Ebersberg, Germany) and the Microarray Core Facility (University of
Nebraska Medical Center). For each time point, 20 mg of total RNA was reversetranscribed using oligo(dT) as primers and cDNA was labeled with Cy3 or Cy5-dUTP
(GE Healthcare, Piscataway, NJ) with the aid of a SuperScript Indirect cDNA Labeling
6\VWHP ,QYLWURJHQ &DUOVEDG &$  IROORZLQJ WKH VXSSOLHU¶V GLUHFWLRQV  &RPSHWLWLYH
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hybridization experiments were conducted for each time point against a pool of
transcripts representing every gene isolated in the time course.

2.4 Microarrays analysis. Results from three independent biological hybridizations were
analyzed using the GenePix Pro v.6.0 software (Molecular Devices, Sunnyvale, CA) and
TIGR microarray software suite (TM4) [10]. Many transformations were performed to
eliminate low quality data, to normalize the measured intensities using Lowess algorithm,
and to regularize the standard deviation of the intensity of the Cy3/Cy5 ratio across the
blocks. Genes that displayed statistically significant modulation were identified by a oneway analysis of variance, using P values of <0.01 as a cutoff. Genes with similar
expression profiles were grouped into 10 different clusters using a K-means algorithm.

3. RESULTS and DISCUSSION
3.1. Viruses analyzed and criteria used to define genes and promoter regions in this
study. The three chlorella viruses chosen for this study are PBCV-1, NY-2A, and MT325
that have 366, 404, and 329 putative protein-encoding genes, respectively.
Approximately 80% of the genes are present in all three viruses. PBCV-1 and NY-2A
infect the same host, Chlorella NC64A, and presumably are more closely related, in
terms of evolutionary distance, to each other than to MT325, which infects Chlorella Pbi.
However, the two NC64A viruses are among the most diverse of the NC64A viruses.
The average amino acid identity between PBCV-1 and NY-2A homologs is ~75% [4],
whereas the average amino acid identity between PBCV-1 and MT325 is ~50% [5].
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Most PBCV-1 and NY-2A gene homologs are located co-linearly; in contrast,
homologous genes in PBCV-1 and MT325 have almost no co-linearity with each other
(Fig. 1). Thus, the promoter elements of the two NC64A viruses might be expected to be
more similar to each other than between NC64A and Pbi viruses.

Table 1. Promoter motif optimization based on generating the motif that has the most
occurrences in the promoter region relative to the total number of occurrences in the
PBCV-1 genome.

*Shown is the total number of times the motif occurred in the promoter regions. Note the
same motif can occur multiple times within the same promoter region. For example,
there are 91 unique genes that contain the promoter sequence ARNTTAANA; 84 of these
genes contain the sequence one time and 7 genes contain the sequence twice.
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The following criteria were originally used to define genes in the three viruses: i)
a minimal size of 65 codons initiated by an ATG codon, ii) when genes overlapped, the
largest gene was chosen and iii) genes typically contain A+T-rich (>70%) regions in the
50 nucleotides upstream of the ATG translation start codon [1]. For this study, promoter
regions were defined as encompassing a 200 bp region (150 bp upstream and 50 bp
downstream of the ATG translation start site) of each viral encoded gene. However, the
intergenic regions between PBCV-1 genes have an average size of 81 nucleotides with a
standard deviation of 83 nucleotides (excluding the two-tailed 5% most extreme data
points). In fact, 260 of the 366 PBCV-1 genes have less than 100 nucleotides between
them. Using this definition, many of the putative viral promoter regions are located in an
adjacent gene.

3.2. Three conserved sequences occur in the chlorella virus promoter regions. Using
AlignAce software, three highly conserved nucleotide sequences were identified in the
PBCV-1 promoter regions (Fig. 2). These sequences were optimized as described in the
Materials and Methods section to generate three sequences that range in size from 7 to 9
nucleotides (Table 1); one or more degenerate positions occur in two of the three
sequences. Some promoter regions contain more than one copy of either the same or
different conserved sequences. As reported in Fig. 3, most of the sequences occurred in
the -150 to 0 nucleotide region.
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Sequence ARNTTAANA. The sequence ARNTTAANA occurs in the promoter region in
91 of the 366 PBCV-1 genes (25%), in 90 of the 404 virus NY-2A genes (22%), and in
40 of the 329 MT325 genes (12%) (Table 2).

Relative to the entire genome, this

sequence is present within the 200-nucleotide promoter region 44% of the time in PBCV1, 49% of the time in NY-2A, and 37% of the time in MT325. Furthermore, the location
of the sequence is biased to nucleotide position -15 to -45, relative to the ATG translation
start codon (64% in PBCV-1, 66% in NY-2A, and 65% in MT325) (Fig. 3A). Thus the
region between nucleotides -15 and -45 is a hotspot for the ARNTTAANA sequence.

Sequence AATGACA. The sequence AATGACA occurs in the promoter region in 60 of
the 366 PBCV-1 genes (16%), in 74 of the 404 NY-2A genes (18%), and 25 of the 329
MT325 genes (8%) (Table 2). Relative to the entire genome, this sequence is present
within the 200-nucleotide promoter region in 54% of the PBCV-1 genes, 53% of the NY2A genes, and 25% of the MT325 genes. Furthermore, the AATGACA sequence is
biased to nucleotide position -60 to -90, relative to the ATG initiation codon (44% in
PBCV-1, 37% in NY-2A, and 33% in MT325) (Fig. 3B). These results indicate that the
region between nucleotides -60 and -90 is a hotspot for the AATGACA sequence. This
sequence resembles the consensus -35 element (TTGACA) in E. coli promoters.

Sequence GTNGATAYR. The sequence GTNGATAYR occurs in the promoter region in
49 of the 366 PBCV-1 genes (13%), 58 of the 404 NY-2A genes (14%), and 36 of the
329 MT325 genes (11%) (Table 2). Relative to the entire genome, this sequence is found
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specifically within the 200-nucleotide promoter region in 28% of the PBCV-1 genes,
22% of the NY-2A genes, and 21% of the MT325 genes. The location of the sequence is
biased to nucleotide positions -50 to -80, relative to the ATG initiation codon (39% in
PBCV-1, 38% in NY-2A, and 70% in MT325) (Fig. 3C). These results indicate that the
region between nucleotides -50 and -80 is a hotspot for the GTNGATAYR sequence.

Table 2. General characteristics of three conserved, putative promoter elements in
three chlorella viruses.

3.3. Occurrence of conserved sequences in PBCV-1 allowing a one base mismatch.
The presence of these three conserved sequences in the promoter regions was also
determined with one base mismatch in PBCV-1. Under complete stringency, 48% of the
366 PBCV-1 gene promoter regions contain at least one of the three conserved
sequences. With one base-pair mismatch, ARNTTAANA occurs in 306 (84%) of the
gene promoter regions, AATGACA occurs in 204 (56%) of the gene promoter regions,
and GTNGATAYR occurs in 155 (42%) of the PBCV-1 366 promoter regions. [Note:
some of the genes have two sequences located one or more times in the same promoter
region (supplement 1).] Allowing a one base mismatch, one of these three motifs is
present in all but 15 of the 366 PBCV-1 promoter regions. The locations of the
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Figure 3. The positional distributions of three conserved nucleotide sequences in the
gene promoter region of chlorella viruses PBCV-1, NY-2A, and MT325 with respect to
the ATG translation start codon.
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sequences with one base pair mismatch relative to the ATG translation start codon are
similar to the locations under complete stringency (results not shown).

3.4. The conserved motifs are not specific to direction or location within the genome.
None of the three conserved sequences exhibit a preference for direction or location
within the three viral genomes. This finding is not surprising because genes classified as
early or late occur throughout the PBCV-1 genome (Yanai-Balser et al., unpublished
results) and they are approximately equally positioned in both orientations.

3.5. Homologous virus genes often share similar motif patterns at conserved
locations. Viruses PBCV-1, NY-2A, and MT325 share many homologs (~80% of the
genes are conserved among the three viruses). Therefore, we examined the occurrence of
the conserved sequences among homologs in the three viruses.

Homologous gene

products often share similar motif patterns at conserved locations relative to the ATG
translation start site (supplement 1). For example, a putative VLTF2-type transcription
factor is a gene product encoded by all three viruses. Homologs in each of the viruses
have the same motif (ARNTTAANA) in a similar location (-32, -31, and -33 nucleotides
from the ATG translation start codon in viruses PBCV-1, NY-2A and MT325,
respectively). Furthermore, if a specific motif occurs outside of the expected promoter
region (e.g. outside of the -50 and -80 region for GTNGATAYR), homologous genes
contain the motif in a similar location. For example, a gene encoding a putative PBCV-1
replication factor C protein subunit (a417l) contains the GTNGATAYR sequence
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beginning at -146.

The homologous gene in NY-2A contains the same sequence

beginning at nucleotide ±142. This sequence is not present in the MT325 replication
factor C gene homolog.

3.6. Conserved sequences in the promoter region of homologous genes often contain
identical nucleotides at degenerate positions. In addition to conserved sequences in
their promoter regions, homologous genes often have similar nucleotide preferences at
degenerate nucleotide positions within those sequences. Two of the three conserved
nucleotide sequences (ARNTTAANA and GTNGATAYR) have degenerate nucleotide
positions, and conserved nucleotide preferences occur among homologs for each of these
two sequences. For example, the promoter region of the ribonucleotide reductase large
subunit gene (a629r in PBCV-1 and b832r in NY-2A) contains the sequence
*71*$7$<5 D VHTXHQFH ZLWK WKUHH GHJHQHUDWH QXFOHRWLGH SRVLWLRQV  $W WKH µ1¶
position, the PBCV-1 and NY-$ KRPRORJV FRQWDLQ D F\WLGLQH UHVLGXH  $W WKH µ<¶
position, botKYLUDOJHQRPHVFRQWDLQDF\WLGLQHUHVLGXHDQGDWWKHµ5¶SRVLWLRQERWKYLUDO
genomes contain an adenine residue (Table 3).

Not surprisingly, the nucleotide

conservation at degenerate positions is more frequent between PBCV-1 and NY-2A than
between either of these viruses and MT325.

3.7. Motif AATGACA is strongly associated with PBCV-1 early gene expression. To
determine if there is a correlation between time of expression and the presence of a
putative promoter sequence in the PBCV-1 genes, we constructed a microarray
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Early/Late
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15%
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Figure 4. Distribution of three putative promoter motifs relative to when PBCV-1 genes
are expressed. Transcripts of genes classified as early/late are detected prior to the
beginning of DNA replication and are present after DNA synthesis begins.

containing probes from each gene in the genome. Competitive hybridization experiments
were conducted employing cDNA from poly A-containing viral RNAs obtained from
cells at 20, 40, 60, 90, 120, 240, and 360 min p.i., which allows us to follow global
transcription of PBCV-1 replication.
The microarray results established that PBCV-1 transcripts fall into two groups:
(i) early genes (59%), expressed before 60 min p.i. (the beginning of DNA synthesis) and
(ii) late genes (41%), expressed after 60 min p.i. However, transcripts of 42% of the
early genes are also present at late times after infection, referred to as early/late genes in
Fig. 4 (Yanai-Balser et al., unpublished results).
Most of the genes with the AATGACA sequence are expressed early during
infection (83%); transcripts from 24% of these early genes are also present after virus
DNA synthesis begins (Fig. 4).

The remaining 17% of the genes containing the

AATGACA sequence are expressed late.
The other two sequences, ARNTTAANA and GTNGATAYR, have a no
correlation with expression time.

Sixty percent of the genes with the sequence

ARNTTAANA are transcribed early; transcripts from 56% of these early genes are also
present after virus DNA synthesis begins. The remaining 40% of the genes with the
ARNTTAANA sequence are expressed late.

Likewise, 60% of the genes with the
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sequence GTNGATAYR in the promoter region are transcribed early and 25% of these
genes produce transcripts that are also detected late during infection. The remaining 40%
of the genes containing the GTNGATAYR sequence are expressed late. However, since
60% of the total genes are expressed early and 40% of the total genes are expressed late,
there is no correlation with time of expression and these two sequences.

Table 3. Examples of homologous proteins of known function containing promoter motifs
with conserved nucleotides at degenerate positions.

Bold nucleotides represent non-degenerate positions. A (-) denotes either a
homolog does not exist or a homologous protein does not contain the motif. Degenerate
positions are as follows: N = A/C/G/T, R = A/G, and Y = C/T
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3.8. Promoter elements in related viruses. This is the first attempt to identify promoter
elements by bioinformatic procedures in the phycodnaviruses. However, two previous
reports described conserved nucleotide sequences in promoter regions that are associated
either with a single chlorella virus gene, a gene encoding a potassium ion channel protein
[11], or with 23 immediate early expressed genes in chlorella virus CVK2 [12]. The
motif identified in the immediate early genes by Kawasaki et al. (ATGACAA) is similar
to a motif identified in this manuscript (AATGACA), which also correlated with early
transcripts.
The phycodnaviruses probably share a common evolutionary ancestry with the
poxviruses, iridoviruses, asfarviruses, and the mimivirus [13, 14, 15].

All of these

viruses have nine gene products in common and at least two of these viral families have
an additional 41 homologous ORFs [14]. Collectively, these large dsDNA viruses are
referred to as nucleocytoplasmic large DNA viruses [13].
A bioinformatics study on mimivirus identified an eight-nucleotide sequence,
AAAATTGA, which occurs in the putative promoter regions (-150 to 0) of 403 of the
911 (45%) mimivirus ORFs [16]. This element is specific to the mimivirus lineage and
the authors suggest that the element may correspond to an ancestral promoter structure
predating the radiation of the eukaryotic kingdom.
In the iridovirus, Chilo iridescent virus (CIV), 5 nucleotides (AAAAT) located
between

-19 and -15 have been described as essential for promoter activity [17].

Interestingly, this promoter sequence is not only in the putative promoter regions of other
CIV genes but also in other iridoviruses.

Conserved nucleotide sequences in the
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promoter regions of the poxviruses [18] and the asfarvirus, African swine fever virus
[19], have also been reported.

4. CONCLUSIONS
This study identified three conserved 7 to 9 nucleotide sequences that probably
function as promoter elements in the chlorella viruses. One of these sequences is
associated primarily with early viral gene transcription and is likely to serve as a
promoter for early genes. One way to test these predictions is to place one or more of
these suspected early gene promoter regions in front of a late virus gene and determine if
the "late" gene is now expressed early. Unfortunately, these experiments are not possible
at the present time because procedures for manipulating the chlorella virus genomes are
lacking.
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5. SUPPLEMENT
5.1. Supplement Table 1. Putative PBCV-1, NY-2A and MT325 genes are grouped by
their functional categories. If a conserved nucleotide motif has been identified within the
promoter region of the gene, the sequence and location are noted.

DNA Replication, Recombination and Repair
PBCV-1
Gene
į'1$SRO\PHUDVH
Archaeo-eukaryotic primase

PCNA

Replication factor C

Sequence

NY-2A
Location

Gene

MT325
Location

Gene

a185r

b249r

a468r

b633r

GTCGATATG

-85

b633r

AATGACA

-71

b261l

AACTTAAGA

-29

GTCGATATG

-142

m430l

GTCGATATG

-83

m674r

b734r

GTCGATACA

-13

b734r

AATGACA

0

b734r

AATGACA

7

a193l

AACTTAAGA

-33

a574l
a417l

AGATTAAAA

-49

a417l

GTCGATACG

-146

b571l

RNase H

a399r

b547r

a456l

b623l

a583l
a544r

-28

ATP-dependent DNA ligase

m570l

AATGACA

37

m546r

b744l

m389r

ATPase (DNA packaging)
Pyrimidine dimer-specific
glycosylase

a392r

b536r

m586l

Exonuclease

a166r

-29

-61

m014r

a554/556/557l

AACTTAACA

GTCGATATA

m664l

ATPase (PP-loop)

a050l

Location

m697l

b781l
AACTTAATA

Sequence

m019l

b767l

Helicase-Superfamily III
DNA Topoisomerase II

Sequence

b076l

m627l

b214r

m215r

Transcription
PBCV-1

Transcription factor TFIIB
Transcription factor TFIID

Transcription factor TFIIS
VLTF2-type transcription factor

Superfamily II helicase

NY-2A

MT325

Gene

Sequence

Location

Gene

Sequence

Location

Gene

a107l

AATGACA

-86

b154l

AATGACA

-25

m139l

a552r

AATTTAAAA

-147

b743r

AATTTAAAA

-7

b743r

GTCGATATG

-73

a125l

b175l

Sequence

Location

m266r

GTCGATATA

-78

m163l

AGATTAATA

-33

m163l

GTCGATATA

-62

AACTTAACA

-33

GTCGATATA

-60

a482r

AATTTAAGA

-32

b647r

AATTTAAGA

-31

m635r

a153r

AAATTAAGA

38

b203r

AACTTAATA

-9

m201r

a241r

AATGACA

-61

b203r

AAATTAAGA

38

a241r

AAATTAAAA

-8

b316r

a241r

GTCGATACG

-75

b508r

m225l
m372r

a363r
mRNA guanylyltransferase

a103r

AATGACA

-56

b148r

AATGACA

-84

m133r

AGCTTAAAA

-44

RNA triphosphatase

a449r

AACTTAACA

-30

b612r

AACTTAACA

-36

m399l

AGCTTAACA

-41

a612l

AATGACA

7

b268l

m727l

AATGACA

10

a612l

GTGGATATG

41

b813l

a548l

AATGACA

-147

b738l

AATGACA

-70

a548l

AATGACA

-140

b738l

AATGACA

-63

a548l

AATGACA

-133

Histone H3, Lys 27 methylase
SWI/SNF chromatin remodeling
complex
SWI/SNF helicase

a189/192r

b258r

m015l
m272l

138

RNase III

a548l

AATGACA

-126

a548l

AATGACA

-119

a548l

AATGACA

-112

a464r

AATTTAAGA

-7

b628r

AATTTAAGA

-27

a200r

AATGACA

-75

b271r

AATGACA

-20

a200r

AATGACA

0

b271r

AATGACA

0

m672l

AACTTAATA

13

m672l

GTCGATATG

-27

m010l

Cytosine deaminase

Sugar Manipulation
PBCV-1
Gene
D-lactate dehydrogenase
GDP-D-mannose dehydratase

NY-2A

Sequence

Location

Gene

Sequence

MT325
Location

a053r
a118r

AACTTAACA

-28

b163r

AACTTAACA

b163r

AATGACA

Location

0

-28

AATTTAAGA

-22

b395l

AACTTAAGA

-28

UDP-glucose 6-dehydrogenase

a609l

AGATTAACA

-101

b465r

AATTTAACA

-131

Glucosamine synthetase

a100r

Hyaluronan synthase

a098r

b143r

m719l
m037r
m128r

b139r

Chitin synthase

b472r

AAATTAAAA

-16
m354r

Cellulase precursor
b469l

Polysaccaride deacetylase
a064r
a111/114r
Glycosyltransferase

Sequence

m026l

a295l

Fucose synthase

Gene

AAGTTAATA

-83

a219/222/226r

b159r

m186r

AATGACA

-28

b618r

m467r

GTCGATATA

-78

m467r

GTTGATACA

-52

b736l

AACTTAAGA

-31

a473l

GTCGATATG

-88

m491r

a546l

AACTTAAGA

-90

m721l
m174l

dTDP glucose pyrophosphorylase

Lipid Manipulation
PBCV-1

Acetyltransferase

NY-2A

Gene

Sequence

Location

a254r

GTTGATACG

-60

Gene

N-acetyltransferase

a654l

b853l

Glycerophosphoryl diesterase

a049l

b075l

Lipoprotein lipase

a402r

Lysophospholipase

a271l

b354l

Patatin-like phospholipase

a173l

b226l

AGCTTAACA

-32

b550r

Sequence

MT325
Location

Gene

Sequence

Location

m758r

AGCTTAACA

-16

m564l

m219l

Cell Wall Degradation
PBCV-1

Chitinase

Chitosanase
ȕ ĮOLQNHGJOXFXURQLFO\DVH

ȕ-1,3-glucanase

NY-2A

MT325

Gene

Sequence

Location

Gene

Sequence

Location

Gene

a181/182r

AATTTAAAA

-28

b239r

GTCGATACG

-56

m085r

a260r

GTCGATATG

-68

a260r

GTTGATATG

-57

Sequence

Location

GTCGATATA

-101

m791r

a292l

b393l

m091r

a215l

b288l

m289r

b468r
a094l

AATGACA

-90

b137l

AATGACA

-14

a094l

AATGACA

-83

b137l

AATGACA

0

a094l

AATGACA

-76

a094l

AATGACA

-69

a094l

AATGACA

-62

a094l

AATGACA

-55

m124l

Signaling
PBCV-1

NY-2A

MT325

139

Gene

Sequence

Location

Gene

Sequence

Location

Potassium channel protein

a250r

Ligand-gated channel protein

a163r

Glutamate receptor

a162l

b336r
AGTTTAAGA

Sequence

Location

m183r

-36

m535l

Ca2+ transporting ATPase
Dual specificity phosphatase

Gene
m030r

Aquaglyceroporin

a305l

b430l

a034r

b331r

GTCGATATG

-13

a248r

m313l

AAATTAAAA

-28

m143l

AATTTAATA

-21

b331r

AATGACA

0

m221l

a277l

b331r

AATGACA

7

m543r

AATGACA

-76

a278l

b365l

AAATTAACA

-55

m729l

AAATTAAAA

-23

a282l

b368l

m729l

AATTTAATA

-9

a289l

b388l

m729l

AATGACA

-139

AATGACA

-80

Serine/Threonine protein kinase
GTCGATACG

-74

a614l

b816l

m733r

a617r

b818r

m794r

Integration and Tranposition
PBCV-1
Gene

Sequence

NY-2A
Location

a625r

Transposase

MT325

Gene

Sequence

Location

b080l

AATTTAACA

-37

b080l

AATGACA

-92

b334r

AATGACA

-73

b334r

AATGACA

0

b378l

AATTTAACA

-37

b378l

AATGACA

-92

b702l

AATGACA

0

b829r

AATTTAAAA

-144

b083l

AATTTAACA

-42

b083l

AATGACA

-97

b381l

AATTTAACA

-42

Gene

Sequence

Location

m150r

AACTTAACA

-11

b711l

Resolvase

Tlr 6Fp DNA mobile protein

a121r

b381l

AATGACA

-97

b715l

AATTTAACA

-42

b715l

AATGACA

-97

b168r

AAATTAATA

-25

a134l

AATTTAAGA

-37

b039l

a287r

AATGACA

-80

b185l

AACTTAAGA

-36

b185l

GTCGATACA

-47

a315l

m032l
m111r

a351l

AATGACA

-80

b206l

a351l

AATGACA

-73

b246r

m180l

a351l

GTTGATATA

-100

b286r

AAATTAATA

a495r

b286r

GTCGATACG

-71

m370r

AATGACA

-123

a539r

b286r

AATGACA

-58

m370r

AATGACA

-103
-83

-85

m288l

GTCGATATA

-60

m370r

AATGACA

-143

a651l

AATGACA

-64

b346l

GTCGATACA

-145

m370r

AATGACA

a651l

AACTTAAAA

-38

b346l

AATGACA

-77

m460r

AGGTTAACA

41

b389r

AATGACA

0

m465l

AATTTAACA

-90

b389r

AATGACA

7

m465l

GTCGATATA

-61

AATGACA

-62

GIY-YIG endonuclease

b433l

m502l

b440l

m517r

b497l

AATTTAAAA

-132

b497l

GTCGATATA

-142

b499l

GTCGATATA

-99

m683l

b602l

HNH endonuclease

a087r

AATGACA

-26

b629r

AATGACA

-46

b724r

AATTTAATA

-47

b724r

AATGACA

-53

b850l

GTCGATATG

-99

b022r

m069r

140

a267l

b061r

AATTTAATA

-29

m093l

a354r

b133r

AATGACA

-77

m578r

GTCGATATA

-60

a422r

b165r

m622l

GTCGATATA

-59

a478l

b173l

Gene

Sequence

Location

m375r

GTTGATATA

-27

AATGACA

-29

GTCGATATA

-59

m496l

AATTTAATA

-20

m488l

AATGACA

12

a490l

AATGACA

-37
-25

b173l

AATGACA

b199r

GTCGATACA

-71

b199r

AATGACA

-58

b218r

AATGACA

-55

b370l

AATGACA

-70

b370l

AATGACA

-63

AATGACA

-55

-81

b324l

b424l
b446r
b598l
b718l
b747l
b753l

AATGACA

b798r

AAATTAATA

-82

b798r

AATGACA

-62

b805r
b878l

Protein Synthesis, Modification and Degradation
PBCV-1

Translation elongation factor-3

Sequence

Location

a646l

AAGTTAATA

29

a085r

Thiol oxidoreductase

a465r

SKP-1 protein

Gene

Sequence

MT325
Location

a666l

Prolyl-4-hydroxylase

Protein disulfide isomerase

NY-2A

Gene

a448l

a039l

m742r
AATGACA

0

b126r

AATGACA

-29

b630r
AATGACA

AATGACA

-55

-76

m670r

b611l

GTTGATATA

-88

b611l

AATGACA

-66

b068l

AATGACA

-77

b068l

AATGACA

-64

m403r

m807r

b699l

Ubiquitin
a481l

AAATTAAAA

-88

b645l

AAATTAAAA

-45

Ring finger ubiquitin ligase

a481l

AACTTAAGA

-29

b645l

AACTTAAGA

-28

Ubiquitin C-terminal hydrolase

a105l

AGCTTAACA

-31

b150l

AGTTTAACA

-29

a521l

AACTTAATA

-44

b685l

a604l

AATGACA

-96

b803l

AAATTAAGA

-86

Zn metallopeptidase

m401r

a604l

AATGACA

-89

b803l

GTCGATATA

-73

a604l

GTTGATATA

-111

b803l

AATGACA

-59

m629l

m137l

Initiation factor 2
m489r

Nucleotide Metabolism
PBCV-1

NY-2A

MT325

Gene

Sequence

Location

Gene

Sequence

Location

Aspartate transcarbamylase

a169r

GTCGATACG

-80

b222r

AATTTAACA

-28

Ribo. Reductase (small subunit)

a476r
a629r

AATTTAAAA

-133

b832r

GTGGATACA

-105

a629r

GTCGATACA

-96

Ribo. Reductase (large subunit)

b641r

Gene

Sequence

Location

m653l

AATGACA

-97

m777l

AATGACA

-66

Deoxynucleoside kinase

a416r

dCMP deaminase

a596r

AATTTAAAA

-29

b795r

AATTTAACA

-33

m530l

a551l

GTTGATACG

-95

b741l

AAATTAAAA

-114

m264l

GTCGATATA

-78

b741l

GTTGATATA

-75

b865r

AATGACA

-78

m034l

GTCGATATA

-84

dUTP pyrophosphatase
Thymidylate synthase X

a674r

m425r

AATGACA

-84
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Glutaredoxin

Thioredoxin

a438l

b592l

m241l

AGCTTAAAA

-29

m423r
a427l

AATGACA

-47

a427l

AAATTAACA

32

b581l

AATGACA

-47

m445l

GTCGATATG

-61

m448l

AATTTAAGA

-30

m449l

DNA Restriction/Modification
PBCV-1
Gene

Sequence

NY-2A
Location

MT325

Sequence

Location

AAGTTAAAA

34

AATTTAAAA

-34

AATTTAAGA

7

-27

Gene

Sequence

Location

b010r

a251r
a581r

Gene

AAGTTAATA

-55

b016l
b230l
b236l
b359r
b399r

Adenine methyltransferase

b416r
b418r
b543l
b567l
b774r
a517l

AGTTTAAGA

-29

a530r

b008r

m359l

b088r

a683l
Cytosine methyltransferase

b411l

AACTTAACA

b566r

AACTTAACA

19

b681l

AATTTAAGA

-44

b681l

AATGACA

-60

GTCGATATG

-54

b697r
b769r
a252r

AATGACA

0

b361r

a579l

AATGACA

-17

b542r

a579l

AACTTAAAA

-29

a579l

GTTGATATA

-40

DNA restriction endonuclease

Miscellaneous
PBCV-1
Gene
Ornithine/Arginine decarboxylase
Agmatine iminohydrolase

a638r
a078r

Homospermidine synthase

a237r

Monoamine oxidase

NY-2A
Location

a207r

N-carbamoylput. amidohydrolase

Histidine decarboxylase

Sequence

a598l

GTTGATATG

-75

m307l

b844r

m766l

b116r

m103l

b305r
AAATTAATA

-51

AATTTAAGA

-33

b796l

GTCGATATA

-70

-20

b289l

AATGACA

-29

-10

b289l

AATGACA

0

a217l

AATGACA

0

a217l

AATGACA

33

AAATTAACA

-114

O-methyltransferase

a061l

b371l

a445l

Location

AATTTAATA

-33

m601l

m283r

m101r
m099r

b183l

FkbM Methyltransferase

Sequence

m233l

b796l

AATGACA

a284l

Gene

b278r

AATGACA

a245r

Fibronectin binding protein

MT325
Location

a217l

Amidase

ATPase (SequenceA+ class)

Sequence

a217l

Cu/Zn-superoxide dismutase

ABC transporter protein

Gene

m177l

b606l

GTCGATACG

-147

a044l

AAATTAATA

-40

b073l

AATTTAAGA

-29

a044l

AACTTAAAA

-32

b073l

GTTGATACA

-126

a180r

AAATTAATA

-8

m404r

m789l
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CHAPTER IV
CONCLUSIONS AND FUTURE PROSPECTS

1. OVERVIEW
Only recently, the role of viruses in the ecology of aqueous environments has
begun to be appreciated [1, 2, 3, 4]. Viruses are major players in the mortality of aquatic
microorganisms and, consequently, contribute to geochemical cycles as well as structure
of microbial communities [4]. Research focusing on individual viruses infecting
unicellular and multicellular algae has made progress in recent years, but the field of
algal virology is still in its infancy [5, 6, 7, 8, 9, 10, 11]. Questions about the long-term
effects of viral-mediated processes and their true biological potential in maintaining
aquatic communities remain unanswered.
To help recognize the importance of viruses in freshwater, we investigate the
virus PBCV-1 that infects the eukaryotic unicellular green alga, Chlorella NC64A. Since
its discovery in the early 1980s [12], many fascinating characteristics about this virus
have been found. For example, this virus has a large genome and it is predicted to encode
~365 proteins. PBCV-1 CDSs resemble genes from all domains of life. Some of the
PBCV-1 encoded proteins have been independently characterized by producing
recombinant proteins. There was, however, a big gap in the understanding of how, where,
and when viral gene expression occurs and if the 365 CDSs were transcribed. It was also
not clear how the expression of each CDS is regulated, and ultimately, how virus proteins
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take control of the host and drive the successful infection resulting in host cell lysis and
spread of progeny virion. In an attempt to find answers as to which and when PBCV-1
CDSs are expressed, we monitored virus transcription during the replication cycle in
Chlorella NC64A by microarray analysis. This allowed us to group each CDS with
respect to time of expression. The results from this study led to the following
conclusions: (i) most PBCV-1 CDSs (99%) are expressed during the virus life cycle in
laboratory conditions. However, many PBCV-1 CDSs are not essential for replication in
vitro because PBCV-1 deletion mutants (with deletions up to ~37 kb) produce viable
progeny [13]. Microarray analysis of other large DNA viruses also reveals expression of
the majority of genes (e.g., poxviruses, iridoviruses). (ii) PBCV-1 temporally regulates
the expression of each CDS and most late CDS expression depends on the onset of viral
DNA synthesis. This pattern is common for other viral systems (e.g., poxviruses and
iridoviruses). (iii) By classifying PBCV-1 CDSs according to time of expression and
putative function, it was determined that many of the early CDSs were involved with
virus DNA replication and many late CDSs were packaged in the virion.
This transcriptional study contributes to our understanding of PBCV-1 infection,
but it also raises many questions that are mentioned below.

-

Do PBCV-1 CDSs have additional promoters?
Although three sequences were found in many putative promoter regions of the

PBCV-1 genome, only one of them (5’-AATGACA-3’) correlates with early expression
of PBCV-1 CDSs (Chapter III). However, many early CDSs do not possess this sequence
and more importantly, no conserved putative promoter sequences were found for CDSs
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that are expressed early/late and late stages of infection. In Chapter III, the search for
putative promoter sequences is described and it primarily focused on a specific region (150 to +50 from the translation start site), assuming promoter sequences are found within
this range and also assuming they are ubiquitous. Rare promoter sequences are not easily
identified since they cannot always be distinguished from random background noise
using bioinformatics tools. Microarray results, as described in Chapter II, revealed that
35% of the PBCV-1 CDSs are transcribed early, 27% are transcribed early/late, and 37%
are transcribed late. The earliest time point analyzed was 20 min p.i., however, not all
early CDSs were detected at 20 min p.i. The same phenomenon was observed for late
CDS, not all late viral transcripts were detected at the same time post-infection. The
pattern is even more complicated for early/late CDSs, as their transcripts are detected at
different times, and sometimes, the transcript is present at an early time, then disappears,
and reappears at a late time. This suggests that there are additional promoters elements in
each transcriptional class that have not been identified.
Because ~80% of the PBCV-1 CDSs are conserved in other chloroviruses, it may
be possible to compare, for example, the promoter regions of all early PBCV-1 CDSs to
the promoter regions of their orthologs. Assuming CDSs with the same function are
transcribed at the same time during infection, and also assuming the promoter sequence is
conserved, it may be possible to find putative signals in this comparison

-

Assuming PBCV-1 is dependent on host transcription machinery, do viral

CDSs, promoters, and terminators resemble host genes?
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Now that the genome sequence of the host Chlorella NC64A is available and
assuming virus gene expression depends on host transcriptional machinery, it will be
interesting to search for the putative promoter sequences identified in PBCV-1 genome
and determine whether they are also found in the Chlorella NC64A genome. Also, if
putative promoter sequences are found in Chlorella, they should also be compared to the
putative promoter regions in the PBCV-1 genome. An experiment using the yeast-twohybrid system could be carried out to test if transcription factors from the virus or host
bind to the putative promoter sequences.

-

Are “minor” CDSs important for PBCV-1 replication?
All of the PBCV-1 CDSs described in this work were considered “major” CDSs;

i.e., protein encoding genes. “Minor” CDSs are also present in the virus genome and they
are mostly ignored. A CDS is classified as minor in PBCV-1 if: (i) it resides inside a
major CDS, regardless of orientation; (ii) if it overlaps within a major CDS, regardless of
orientation. However, mass-spectrometry analysis of virion-associated proteins (D.
Dunigan, unpublished results) has revealed several (~12) minor CDSs expressed and
found to be virion-associated. This indicates that some minor CDSs might have important
roles in PBCV-1 replication. In addition, preliminary analysis of the transcriptome
sequence of uninfected cells and PBCV-1 infected cells at 20 min p.i. reveals that some
of the minor CDSs are expressed.
Minor CDS microarray probes were not used in this study, thus it would be
interesting to check if they are expressed and when they are expressed. However, it is not
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trivial to distinguish a minor from a major CDS especially when they are co-localized in
the genome. Thus, the results from this type of experiment must be carefully interpreted.

-

Are predicted initiation and termination sites correct for PBCV-1 CDSs? Are

there additional introns in PBCV-1 CDSs?
In the microarray analysis, PBCV-1 CDSs were classified according to their
expression time, i.e., when hybridization occurred with the corresponding 50 nucleotidelong probe. The probes were designed to be specific and they correspond to various sites
within each known CDS. Thus, microarrays do not provide any information regarding
initiation and termination sites or intron regions.
As mentioned above, transcriptome mapping of PBCV-1 infected cells at 20 min
p.i. shows transcription of a few CDSs starting before the predicted start codon and bases
after the termination codon. The mapping also reveals the presence of introns that were
not previously identified. It will be important to repeat this experiment in order to
confirm these results.

-

Are some PBCV-1 messages are polycistronic?
We suspect that some of PBCV-1 messages are polycistronic because Northern

blot analyses revealed RNA bands running larger than their expected sizes from
denaturing agarose gels electrophoresis. However, a comprehensive characterization of
PBCV-1 transcripts and processing is lacking. We expect most CDSs to be monocistronic
because microarray analysis shows very few clusters with nearby genes showing the
same expression pattern.
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-

Where does PBCV-1 transcription occur?
It has been assumed that PBCV-1 DNA and some virion-associated proteins are

directed to the nucleus upon infection. This is in part because the virus lacks a
recognizable RNA polymerase gene and the assumption is that the virus uses the host
transcription machinery for expression of viral messages. Although a few viral proteins
(e.g. restriction endonucleases) likely go to the nucleus, there is no direct evidence that
the virus DNA goes to the nucleus.
The results obtained by the microarray analysis do not provide any evidence as to
where transcription occurs. However, if it is shown that virus promoters are similar to
host promoters, then this will probably indicate that the virus uses transcription
machinery from the host and consequently goes to the cell nucleus.

-

How does PBCV-1 transcription time correlate to translation time?
The presence of a transcript as indicated by the microarray may or may not

directly correlate with the presence of translation products. Western blots of a few
PBCV-1 proteins have shown a ~30 min lag after expression of the mRNA. However,
translation of the majority of PBCV-1 CDSs have not been analyzed.

-

Are mRNAs packaged in the virion?
Since virus transcription begins almost immediately after infection (within 2-5

min p.i.), it is possible that some messages required very early are packaged in the virion.
It is possible to test this hypothesis using the PBCV-1 microarray. Disrupted virus
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particles can be used for cDNA synthesis, and the product can later be fluorescently
labeled and hybridized with the probes in the microarray. It will not be surprising if some
mRNAs are packaged in the virion since viral messages can be detected as early as 5 min
p.i. [14]. However, recent calculations of transcription rates in vivo reveal that
transcription can occur as fast as 4.4 kb/min and the average PBCV-1 average CDS size
is 0.9 kb, which means it could be synthesized in ~ 15 seconds.

-

How is viral mRNA degradation carried out during infection?
PBCV-1 microarray analysis classified each viral CDSs according to the presence

of the transcript in the time points investigated. The presence of specific transcription
classes also indicates that the infected cell has a very efficient process for degrading virus
mRNAs. It is not known how this is regulated by the virus.
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APPENDIX I
CHLORELLA VIRUSES CONTAIN GENES ENCODING A
COMPLETE POLYAMINE BIOSYNTHETIC PATHWAY

1. OVERVIEW
Polyamines are small cationic organic molecules of vital importance for all living
organisms. The primary polyamines in eukaryotes are putrescine and the putrescinederived spermidine and spermine (Fig. 1A). Putrescine is formed either directly by the
decarboxylation of ornithine by ornithine decarboxylase (ODC) or indirectly from
arginine by the sequential action of arginine decarboxylase (ADC), agmatine
iminohydrolase (AIH, also known as agmatine deiminase), and N-carbamoylputrescine
amidohydrolase (CPA). Both pathways occur in plants although the model plant
Arabidopsis thaliana lacks an ODC gene [1] and is therefore completely dependent on the
ADC pathway. Putrescine is converted to spermidine by spermidine synthase (SPDS) and
S-adenosylmethionine decarboxylase; the latter enzyme produces decarboxylated Sadenosylmethionine (dcSAM) which serves as the aminopropyl donor for SPDS.
Spermine is synthesized in a similar way from spermidine and dcSAM by spermine
synthase. Although putrescine, spermidine,and spermine are the main polyamines in
eukaryotes, many other polyamines have been identified in nature that are either derived
from the putrescine pathway, such as 1,3-diaminopropane and homospermidine, or from
other precursors,e.g. cadaverine is derived from lysine [2].
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Figure 1. Polyamine biosynthesis pathways. (A) Overview. (B) Details of the reactions
catalyzed by agmatine iminohydrolase and N-carbamoylputrescine amidohydrolase.
ADC,

arginine

decarboxylase;

AIH,

agmatine

iminohydrolase;

CPA,

N-

carbamoylputrescine amidohydrolase; HSS, homospermidine synthase, ODC, ornithine
decarboxylase; SAMDC, S-adenosylmethionine decarboxylase; SPDS, spermidine
synthase; SPMS, spermine synthase.
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Polyamines are not only essential for living cells butthey also occur in the capsids
of many viruses and, in some cases, are important for virus multiplication (reviewed in
[3, 4]). In other systems, host polyamines are important for resistance against viruses
(reviewed in [4]).
The relationship between viruses and polyamines took a new turn with the
discovery that chlorella virus Paramecium bursaria chlorella virus (PBCV-1) (family
Phycodnaviridae) has genes encoding the two polyamine biosynthetic enzymes, ODC [5]
and homospermidine synthase (HSS) [7]. HSS synthesizes the rare polyamine
homospermidine from two molecules of putrescine (Fig. 1A). Although PBCV-1 ODC is
able to directly convert ornithine to putrescine, its preferred substrate is arginine [8];
consequently the PBCV-1 enzyme is referred to as ODC/ADC.
PBCV-1, the prototype chlorella virus, has a 331-kb dsDNA genome that
contains 366 putative protein-encoding genes and a polycistronic gene that encodes 11
tRNAs [9, 10]. PBCV-1 and another virus used in this study, NY-2A (370 kb genome),
infect Chlorella NC64A (NC64A viruses), which is an endosymbiont of the protozoan P.
bursaria that was originally isolated in North America. Other viruses, such as MT325
(314 kb genome) infect Chlorella Pbi (Pbi viruses), an endosymbiont of P. bursaria that
was isolated in Europe [11, 12].
The genes for the polyamine biosynthetic enzymes AIH and CPA from A.
thaliana were recently identified [12, 13, 14]. This identification was due to their
similarity to the corresponding enzymes from Pseudomonas aeruginosa PAO1, which
were identified previously [15, 16]. Database searches revealed that homologs of both
enzymes are also encoded by PBCV-1. Here we report the characterization of these genes
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and their products from PBCV-1, as wellas from chlorella viruses NY-2A and MT325.
Our results establish that chlorella viruses encode a complete polyamine biosynthetic
pathway that allows the formation of homospermidine from arginine via agmatine, Ncarbamoylputrescine, and putrescine.

2. MATERIALS AND METHODS
2.1 Cloning of viral genes for AIH and CPA. Isolation of viral DNAs has been
described [17]. The ORFs for the AIH and CPA proteins were amplified by PCR using
the DyNAazyme EXT DNA polymerase (Finnzymes, Espoo, Finland). Each forward
primer begins with an NdeI restriction site including an in frame start codon (CATATG),
the reverse primers omit the stop codon and end with XhoI restriction sites for in frame
cloning with the (His)6-tag of the pET-21b(+) vector (Novagen, Nottingham, UK). If
XhoI sites were present in the ORF, XhoI-compatible SalI restriction sites were used
instead. PCR products were T/A cloned into pGEM-T (Promega, Madison, WI). After
establishing that the PCR products were free of error by sequencing (MWG Biotech,
Ebersberg, Germany), the ORFs were cloned into the NdeI and XhoI sites of pET-21b(+).
The accession numbers for the virus genomes are U42580, DQ491002,
DQ491003, DQ491001, and DQ890022 for viruses PBCV-1, NY-2A, AR158, MT325,
and FR483, respectively. The DNA sequences can also be found at http://greengene.uml.
edu.

2.1 Expression of viral proteins in E. coli and purification of the (His)6-tagged
proteins. The proteins were expressed in E. coli strain CodonPlus (DE3) RIL
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(Stratagene, La Jolla, CA). Pre-cultures were grown overnight in 2YT medium [18]
containing ampicillin (100 μgmlí 1)and chloramphenicol (30 μgmlí 1)in an orbital
shaker (220 rpm) at 37 °C. The expression cultures were inoculated 1:10 in 2YT medium
(including ampicillin and chloramphenicol) with the pre-cultures. Optimized expression
conditions to produce the recombinant proteins are described in the Supplementary Table
S3.

Table1. Characteristics of AIH and CPA proteins from chlorella viruses in comparison
to the enzymes from Arabidopsis thaliana and Pseudomonas aeruginosa PAO1

Bacteria were harvested by centrifugation and stored frozen at í80 °C. For protein
purification the cell pellets were resuspended in 1/10 of the culture volume of lysis buffer
(50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 5 mM 2mercaptoethanol, 1 mg mlí 1
lysozyme) and incubated for 15 min on ice. Cell lysis was completed by sonification with
an ultrasound tip for 4×1 min at 50 W (Sonifier B17, Branson, USA). After removing the
insoluble material by centrifugation (Sorvall GSA rotor, 10,000 rpm, 10 min), the
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supernatant was loaded onto a Ni2+-NTA agarose (Qiagen, Hilden, Germany) column
(bed volume 2 ml), which was equilibrated in 50 mM sodium phosphate, pH 8.0, 300
mM NaCl, 10 mM imidazole. The column was washed with 50 mM sodium phosphate,
pH 8.0, 300 mM NaCl, 30 mM imidazole, and bound proteins were eluted in a total
volume of 2.5 ml with 50 mM sodium phosphate, pH 8.0, 300 mM NaCl, and 250 mM
imidazole. After desalting on PD-10 columns (GE Healthcare, Freiburg, Germany) into
50 mM potassium phosphate, pH 8.0 and 1 mM DTT (for the CPA proteins) or 50 mM
potassium phosphate, pH 8.0 and 0.5 mM DTT (for AIH proteins), the purified
recombinant proteins were frozen in 0.5 ml aliquots in liquid nitrogen and stored at í80
°C. Under these conditions the enzymes were stable for at least 2 months.

2.3 Enzyme assays. Enzymes assays were conducted in triplicates with a background
control in which the protein was inactivated by boiling for 10 min. The typical CPA assay
was performed in 50 mM MES, pH 6.0, 1 mM DTT, 1 mM N-carbamoylpu-trescine and
1μg ofprotein in a totalvolume of0.5 ml at 37 °C. The AIH assays consisted of 50 mM
potassium phosphate, pH 7.5, 0.5 mM DTT, 1mM agmatine and1μg protein in a total
volume of 1 ml and were incubated at 30 °C.
Activity was measured as the release of ammonia from the substrates (Fig. 1B).
Ammonia was detected with the indophenol blue method: a 100 μl aliquot of sample was
mixed with 100 μlof 0.33 Msodium phenolate, 0.02 Msodium hypochlorite (prepared
fresh daily), and 0.01% (w/v) sodium nitroprusside. The reaction was incubated for 3 min
in a boiling water bath and then 600 μlof water was added. The absorbance at 640 nm
was determined and compared to a calibration curve made with NH4Cl.
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Thin-layer chromatography was conducted on silica plates (PolygramSIL 201
G/UV254, Macherey-Nagel,Düren, Germany) that were developed in ethanol/NH4OH
(25%) 1:1. About 5 to 10 μlof sample was applied to the plates. Amines were detected by
spraying with ninhydrin (0.2% in ethanol).

Figure 2. Expression and purification of (His)6-tagged PBCV-1 AIH and CPA from E.
coli. About 10 μl each of bacterial crude extracts (CE) and the column flowthrough (FT)
were loaded on the gel. 2and 10 μlofthe AIH and CPAeluates (E) were loaded,
respectively. M: low-molecular weight markers.

2.4 RNA isolation. Infected chlorella cells (m.o.i. of 5) were collected at 20, 40, 60, 90,
120, 240, 360 min p.i. Cells were disrupted with glass beads in the presence of Trizol
(Invitrogen, Carlsbad, CA) and RNA was isolated using an Absolutely RNA Miniprep
Kit (Stratagene, LaJolla, CA) according to the manufacturer's instructions. RNA integrity
was verified in denaturing 1% agarose gels where intact host cytoplasmic and chloroplast
rRNAs were visualized.
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2.5 Microarray and dot blot analyses. A microarray containing 50-mer probes
representing each ORF in the PBCV-1 genome was constructed by MWG Biotech
(Ebersberg, Germany) and the Microarray Core Facility (University of Nebraska Medical
Center). Four replicas of the entire genome are present in each array. For each time point,
20 μgof total RNA was reverse-tr anscribed using oligo(dT) as primers and cDNA was
labeled with Cy3 or Cy5-dUTP (GE Healthcare, Piscataway, NJ) with the aid of a
SuperScript Indirect cDNA Labeling System (Invitrogen, Carlsbad, CA) following the
supplier's directions. Competitive hybridization experiments were conducted for each
time point against a pool of transcripts representing every gene present in the time course.
Results from three independent biological hybridizations were analyzed using the
GenePix Pro v.6.0 software (Molecular Devices, Sunnyvale, CA) and TIGR microarray
software suite (TM4) [19]. A number of transformations were performed in order to
eliminate low quality data, to normalize the measured intensities using the Lowess
algorithm, and to regularize the standard deviation of the intensity of the Cy3/Cy5 ratio
across the blocks. Genes that displayed statistically significant modulation were
identified by a one-way analysis of variance, using P values of <0.01 as a cutoff. Genes
with similar expression profiles were grouped into 10 different clusters using a K-means
algorithm.
Viral DNAs used for dotblots were denatured, applied to nylon membranes fixed
by UV cross-linking, and hybridized with 32Plabelled gene probes as described
previously [20].
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Figure 3. Enzymatic activities of PBCV-1 AIH and CPA. The release of ammonia (A)
as well as the turnover of the substrates to the products (B) were analyzed. Agmatine (1
mM) was incubated with PBCV-1 AIH (20 μg) for 90 min, then 15 μgof PBCV-1 CPAwas
added. C, Cƍ: controls with heat denatured enzyme after 10 and 240 min incubation,
respectively;

M:

standard

mixture

of

2mMeach

of

agmatine

(Agm),

N-

carbamoylputrescine (N-CP) and putrescine (Put).

2.6 Phylogenetic analysis. The amino acid sequences of PBCV-1 polyamine
biosynthesis enzymes were used to search the “non-redundant” dataset of GenBank using
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BLASTP [21]. All sequences showing similarities greater than 50% over the full
sequence were collected (between 30 and 130 entries) and multiple entries from the same
species were discarded. The remaining 30–70 sequences were aligned using the
DNAMAN program (version 5.2.2, Lynnon Corp., Vaudreuil-Dorion, Canada) and
sequences which obviously altered the alignment were discarded. A new alignment was
produced with the remaining sequences, extremely diverse N-and C-terminal sequences
were deleted, and neighbor-joining trees using Kimura distances and 1000 bootstrap
replicates were constructed with the DNAMAN software. These trees were used to
discard additional sequences in overrepresented monophyletic clades with high bootstrap
support. To root the trees paralogous sequences were included (arginine deiminase for the
AIH sequences and N-carbamoyl-ȕ-alanine amidohydrolase for the CPA sequences).
Again a new alignment was created with the remaining sequences (43 and 57 for the
AIHs and CPAs, respectively). From these alignments phylogenetic inference was
performed by Bayesian analysis using the MrBayes software (version 3.1.2; [22])
(gamma rates, model: mixed, 250,000 generations, burn-in: 25% of saved trees).

4. RESULTS
In the following sections we only show results obtained with recombinant AIH
and CPA proteins from PBCV-1 genes; results obtained with recombinant AIH and CPA
proteins from viruses NY-2A and MT325 will be mentioned in the text or, where
appropriate, listed in the tables.
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Table 2. Enzymatic properties of AIH and CPA proteins from chlorella viruses,
Arabidopsis thaliana, and Pseudomonas aeruginosa PAO1

a Not

determined (see text).

b From
C

[13].

From [16].

d From

[14].

3.1 Identification of aih and cpa genes in chlorovirus genomes. BLAST [21] searches
using the AIH and CPA sequences from A. thaliana revealed homologous genes encoding
both enzymes in the virus PBCV-1 genome. The predicted gene products from PBCV-1
open reading frames (ORF) A638R and A78R have 48% and 49% amino acid identity to
AtAIH and AtCPA, respectively (Table 1). Two other chlorella viruses have been
sequenced recently [23, 24], virus NY-2A that infects the same host as PBCV-1
(Chlorella NC64A) and virus MT325 that infects Chlorella Pbi. Both of these viruses also
contain putative AIH and CPA encoding genes (Table 1) as well as PBCV-1 ODC/ ADC
and HSS homologs (Table 3). The PBCV-1 AIH has 97% and 63% amino acid identity to
its NY-2A and MT325 homologs, respectively. Similar amino acid identities occur
between PBCV-1 CPA and its homologs from NY-2A and MT325 (97% and 68%amino
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acid identity, respectively). These values are similar to the amino acid identities of
PBCV-1 ODC/ ADC (86% and 63%) and HSS (93% and 69%) to their respective NY-2A
and MT325 homologs (see also Supplementary Fig. S1). The viral AIH proteins are 5 to
24 amino acids shorter than the enzymes from P. aeruginosa and A. thaliana, while all of
the CPA proteins are of similar size.

3.2 Chlorella virus AIH and CPA proteins are functional enzymes. We amplified the
aih and cpa genes from PBCV-1, NY-2A and MT325 genomes by PCR. Recombinant
proteins were expressed in Escherichia coli with C-terminal (His)6-tags and were
subsequently purified by metal affinity chromatography (Fig. 2). AIH proteins from
PBCV-1 and NY-2A were obtained as soluble proteins in large amounts (up to 20 mg
from 100 ml bacterial cultures), whereas the CPA proteins were expressed in lower
amounts (up to 1 mg from 300 ml cultures). In contrast, only small amounts of soluble
proteins were obtained from both MT325 genes (about 200 μg per 300 ml culture)
because most of the expressed proteins appeared in inclusion bodies.
A colorimetric ammonia assay was used to test the recombinant proteins for
activity because AIH and CPA each release ammonia from their presumed substrates in
stoichiometric amounts with their products (Fig. 1B). In addition, thin-layer
chromatography was used to verify the products of the two reactions as Ncarbamoylputrescine (for AIH) and putrescine (for CPA). PBCV-1 AIH produced
ammonia from agmatine, while at the same time N-carbamoylputrescine was formed
(Figs. 3A, B, 0–90 min). This N-carbamoylputrescine was subsequently converted to
putrescine with a concomitant release of more ammonia after addition of PBCV-1 CPA
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(Figs. 3A, B, 90–240 min). Thus, PBCV-1 AIH and CPAwere both functional enzymes
displaying their predicted activities. Similar results were obtained with recombinant
proteins from
NY-2A and MT325 (results not shown). When PBCV-1 AIH was heat-denatured
before assaying, no release of ammonia and no conversion of agmatine occurred, even
after prolonged incubation (Fig. 3B, lane Cƍ). This experiment also establishes that
agmatine is not a substrate for PBCV-1 CPA.

3.3 Enzyme characterization. The properties of both enzymes (pH and temperature
optima, m and kcat)were determined and the results are summarized in Table 2. The pH
optima of the viral AIH enzymes (pH 7.5)were similar to those from A. thaliana and P.
aeruginosa. In contrast, the viral CPA enzymes had highest activities in slightly acidic
conditions (pH 5.5–6.5), when compared to the CPA enzymes from A. thaliana and P.
aeruginosa (pH 8.0–9.0). The temperature optima for both enzymes from the Pbi virus
MT325 (20 °C for AIH and 30 °C for CPA) were slightly lower than the two enzymes
from the NC64A viruses and from A. thaliana and P. aeruginosa (Table 2).
The Km values were similar within each group of enzymes with the exception of
the P. aeruginosa enzymes, which had higher Km values for both enzymes. The protein
concentrations of the purified MT325 enzymes were so low that they could not be
reliably determined; therefore, we did not calculate kcat values for these two enzymes.
The kcat values for the other viral enzymes were similar to those obtained from A.
thaliana and P. aeruginosa enzymes.

167

Figure 4. Release of ammonia from agmatine and arcaine by PBCV-1 AIH. 40 μg of
protein was incubated with 1mM of the substrates and the released ammonia was
quantified at the indicated time points. In the second arcaine sample (third set of
columns) the protein was heat inactivated after 30 min (indicated with an arrow). The
dotted line shows the 1 mM level.

3.4 Substrate specificities. We tested the structurally similar compounds arginine,
arginine methyl ester, argininamide, and arcaine (1,4-diguani-dinobutane), which is a
derivative of agmatine (1-amino-4-guandinobutane), as possible substrates for PBCV-1
AIH. Under standard conditions (0.5 μg protein/ml, 1mM substrate, 30 °C, 30 min), no
ammonia was released from arginine, arginine methyl ester or argininamide. However,
increased amounts of enzyme (80 μg/ml) and prolonged incubation (1 and 2 h), resulted
in very weak activity with arginine methyl ester (0.2 nkat/mg protein). In contrast,
arcaine was a relatively good substrate for the viral AIH enzymes (Fig. 4); the specific
activity of PBCV-1 AIH with arcaine was only 4-fold less than with agmatine (results not
shown). Arcaine has been reported to inhibit plant AIH enzymes [25, 26]. These authors
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reported about 28% to 50% inhibition of maize AIH with 1 or 2 mM arcaine; 2 mM
arcaine inhibited A. thaliana recombinant AIH by 39% (Janowitz and Piotrowski,
unpublished results). Therefore, we were surprised that arcaine was a substrate for the
viral AIHs. We tested the plant AtAIH and also observed release of ammonia from
arcaine by this enzyme (results not shown). Although arcaine has two guanidino groups,
only one molecule of ammonia per molecule of arcaine is released initially by the viral
enzymes. However, prolonged incubation with the enzyme results in the release of
ammonia that clearly exceeds the molar amount of arcaine (Fig. 4). This result can be
explained if the product of the first reaction, 1-carbamoyl-4-guanidinobutane, is also a
substrate for the viral AIH but the specific activity of the enzyme for this substrate is
lower.

Figure 5. Expression of PBCV-1 polyamine biosynthesis genes during the infection
cycle as revealed by microarray analyses. Color code represents the log2 (Cy5/ Cy3)
ratio for each time point and has Cy3 as a reference.

We tested N-carbamoyl-D, L-aspartic acid, N-carbamoyl-ȕ-alanine, and Lcitrulline as substrates for the viral CPA enzymes. However, no ammonia was released
from any of these compounds indicating that they are not substrates for the viral CPA
enzymes.
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3.5 Expression of PBCV-1 polyamine biosynthesis genes during infection. The
expression of the PBCV-1 aih and cpa genes during virus replication was monitored by
Northern blot (results not shown) and by microarray analyses (Fig. 5). Both genes are
expressed only within the first 20 to 40 min of infection. Since PBCV-1 DNA replication
begins between 60 and 90 min p.i. [27], aih and cpa are early expressed genes. Their
expression overlaps with expression of the PBCV-1 odc/ adc gene (ORF A207R) that is
also expressed early (Fig. 5 and [5]). However, the PBCV-1 odc/adc gene is also
expressed late (from 90 to 360 min) and, therefore, also overlaps with expression of the
hss gene (ORF A237R) that is a typical late gene (Fig. 5). The aih and cpa transcripts are
each about 1600 nt in size as revealed by Northern blot analyses (results not shown).
These are appropriate sizes for the AIH and CPA proteins, which are 359 and 298 amino
acids, respectively.
Immediate early genes (detectable expression within the first 5 to 10min after
infection) often have ATGACAA sequences in their predicted promoter regions [28].
However, this sequence was absent in the putative promoter regions of aih and cpa genes
from all three viruses (data not shown).

3.6 Occurrence of aih and cpa genes in other chlorella viruses. To determine if the aih
and cpa genes are common among the chlorella viruses, a638r and a78r were hybridized
to DNA isolated from 37 additional viruses that infect Chlorella NC64A and 5 viruses
that infect Chlorella Pbi. The a638r (aih) probe hybridized to some extent with all 37
NC64A viruses (Fig. 6A). The a78r (cpa) probe hybridized to 33 of the NC64A viruses
(Fig. 6B). Neither probe hybridized to the host DNA or to the 5 Pbi virus DNAs. These
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results suggest that the aih gene is common in all of the NC64A viruses and that the cpa
gene might be absent in a few NC64A viruses, i.e. NYs-1, IL-5-2s1, MA-1D, and NY2B, or that the nucleotide sequence is sufficiently different from the PBCV-1 cpa gene so
that hybridization is not detected. The lack of hybridization to the 5 Pbi viruses by both
genes is very likely due to differences in their nucleotide sequences.

Table 3. Polyamine biosynthesis ORFs in several chlorella viruses

New sequencing projects have identified aih and cpa genes, as well as odc/adc
and hss genes, in the NC64A virus AR158 [24] and in a new chlorella virus, ATCV-1,
that infects endosymbiontic chlorella from the heliozoon Acanthocystis turfacea [29]
(Table 3, unpublished results). However, a newly sequenced Pbi virus, FR483, lacks the
aih gene, but contains the other three polyamine biosynthetic genes [23].

3.7 Phylogenetic analysis of viral polyamine biosynthesis genes. Neighbor-joining
phylogenetic analyses of the polyamine biosynthetic gene products (ADC/ODC, AIH,
CPA, and HSS) of PBCV-1, NY-2A, AR158, MT325, and FR483 and of 30–60
homologs from other species resulted in four trees in which the virus sequences formed
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monophyletic clades with bootstrap support of 100%, indicating that the last common
ancestor of the NC64A and Pbi viruses already contained these genes. Additionally, all
four trees supported the monophylly of the NC64A and the Pbi viruses with 100%
bootstrap support (data not shown and Supplementary Fig. S2).
Previous studies indicate that the PBCV-1 HSS enzyme is bacterial-like [6] and
phylogenetic analyses depict the PBCV-1 ODC/ADC protein arising near the ancestral
origin of the ODC clade [5, 7]. Aih and cpa genes are common in bacteria and plants; in
Pseudomonas aeruginosa PAO1 both genes are organized in an operon [15] and they are
also clustered in many other bacteria (Supplementary Fig. S2). However, determining the
ancestors of the viral aih and cpa genes was difficult because of apparent horizontal gene
transfer events, indicated by the unusual groupings of sequences from distant bacterial
species (e.g. Firmicutes together with Ȗ-Proteobacteria), and by the absence of a clear
plant–bacteria split (Supplementary Fig. S2). Therefore, we cannot unequivocally
determine if the viral aih and cpa genes are of bacterial or plant origin.
Polyamine biosynthesis genes have only been found in chlorella viruses and are
absent in viruses from the other five Phycodnaviridae genera. Therefore, the chlorella
viruses either acquired these genes after separation from the other phycodnaviruses or the
genes were lost by the other phycodnaviruses during evolution. It is interesting that the
G+C content of the four genes encoding the polyamine biosynthetic enzymes is always
higher than the mean G+C content of their respective viral genomes (Table 4). This
higher G+C content is especially striking for the cpa gene. Deviation of the G+C content
of a gene from the mean G+C is often interpreted as a sign of a recent horizontal gene
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transfer [30]. Therefore, maybe the chlorovirus polyamine biosynthesis genes were
acquired after separation from the other phycodnaviruses.

Figure 6. Hybridization of the PBCV-1 aih gene (A) and cpa gene (B) to DNAs isolated
from the host Chlorella NC64A, 37 NC64A viruses and 5 Pbi viruses (CVA-1, CVB-1,
CVG-1, CVM-1, and CVR-1). The DNAs were hybridized with a

32

P-labelled a638r

(aih)gene probe (A) or a a78r (cpa)gene probe (B). The blots in each row contain 1, 0.5,
0.25, and 0.12 μgof DNA from left to right, respectively.
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4. DISCUSSION AND CONCLUSIONS
The importance of polyamines in virus replication has often been discussed in the
literature (reviewed in [3, 31]) and these discussions can be summarized as follows: i)
Polyamines, primarily putrescine, spermidine and spermine, are present in large amounts
in the capsids of some viruses where they can neutralize up to 50% of the viral nucleic
acid (e.g. [3, 32, 33, 34]). In contrast, other viruses are devoid of polyamines (e.g. [35]).
ii) Virus infection often leads to an increase in polyamine biosynthesis and consequently,
in the polyamine content of infected cells [36, 37]. iii) Depletion of intracellular
polyamine pools (e.g. by using inhibitors of polyamine biosynthesis) inhibits the
replication of some viruses but not others (e.g. [38, 39, 40, 41]).

These previous studies assumed that the polyamines associated with virus
replication are synthesized by host enzymes. However, this assumption is no longer valid
for all viruses because two genes encoding functional polyamine biosynthetic enzymes
were recently discovered in the chlorella virus PBCV-1, an ODC/ADC [5, 7] and a HSS
[6]. As reported here, PBCV-1 and at least two other chlorella viruses, NY-2A and
MT325, have two additional genes that encode functional AIH and CPA enzymes. Thus,
PBCV-1, and most likely NY-2A and MT325, encode a complete ADC pathway that
converts arginine to putrescine (ODC/ADC proteins from NY-2A and MT325 have not
been tested for activity). Consequently, these viruses are not dependent on their hosts for
polyamine biosynthesis.
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Table 4. G+C content of the chlorella virus genes encoding polyamine biosynthetic
enzymes.

The fact that all four polyamine biosynthetic encoding genes are present in most
chloroviruses, as shown by Southern blot analyses (Fig. 6; [5, 6]) and genomesequencing projects (Table 3), suggests that these proteins are important for chlorella
virus replication. However, at least one chlorella virus, FR483, which infects Chlorella
Pbi lacks an aih gene [23]. The other three genes encoding polyamine biosynthetic
enzymes are present in all chlorella viruses sequenced to date. Chlorovirus is the only
genus within the family Phycodnaviridae, currently consisting of 6 genera [42], with
genes encoding polyamine biosynthetic enzymes; thus, either polyamines are especially
important for chlorella virus replication or the chlorella host, in contrast to other algal
hosts, is unable to provide the necessary amounts of polyamines for virus replication. The
results also indicate that the chlorella viruses either acquired these enzymes after
separation from the other phycodnaviruses or that all of the phycodnaviruses originally
had the polyamine biosynthetic genes and that they have been selectively lost by the other
phycodnaviruses during evolution. However, one should keep in mind that only a few
other phycodnavirus genomes have been sequenced [43] and so the concept that only
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chlorella viruses encode these enzymes could change as more algal virus genomes are
sequenced. It may not be relevant, but one distinction between the chlorella viruses and
members of the five other phycodnavirus genera is that the chlorella viruses exist in fresh
water and the other viruses occur in marine environments.
Unfortunately, not much is known about polyamine metabolism in chlorellae.
ADC and ODC activities were reported in Chlorella vulgaris Beijerinck [44, 45]. The
related green alga Chlamydomonas reinhardtii only uses the ODC pathway to synthesize
putrescine [46]. However, although Chlamydomonas lacks an adc gene it has aih and cpa
genes (available at: http:// genome.jgi-psf.org/Chlre3/Chlre3.home.html), but, according
to EST data, they are not expressed. It is unknown if Chlorella NC64A and Chlorella Pbi
possess a complete ADC pathway consisting of ADC, AIH and CPA; if they do the host
chlorella AIH may functionally replace the absent viral AIH in FR483 during infection.
The genome of Chlorella NC64A, the host for PBCV-1 and NY-2A, is currently being
sequenced and annotation of its sequence will provide information on its polyamine
biosynthetic capability. However, it is unlikely that the four PBCV-1 polyamine
biosynthetic genes are acquired from Chlorella NC64A because none of the four virus
genes hybridize with Chlorella NC64A DNA (Fig. 6A, B; [5, 6]).
PBCV-1 aih and cpa genes are transcribed as early genes, appearing within the
first 20 min p.i. Their expression overlaps with transcription of the PBCV-1 odc/adc gene
so that all three putrescine biosynthetic enzymes are presumably present early in
infection. Therefore, one might expect the polyamine levels to increase during the first 60
min of PBCV-1 infection. However, little change occurs in either the polyamine
concentration

or

its

composition

(putrescine,

cadaverine,

spermidine,

and
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homospermidine are present) during the first 60 min of virus infection [6]. By 240 min
p.i., the concentration of putrescine increases about 3.5 times, whereas the other
polyamines decrease duringthis time. The net result is that the total polyamine
concentration decreases slightly during virus replication [6]. It is unlikely that polyamines
play a role in the neutralization of PBCV-1 DNA in the capsid because the number of
polyamine molecules per PBCV-1 virion is so low that they can only neutralize 0.2% of
the virus phosphate residues [6]. Furthermore, the physiological significance of the
polyamines in the PBCV-1 particles must be limited because they are only loosely
associated with the virions, i.e. they can be replaced by Tris or displaced by washing the
particles in a polyamine-free buffer without affecting virus infectivity [6].
The dual expression pattern (early and late) of the viral genes encoding the
polyamine biosynthetic enzymes may indicate that putrescine (early in viral replication)
and homospermidine (late in viral replication) have different functions in virus
replication. It should be mentioned that the HSS protein, but not the other three
polyamine biosynthetic enzymes, is a major component of PBCV-1 virions (Dunigan et
al., manuscript in preparation). Therefore, the HSS protein may also serve a structural
role in the virus life cycle.
In summary, most of the chlorella viruses have four genes that encode functional
enzymes involved in polyamine biosynthesis. However, the biological function(s) of
these enzymes and their products is currently an enigma.
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APPENDIX II
CHLORELLA VIRUSES ENCODE MOST, IF NOT ALL, OF THE
MACHINERY TO GLYCOSYLATE THEIR GLYCOPROTEINS
INDEPENDENT OF THE ENDOPLASMIC RETICULUM AND GOLGI

1. VIRUS ENCODED GLYCOSYLTRANSFERASES
Structural proteins of many viruses, such as rhabdoviruses, herpesviruses,
poxviruses, and paramyxoviruses are glycosylated. Most virus glycoproteins, which can
have very complex glycans, are linked to Asn via N-acetylglucosamine, although some
viruses have O-linked sugars attached to Ser or Thr residues via an amino sugar, usually
acetylglucosamine or acetylgalactosamine. Typically, viruses use host-encoded
glycosyltransferases and glycosidases located in the endoplasmic reticulum (ER) and
Golgi apparatus to add and remove N-linked sugar residues from virus glycoproteins
either co-translationally or shortly after translation of the protein. This post-translational
processing aids in protein folding and involves other host-encoded enzymes such as
protein disulfide isomerase.

After folding and assembly, virus glycoproteins are

transported by host sorting and membrane transport functions to virus specified regions in
host membranes where they displace host glycoproteins.

Progeny viruses then bud

through these virus-specific target membranes, which is usually the final step in the
assembly of infectious virions [1-4]. Thus, nascent viruses only become infectious by
budding through the membrane, usually the plasma membrane, as they are released from
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the cell. Consequently, the glycan portion of virus glycoproteins is host-specific. The
theme that emerges from these studies is that virus glycoproteins are synthesized and
glycosylated by the same mechanisms as host glycoproteins. Therefore, the only way to
alter glycosylation of virus proteins is to either grow the virus in a different host or have a
mutation in the virus protein that alters the protein glycosylation site.
One outcome of this scenario is that, in general, viruses lack genes encoding
glycosyltransferases.

However, a few virus-encoded glycosyltransferases have been

reported in the last few years (see review [5]).

Sometimes these virus-encoded

glycosyltransferases add sugars to compounds other than proteins. For instance, some
phage-encoded glycosyltransferases modify virus DNA to protect it from host restriction
endonucleases [e.g., 6-8], and a glycosyltransferase encoded by baculoviruses modifies a
host insect ecdysteroid hormone leading to its inactivation [9]. Bovine herpesvirus-4
encodes aҏ E-1,6-N-acetyl-glucosaminyltransferase that is localized in the Golgi and is
probably involved in post-translational modification of virus structural proteins [10-12].
Additional putative virus encoded glycosyltransferases of unknown function include
certain pox viruses [13, 14], Ectocarpus siliculosus virus 1 [15], Ostreococus virus OsV5
[16], Acanthamoeba polyphaga Mimivirus [17], and two Archaea viruses, Acidianus
filamentous virus 3 [18], and Sulfolobus virus STSV1 [19]. With the rapid increase in
sequencing virus genomes, additional virus encoded glycosyltransferases will
undoubtedly be discovered.
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Figure 1. A ribbon diagram of the crystal structure of the virus PBCV-1 major capsid
protein, Vp54, monomer with strategic amino acids labeled. The carbohydrate moieties
(yellow) and glycosylated Asn and Ser residues (blue and gray, respectively) are shown
as space-filling atoms. The green and red regions indicate the consecutive "jelly roll"
domains of the protein. The arrow shows the orientation of the protein from the inside to
the outside of the virus. Reproduced from [62].

One group of viruses that differs from the scenario that viruses use the host
machinery located in the ER and Golgi to glycosylate their glycoproteins is the
chloroviruses (family Phycodnaviridae) that infects eukaryotic algae. Phycodnaviruses
are large (150 to 190 nm in diameter) polyhedral, dsDNA-containing viruses with an
internal lipid membrane (genomes of 170 to 560 kb) [20-23]. They are present in aqueous
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environments throughout the world and play dynamic, albeit largely unknown, roles in
regulating algal communities in aqueous environments, such as the termination of
massive algal blooms commonly referred to as red and brown tides [e.g., 24-27]. Some
phycodnaviruses encode as many as 600 proteins, which is more protein-encoding genes
than in the smallest bacteria.
The phycodnaviruses probably have a common ancestor with the poxviruses,
iridoviruses, African swine fever virus, and Mimivirus [e.g., 28-30], and accumulating
evidence indicates that the phycodnaviruses have a long evolutionary history, possibly
dating from the time eukaryotes arose from prokaryotes (2-3 billion years ago) [e.g., 3032]. Some algal virus genes encode commercially important enzymes such as DNA
restriction endonucleases [e.g., 33, 34], whereas other viral genes encode proteins that are
the smallest in their class and may represent the minimal catalytic unit. Consequently,
these ‘small’ proteins serve as models for mechanistic and structural studies (e.g., DNA
topoisomerase type II [35] and a K+ ion channel protein [36]).
Phycodnavirus members in the genus Chlorovirus are plaque-forming viruses that
infect certain isolates of unicellular, chlorella-like green algae. The prototype chlorella
virus Paramecium bursaria chlorella virus (PBCV-1) infects a host, Chlorella NC64A,
that is normally a symbiont in the protozoan P. bursaria. The 330 kb PBCV-1 genome
has ~690 potential open reading frames (ORFs) of 65 codons or larger [20]. About 365
of these ORFs are predicted to encode proteins (CDSs) and the functions of 35-40% of
these CDSs have been tentatively identified. Pertinent to this review is that 17 of the
PBCV-1 genes encode enzymes that manipulate sugars, many of which have never been
found previously in a virus (Table 1). At least five of the enzymes are putative
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glycosyltransferases, presumably involved in glycosylation of the PBCV-1 major capsid
protein Vp54. [Note: in our original report on the annotation of the PBCV-1 genome we
identified 7 PBCV-1 encoded glycosyltransferases [37]. However, two of these CDSs,
which were co-linear with an adjacent glycosyltransferase, were the result of sequencing
errors and are part of the adjacent glycosyltransferase.]

Figure 2. A ribbon diagram of the crystal structure of the glycosyltransferase domain
from virus PBCV-1 CDS A64R. Bound Mn2+ and citrate ions are shown in a ball-andstick representation. Alpha (purple) and beta sheets (pink) are color coded. Reproduced
from reference [70] with permission.
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2. CHLOROVIRUS ENCODED SUGAR ENZYMES
Three PBCV-1 encoded enzymes are involved in the synthesis of the extracellular
matrix polysaccharide hyaluronan (also referred to as hyaluronic acid), including the
glycosyltransferase hyaluronan synthase (HAS) [38, 39].

Hyaluronan, a ubiquitous

constituent of the extracellular matrix in vertebrates, consists of ~20,000 alternating E1,4-glucuronic acid and E-1,3-N-acetylglucosamine residues [40]. Hyaluronan synthesis
occurs at the plasma membrane and is simultaneously extruded through the membrane to
the exterior of the cell. Until the has gene was discovered in PBCV-1, hyaluronan was
thought to only occur in vertebrates and a few pathogenic bacteria, where it forms an
extracellular capsule, presumably to avoid the immune system [40, 41].
PBCV-1 also encodes two enzymes involved in the biosynthesis of hyaluronan
precursors,

glutamine:fructose-6-phosphate

dehydrogenase [42].

amidotransferase

and

UDP-glucose

All three genes are expressed early during PBCV-1 infection.

These results led to the discovery that hyaluronan lyase-sensitive hair-like fibers begin to
accumulate on the surface of PBCV-1 infected host cells by 15 min post infection (p.i.).
By 4 hr p.i., the infected cells are covered with a dense fibrous hyaluronan network [39].
The has gene is present in many, but not all, chloroviruses isolated from diverse
geographical regions [39]. Surprisingly, many chloroviruses that lack a has gene have a
gene encoding a functional chitin synthase (CHS). Furthermore, cells infected with these
viruses produce chitin fibers on their external surface [43]. Chitin, an insoluble linear
homopolymer of

-1,4-linked N-acetyl-glucosamine residues, is a common component

of insect exoskeletons, shells of crustaceans and fungal cell walls [44].
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A few chloroviruses contain both has and chs genes, and form both hyaluronan
and chitin on the surface of their infected cells [43, 45]. Finally, a few chloroviruses
probably lack both genes because no extracellular polysaccharides are formed on the
surface of cells infected with these viruses [39]. The fact that many chloroviruses encode
enzymes involved in extracellular polysaccharide biosynthesis suggests that the
polysaccharides, which require a huge expenditure of ATP for their synthesis, are
important in the virus life cycle. However, at present this function(s) is unknown.

Table 1. Virus PBCV-1 encoded enzymes involved in sugar manipulation.

1

The time the genes were expressed was determined by microarray analysis (Yanai-Balser, G.M. et al.,
manuscript in preparation).

2

Another name is GDP-4-keto-6-deoxy-D-mannose epimerase reductase.
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The chloroviruses encode additional enzymes involved in nucleotide sugar
metabolism. Two enzymes encoded by virus PBCV-1, GDP-D-mannose 4,6 dehydratase
(GMD) and a GDP-4-keto-6-deoxy-D-mannose epimerase reductase (GMER) comprise
the highly conserved pathway that converts GDP-D-mannose to GDP-L-fucose. In vitro
reconstruction of the biosynthetic pathway using recombinant PBCV-1 GMD and GMER
synthesized GDP-L-fucose [46, 47]. Unexpectedly, however, the PBCV-1 GMD also
catalyzes the NADPH-dependent reduction of the intermediate GDP-4-keto-6-deoxy-Dmannose, forming GDP-D-rhamnose. Both fucose and rhamnose are constituents of the
glycans attached to the PBCV-1 major capsid protein Vp54 (see below). Therefore, the
virus might encode the enzymes to meet this need. Other chloroviruses encode additional
sugar metabolizing enzymes including a putative mannose-6-phosphate isomerase and a
UDP-glucose 4,6 dehydratase [48] (Tonetti, M. et al., unpublished data).
At least ﬁve PBCV-1-encoded enzymes are involved in polysaccharide
degradation, including 2 chitinases, a chitosanase, a

-1,3-glucanase, and a

- and

-

1,4-linked glucuronic acid lyase (summarized in [21], [49-51]). Finally, one enzyme is a
glycosylase that initiates pyrimidine photodimer excision [52, 53].

3. GLYCOSYLATION OF VIRUS PBCV-1 MAJOR CAPSID PROTEIN VP54
The major capsid protein of PBCV-1, Vp54 (comprises ~40% of total virus
protein), is a glycoprotein with a molecular weight of 53,790 (Table 2). Glycosylation of
Vp54 and two minor structural proteins Vp280 (~1% of the total virus protein) and
Vp260 (~0.1% of total virus protein) differs from other viruses. CDS A430L encodes
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Vp54 with a predicted molecular weight of 48,165 Da. This protein undergoes additional
post-translational modifications in addition to being glycosylated. The amino terminal
Met is removed [54] and the protein is myristylated in the carboxyl-terminal portion of
the protein, probably at an internal Lys or Arg [55]. Vp260 is coded by CDS A122/123R,
a protein of 138 kDa. Since the protein migrates on SDS-PAGE with a weight of ~260
kDa, it probably consists of more than 40% carbohydrate. The CDS encoding Vp280 is
unknown.
Cryo-electron microscopy and three-dimensional (3-D) icosahedral image
reconstruction of the PBCV-1 virion indicate that the outer capsid is icosahedral and
covers a lipid bilayered membrane [56, 57]. The capsid shell consists of 1,680 donutshaped trimeric capsomers plus 12 pentameric capsomers at each icosahedral vertex. The
trimeric capsomers are arranged into 20 triangular facets (trisymmerons, each containing
66 trimers) and 12 pentagonal facets (pentasymmetrons, each containing 30 trimers and
one pentamer at the icosahedral vertices). Trisymmetrons and pentasymmetrons are
made up of trimeric capsomers, with each doughnut shaped capsomer composed of 3
monomers of Vp54. The trimeric capsomers are easy to isolate because heating PBCV-1
to 65oC for a few minutes leads to solubilization of the trimers. However, the monomer
form of Vp54 is insoluble.
Recent five-fold symmetry, rather than icosahedral, averaging of cryoelectron
microscopy data has produced some exciting results on the structure of PBCV-1 [58].
PBCV-1 has a unique pentameric vertex with a 250 Å long and 50 Å wide cylindrical
spike that connects to a large pocket between the capsid and the enveloped nucleocapsid.
Circumstantial evidence suggests that Vp260 may be a component of the spike structure,
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which presumably is involved in virus attachment.
The conclusion that the PBCV-1 proteins are glycosylated by a different
mechanism than those used by other viruses originally arose from antibody studies.
Polyclonal antiserum prepared against intact PBCV-1 virions inhibits virus plaque
formation by agglutinating particles. Spontaneously derived, antiserum-resistant, plaqueforming variants of PBCV-1 occur at a frequency of 10-5 to 10-6. These antiserumresistant variants fall into four serologically distinct classes (Table 2) [59]. Polyclonal
antisera prepared against members of each of these antigenic classes react exclusively or
predominately with the Vp54 (and Vp280 and Vp260) equivalents from the viruses in the
class used for the immunization.

While each of the three glycoproteins from the

antigenic variants migrate faster on SDS-PAGE than those of the strains from which they
are derived, all of the major capsid proteins co-migrate after deglycosylation. Western
blot analyses of Vp54 proteins isolated from the variants, before and after removing the
glycans with trifluoromethane-sulfonic acid or altering the glycan with periodic acid,
established that the antigenic variants reﬂect differences in the Vp54 glycans. In addition,
the ratio of the seven neutral sugars [glucose, fucose, galactose, mannose, xylose,
rhamnose and arabinose [59] attached to PBCV-1 Vp54 and the variants change in a
manner that correlates with antigenicity and Vp54 migration on SDS-PAGE (Table 3).
Variants from different classes can complement and recombine in dual infection
experiments to produce wild-type progeny, indicating that the enzymes involved in
glycosylation reside in different virus-encoded complementation groups [60].
Additional observations indicate that Vp54 glycosylation is unusual: i) Unlike
viruses that acquire their glycoprotein(s) by budding through a plasma membrane, intact
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infectious PBCV-1 particles accumulate inside the host 30-40 min before virus release
[61]. ii) The nucleotide sequence of the Vp54 gene (a430l) in each of the variants is
identical to wild type PBCV-1, thus the peptide portion of Vp54 is not altered in the
mutants [59]. iii) All of the antigenic variants are grown in the same host so the
differences cannot be attributed to the host. iv) Polyclonal antibodies to Vp54 do not
react with host glycoproteins.

v) Neither N-acetylglucosamine (GlcNAc) nor N-

acetylgalactosamine were detected in Vp54 glycans, sugars commonly found in Asnlinked (N-linked) and many Ser/Thr-linked (O-linked) glycoproteins produced via the
cellular ER-Golgi pathway (Table 3) [59]. vi) Unlike most glycoproteins that exhibit size
microheterogeneity, Vp54 appears homogeneous on SDS-PAGE; in addition, mass
spectrometry analysis only reveals one satellite peak that differs in molecular weight by
140 Da, the approximate weight of either one arabinose, xylose, fucose or rhamnose
sugar (Cerny, R. and Van Etten, J.L., unpublished data). vii) The ability to easily
crystallize Vp54 as a homotrimer provides additional evidence that the protein is
essentially homogeneous (Fig. 1) [62].
The glycans are not linked to the major capsid proteins by a traditional N-linkage
because: i) treatment of Vp54 with the enzymes endo-E-N-acetylglucosaminidase F or Nglucosidase F, which cleave glycans from N-linked glycoproteins [63], does not alter
Vp54 migration on SDS-PAGE (Chaney, W.G. and Van Etten, J.L., unpublished data).
ii) The drug tunicamycin, which inhibits synthesis of N-linked glycoproteins [64], has no
effect on PBCV-1 replication nor Vp54 electrophoretic mobility, even at concentrations
three times that required to inhibit host chlorella growth [55]. Finally, an antibody
(provided by Felix Wieland) to a Eglucose Asn linkage present in bacterial
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glycoproteins [65] reacts strongly with Vp54 (Gurnon, J.R. and Van Etten, J.L.,
unpublished data), suggesting that one or more of the Asn linked glycans in Vp54 have
this linkage. This same linkage exists in the B2 chain of mammalian laminin, a major
basement membrane glycoprotein [66].

Table 2. Properties of antigenic classes of viruses derived from PBCV-1.

a

Calculated by subtracting the deduced peptide mass minus the N-terminal initiating Met residue (48,017)

and the mass of one myristate (228.4) from the MW determined by mass spectrometry. All the protein
backbones are identical.
b

nd, not determined.

Modified from [60].

We originally suggested that Vp54 had a single ~30mer glycan or two-15mer
glycans attached to it [60]. However, the Vp54 crystal structure revealed sugars attached
to six amino acids in the protein (Fig. 1) [62]. Comparison of the molecular mass of
Vp54 (53,790 Da) with its predicted molecular weight from the amino acid sequence
(48,165 Da) indicates that the protein contains 30-35 sugar moieties, of which 20 could
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be detected, but not identified, in the crystal density map. At a minimum, single sugars
were found attached to Ser57 and Ser387; six and seven-branched chain sugar moieties
were found attached to Asn280 and Asn302, respectively, as well as three and two sugar
residues were located at Asn399 and Asn406, respectively. As predicted from the antibody
results, the four N-linked glycans are on the external surface of the virus. GlcNAc fits
the carbohydrate electron density at residues Asn280, Asn302, and Asn399. However, the
inability to detect GlcNAc in Vp54 suggests that another modified sugar might be in this
position, e.g., glucose with an O-linked acetate.
The identification of the glycan-linked Asn residues in Vp54 provided additional
evidence that Vp54 glycosylation does not involve host glycosyltransferases. Asn302,
Asn399, and Asn406 occur in the amino acid sequence (A/G)NTXT, and Asn280 occurs in
an ANIPG sequence.

None of these Asn residues reside in a NX(T/S) sequence

commonly recognized by ER located glycosyltransferases [67]. These findings also
explain why previous enzymatic tests for N-glycosylation were negative. Finally, the
major capsid protein, like the glycosyltransferases, lacks an ER or Golgi signal peptide.
Therefore, taken together, the results suggest that PBCV-1 encodes some, if not all, of the
enzymes involved in constructing the glycans attached to Vp54.

4. PBCV-1 ENCODED GLYCOSYLTRANSFERASES
As mentioned above, five putative glycosyltransferase-encoding genes have been
found in PBCV-1, which are scattered throughout the PBCV-1 genome (Table 1). None
of these PBCV-1 encoded glycosyltransferases have an identifiable signal peptide that
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would target them to the ER. Furthermore, the cellular protein localization program
PSORT predicts that all of these proteins, with the exception of A473L, are located in the
cytoplasm. A473L is predicted to contain one transmembrane domain.
The genes for all five PBCV-1 encoded glycosyltransferases are expressed early
during PBCV-1 infection (Yanai-Balser, G.M. et al., manuscript in preparation). Thus,
assuming the proteins are stable, the enzymes should be available for either adding sugars
to the Vp54 glycans or transferring the glycans. The a430l gene is expressed late.
PBCV-1 a64r gene. The PBCV-1 a64r gene encodes a 638 amino acid protein
with 4 motifs that are conserved in the "fringe-class" of glycosyltransferases [68, 69].
Five conserved domains, designated 1-5, have been identified in this class of enzymes
[69]. Domains 3 and 5 contain the proposed catalytic amino acids, the "DXD" sequence
in domain 3 and the first "D" residue in domain 5. The A64R protein contains domains
2-5 although the spacing between some of the domains differs from that of fringeglycosyltransferases. As mentioned above, the A64R protein lacks both an identifiable
signal peptide that would target the protein to the ER and a membrane-spanning domain
in contrast to fringe glycosyltransferases.
Analysis of 13 PBCV-1 antigenic variants revealed mutations in a64r that
correlated with a specific antigenic class, EPA-1 (Table 2). The a64r gene in six of these
antigenic variants was sequenced to determine if mutations in a64r correlated with the
EPA-1 antigenic variation [60]. The a64r sequences from mutants EPA-1, EPA-3, and
P31 have single nucleotide substitutions, which produce a single amino acid substitution
in the A64R protein. Two of the amino acid substitutions occur in the DXD motif
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(domain 3) and the other one is in domain 4. A fourth variant has an extra base in the
coding sequence, which creates a frame shift mutation in the gene. Finally, the entire
gene is deleted in the other two antigenic variants.
Dual infection experiments with the different antigenic variants indicate that
viruses containing wild-type a64r complement and recombine with viruses that contain
variant a64r to form wild-type virus. Therefore, we concluded that a64r encodes a
glycosyltransferase involved in the synthesis of the Vp54 glycan [60].

5. STRUCTURE OF PBCV-1 ENCODED A64R GLYCOSYLTRANSFERASE
Blast searches with the 638 amino acid A64R protein established that the
glycosyltransferase domains are located in the amino-terminal 211 amino acids. The
A64R carboxyl terminus resembles several bacterial proteins of unknown function.
The amino-terminal A64R glycosyltransferase domain (residues 1-211) was
expressed in a bacterial system for crystallization studies. The crystal structure of the
peptide was solved at 1.6 Å resolution (Fig. 2) [70]. The peptide has a mixed
containing a central, six-stranded

sheet flanked by

/

fold

ҏhelices. The overall fold is

similar to catalytic domains of glycosyltransferases in the GT-A group, retaining
glycosyltransferase family 34, although the amino acid similarity between them is low
(less than 14% for equivalent C

atoms). Crystal structures of A64R complexed with

UDP, CMP, or GDP, established that only UDP bound to A64R in the presence of Mn2+,
consistent with its high structural similarity to glycosyltransferases that use UDP as the
sugar carrier. The structure of the A64R, UDP-glucose, and Mn2+ complex showed that
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the largest conformational change occurred when hydrogen bonds were formed with the
ligands. Unlike UDP-glucose, UDP-galactose and UDP-GlcNAc did not bind to A64R,
suggesting a selective binding of UDP-glucose. Thus UDP-glucose is most likely the
sugar donor for A64R, consistent with glucose occurring in the virus major capsid protein
glycans (Table 3).
However, no enzymology has been conducted on the A64R peptide, or any of the
other virus encoded glycosyltransferases because the structure of the Vp54 glycans are
unknown. Consequently, the substrate(s) for A64R or any of the putative viral
glycosyltransferases are unknown.

Table 3. Sugar composition of the glycoproteins from PBCV-1 serotypes.

Values are normalized to that of glucose. The mutants are arranged so that the major capsid protein
decreases in size from PBCV-1 to P100.

Viruses EPA-1 and P31 and viruses P41 and E11 are

serologically similar even though they are separate isolates. Viruses P91, EPA-1, P31 and P41 are derived
from PBCV-1; virus E11 is derived from EPA-1; and virus P100 is from P31. Ara/Rham,
arabinose/rhamnose. (Reproduced from [59]).
*Subsequent experiments established that both Ara and Rham are present in the PBCV-1 major capsid
protein.
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6. WHERE DOES VP54 ACQUIRE ITS GLYCANS?
A brief description of the PBCV-1 life cycle follows. PBCV-1 infects its host
Chlorella NC64A by attaching rapidly, probably at a unique virus vertex [71, 58] via one
of its vertices, to the algal cell wall, followed by degradation of the wall at the point of
attachment [72]. After digestion of the wall, the PBCV-1 internal membrane presumably
fuses with the host membrane to translocate virus DNA and probably some virus
associated proteins to the inside of the host, leaving an empty capsid on the surface.
Two observations suggest that upon infection PBCV-1 DNA and probably DNAassociated proteins quickly move to the nucleus and commandeer at least some of the
host transcription machinery to initiate early viral RNA synthesis; early virus transcripts
can be detected within 5-10 min p.i. [73, 74]. i) PBCV-1 does not encode a recognizable
RNA polymerase gene(s) nor is RNA polymerase activity detected in isolated virions
(Rohozinski, J. and Van Etten, J.L., unpublished data). ii) A small intron with splice-site
sequences characteristic of nuclear-spliced mRNAs exists in the PBCV-1 DNA
polymerase gene [75]. Presumably, this intron is excised in the cell nucleus.
Viral DNA synthesis begins between 60 and 90 min p.i., followed by late viral
transcription [76, 73]. Virus assembly begins ~3 hr p.i. in localized regions of the
cytoplasm called virus assembly centers. By 6-8 hr p.i., virus induced host cell lysis
occurs and results in the release of progeny viruses (~1000 virus particles per cell of
which ~25% are infectious) [72].
The intracellular location of virus protein glycosylation is unknown, although
gold-labelled Vp54 antibody only reacts with proteins in the virus assembly centers
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(Graves, M.V., Gurnon, J.R. and Van Etten, J.L., unpublished data).

This finding

suggests that Vp54 might acquire its glycans in the virus assembly centers.

Table 4.

Glycosyltransferase-like genes encoded by six viruses that infect three

Chlorella species*.

*CDS’s listed in the source line across are considered to be orthologs. The amino acid sequences of each
of them are available at http://GreenGene.uml.edu. Viruses PBCV-1, NY-2A and AR158 infect Chlorella
NC64A, viruses MT325 and FR483 infect Chlorella Pbi and virus ATCV-1 infects Chlorella SAG 3.83.

7. HOW ARE SUGARS ADDED TO VP54?
The structures of the glycans attached to Vp54 are unknown and we are happy to
collaborate with anyone who wants to solve their structures. The prediction is that the
glycan structures differ from typical glycans because it is unlikely that the host ER and
Golgi apparatus are involved in adding sugars to PBCV-1 Vp54.

Vp54 lacks a

recognizable ER signal peptide and so presumably, it does not enter the ER. However,
one can ask the question: Are the sugars added to Vp54 either sequentially or are they
synthesized independently of Vp54, possibly on a lipid carrier, and then attached to the
protein in a single step?

A slight variation of these two possibilities is to synthesize a
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core glycan(s) independently of the protein and attach it to Vp54. This core glycan(s),
which could be either larger or smaller than the final product, is processed further after
attachment to the protein.
To distinguish between these possibilities [2,6-3H]-galactose was added to cells at
the time of PBCV-1 infection and cells collected at various times p.i. [We are aware that
galactose can be converted to other products.] After disrupting the cells, SDS-soluble
materials were separated on SDS-PAGE, and labeled material viewed via fluorography
(Fig. 3) (Graves, M.V. and Van Etten, J.L., unpublished data). Vp54 first appears
between 60 and 90 min p.i. and is a tight homogeneous band suggesting that the fully
synthesized glycans are transferred to the Vp54 peptide "en mass" [Note: the Vp54
equivalent from antigenic variant EPA-1 is easily distinguished from wild type Vp54
even though it is only 2,230 Da smaller; the slightly smaller variant Vp54 from mutant
E11 can be distinguished as well (Fig. 3)] It is interesting that a slowly migrating
radioactive smear is present at the top of the gel first appearing between 15 and 30 min
p.i., prior to the appearance of Vp54; the smear increases in intensity to 90 min p.i. and
then becomes less intense as Vp54 intensifies. Could this "smear" be an intermediate(s)
in the synthesis of the Vp54 glycan?

Interestingly, the appearance of this smear

correlates with the expression of A64R, as well as the other putative glycosyltransferases;
each of the glycosyltransferase gene transcripts begin to be detected at 20 to 40 min p.i.
(Table 3; [Yanai-Balser, G.M. et al., manuscript in preparation]). Note: the smear is
absent in normal cells even after 5 hr of continuous labeling (Fig. 3, lane U).
Assuming the Vp54 glycan precursors are transferred "en mass", one predicts that
they are attached to a lipid carrier such as either undecaprenol-phosphate, which is the
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carrier for bacterial peptidoglycans and cell surface polysaccharides [77], or
dolicholdiphosphate, which is the carrier in eukaryotic cells [67]. It is unlikely that
dolicholphosphate is the carrier because tunicamycin, which interferes with the transfer
of UDP-N-acetylglucoseamine to dolicholphosphate [64], has no effect on either PBCV-1
replication or Vp54 synthesis, even at concentrations three times that required to inhibit
host chlorella growth [55].

8. GLYCOSYLTRANSFERASES CODED BY OTHER CHLORELLA VIRUSES
Polyconal antibodies to wild type PBCV-1 and its antigenic variants do not react
with many other independent virus isolates that infect Chlorella NC64A (NC64A
viruses). This lack of cross-reactivity suggests that the major capsid proteins from these
non-reacting viruses have different glycans and as such these viruses code unique
glycosyltransferases. In addition, two other related virus/chlorella systems are available
for study, viruses that infect Chlorella Pbi (Pbi viruses) and Chlorella SAG 3.83 (SAG
viruses). None of the Pbi viruses or SAG viruses react with PBCV-1 antiserum.
We recently sequenced and annotated five additional chlorella viruses, two more
NC64A viruses [78], two Pbi viruses [79], and one SAG virus [48]. These newly
sequenced viruses encode from 3 to 6 putative glycosyltransferases (Table 4). The
PBCV-1 glycosyltransferase A111/114R is the only protein with an ortholog in all of the
viruses. The orthologs B618R and C559R from NC64A viruses NY-2A and AR158,
respectively, produce a high Blast score with N-acetyglucosaminyltransferases,
suggesting that N-acetylglucosamine might be present in their major capsid proteins. The
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major capsid proteins from NY-2A and AR158 clearly differ from PBCV-1 Vp54
because neither virus reacts with antibodies to PBCV-1 or any of its antigenic variants.
The sugar components of the major capsid proteins have not been determined for any of
these 5 newly sequenced viruses. The prediction is that the sugars will probably differ
both qualitatively and quantitatively from PBCV-1.

Figure 3. Total proteins isolated from virus PBCV-1 infected Chlorella NC64A at the
indicated times (min) p.i. The infection was done in the presence of [3H]-galactose.
Uninfected (lane U) cells were labeled for 300 min. Lanes labeled EPA and E11 contain
total proteins from cells at 120 min after infection with antigenic variant viruses EPA-1
and E11. The slower migrating "smear" described in the text is indicated by the bracket.
Proteins were separated on a 7.5% SDS-PAGE, and labeled proteins visualized by
autoradiography (Graves, M.V. and Van Etten, J.L., unpublished data).

9. IMPLICATIONS
The chlorella viruses contain genes encoding a variety of glycosyltransferases,
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most of which, if not all, lack a recognizable ER signal peptide. Furthermore, hundreds
of these viruses can be isolated easily from natural sources. We assume that different
glycosyltransferases use different sugars and form distinct linkages. Because all of the
virus-encoded glycosyltransferases lack ER signaling domains and most of them lack
transmembrane domains, the virus encoded recombinant glycosyltransferases are likely to
be soluble, which makes them easier to purify and use as reagents for adding sugars to
proteins.

10. CONCLUSION
Collectively, the results indicate that glycosylation of the PBCV-1 major capsid
protein differs from that of other viruses and that glycosylation probably occurs
independently of the ER and Golgi apparatus. Furthermore, most, if not all, of the
machinery to carry out this glycosylation is encoded by the virus. These conclusions lead
to many questions including: i) Could Vp54 glycosylation reﬂect an ancestral pathway
that existed prior to ER and Golgi formation in eukaryotic cells?

ii) Is PBCV-1

glycosylation similar to that of O-antigen-containing bacteria, which add a precise
number of sugars to the basal core polysaccharide [80].

iii) Are the Vp54 glycan

precursors synthesized and assembled on a lipid carrier? iv) How much diversity in the
number of glycosyltransferases and glycan structures exists among chlorella viruses? v)
What is the ultimate function of the capsid protein glycan?
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